Intel (INTC) 10-K 12 Feb 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($) shares in Millions, $ in Billions	12 Months Ended
	Dec. 26, 2015	Feb. 05, 2016	Jun. 26, 2015
Document and Entity Information [Abstract]
Entity Registrant Name	Intel Corporation
Entity Central Index Key	50,863
Company Fiscal Year End Date	--12-26
Entity Filer Category	Large Accelerated Filer
Document Type	10-K
Document Period End Date	Dec. 26, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Common Stock, Shares Outstanding		4,724
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 147.3

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Income Statement [Abstract]
Net revenue	$ 55,355	$ 55,870	$ 52,708
Cost of sales	20,676	20,261	21,187
Gross margin	34,679	35,609	31,521
Research and development	12,128	11,537	10,611
Marketing, general and administrative	7,930	8,136	8,088
Restructuring and asset impairment charges	354	295	240
Amortization of acquisition-related intangibles	265	294	291
Operating expenses	20,677	20,262	19,230
Operating income	14,002	15,347	12,291
Gains (losses) on equity investments, net	315	411	471
Interest and other, net	(105)	43	(151)
Income before taxes	14,212	15,801	12,611
Provision for taxes	2,792	4,097	2,991
Net income	$ 11,420	$ 11,704	$ 9,620
Basic earnings per share of common stock	$ 2.41	$ 2.39	$ 1.94
Diluted earnings per share of common stock	$ 2.33	$ 2.31	$ 1.89
Weighted average shares of common stock outstanding:
Basic (shares)	4,742	4,901	4,970
Diluted (shares)	4,894	5,056	5,097

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Statement of Comprehensive Income [Abstract]
Net income	$ 11,420	$ 11,704	$ 9,620
Other comprehensive income, net of tax:
Change in net unrealized holding gains (losses) on available-for-sale investments	(710)	577	1,181
Change in deferred tax asset valuation allowance	(18)	(41)	(26)
Change in net unrealized holding gains (losses) on derivatives	157	(427)	(89)
Change in net prior service (costs) credits	7	(33)	18
Change in actuarial valuation	128	(402)	520
Change in net foreign currency translation adjustment	(170)	(251)	38
Other comprehensive income (loss)	(606)	(577)	1,642
Total comprehensive income	$ 10,814	$ 11,127	$ 11,262

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Dec. 26, 2015	Dec. 27, 2014
Current assets:
Cash and cash equivalents	$ 15,308	$ 2,561
Short-term investments	2,682	2,430
Trading assets	7,323	9,063
Accounts receivable, net of allowance for doubtful accounts of $40 ($38 in 2014)	4,787	4,427
Inventories	5,167	4,273
Deferred tax assets	2,036	1,958
Other current assets	3,053	3,018
Total current assets	40,356	27,730
Property, plant and equipment, net	31,858	33,238
Marketable equity securities	5,960	7,097
Other long-term investments	1,891	2,023
Goodwill	11,332	10,861
Identified intangible assets, net	3,933	4,446
Other long-term assets	7,735	6,505
Total assets	103,065	91,900
Current liabilities:
Short-term debt	2,634	1,596
Accounts payable	2,063	2,748
Accrued compensation and benefits	3,138	3,475
Accrued advertising	960	1,092
Deferred income	2,188	2,205
Other accrued liabilities	4,684	4,895
Total current liabilities	15,667	16,011
Long-term debt	20,036	12,059
Long-term deferred tax liabilities	2,539	3,775
Other long-term liabilities	$ 2,841	$ 3,278
Commitments and contingencies (Notes 17 and 25)
Temporary equity	$ 897	$ 912
Stockholders' equity:
Preferred stock, $0.001 par value, 50 shares authorized; none issued	0	0
Common stock, $0.001 par value, 10,000 shares authorized; 4,725 shares issued and outstanding (4,752 issued and 4,748 outstanding in 2014) and capital in excess of par value	23,411	21,781
Accumulated other comprehensive income (loss)	60	666
Retained earnings	37,614	33,418
Total stockholders’ equity	61,085	55,865
Total liabilities, temporary equity, and stockholders’ equity	$ 103,065	$ 91,900

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) shares in Millions, $ in Millions	Dec. 26, 2015	Dec. 27, 2014
Current assets:
Accounts receivable allowance for doubtful accounts	$ 40	$ 38
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized	50	50
Preferred stock, shares issued	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	10,000	10,000
Common stock, shares issued	4,725	4,752
Common stock, shares outstanding	4,725	4,748

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Statement of Cash Flows [Abstract]
Cash and cash equivalents, beginning of period	$ 2,561	$ 5,674	$ 8,478
Cash flows provided by (used for) operating activities:
Net income	11,420	11,704	9,620
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	7,821	7,380	6,790
Share-based compensation	1,305	1,148	1,118
Restructuring and asset impairment charges	354	295	240
Excess tax benefit from share-based payment arrangements	(159)	(122)	(49)
Amortization of intangibles	890	1,169	1,242
(Gains) losses on equity investments, net	(263)	(354)	(425)
Deferred taxes	(1,270)	(703)	(900)
Changes in assets and liabilities:
Accounts receivable	(355)	(861)	271
Inventories	(764)	(98)	563
Accounts payable	(312)	(249)	267
Accrued compensation and benefits	(711)	4	155
Income taxes payable and receivable	386	(286)	1,019
Other assets and liabilities	675	1,391	865
Total adjustments	7,597	8,714	11,156
Net cash provided by operating activities	19,017	20,418	20,776
Cash flows provided by (used for) investing activities:
Additions to property, plant and equipment	(7,326)	(10,105)	(10,711)
Acquisitions, net of cash acquired	(913)	(934)	(925)
Purchases of available-for-sale investments	(8,259)	(7,007)	(12,493)
Sales of available-for-sale investments	2,090	1,227	934
Maturities of available-for-sale investments	6,168	8,944	8,336
Purchases of trading assets	(11,485)	(14,397)	(16,718)
Maturities and sales of trading assets	13,372	13,165	13,677
Investments in loans receivable and reverse repurchase agreements	(2,550)	(150)	(200)
Collection of loans receivable and reverse repurchase agreements	2,116	117	50
Investments in non-marketable equity investments	(2,011)	(1,377)	(440)
Purchases of licensed technology and patents	(120)	(92)	(36)
Other investing	735	704	453
Net cash used for investing activities	(8,183)	(9,905)	(18,073)
Cash flows provided by (used for) financing activities:
Increase (decrease) in short-term debt, net	(474)	235	(31)
Proceeds from government grants	105	104	129
Excess tax benefit from share-based payment arrangements	159	122	49
Issuance of long-term debt, net of issuance costs	9,476	0	0
Proceeds from sales of common stock through employee equity incentive plans	866	1,660	1,588
Repurchase of common stock	(3,001)	(10,792)	(2,147)
Restricted stock unit withholdings	(442)	(332)	(293)
Payment of dividends to stockholders	(4,556)	(4,409)	(4,479)
Collateral associated with repurchase of common stock	325	(325)	0
Increase (decrease) in liability due to collateral associated with repurchase of common stock	(325)	325	0
Other financing	(221)	(199)	(314)
Net cash provided by (used for) financing activities	1,912	(13,611)	(5,498)
Effect of exchange rate fluctuations on cash and cash equivalents	1	(15)	(9)
Net increase (decrease) in cash and cash equivalents	12,747	(3,113)	(2,804)
Cash and cash equivalents, end of period	15,308	2,561	5,674
Cash paid during the year for:
Interest, net of capitalized interest	186	167	204
Income taxes, net of refunds	$ 3,439	$ 4,639	$ 2,874

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) shares in Millions, $ in Millions	Total	Common Stock and Capital in Excess of Par Value [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]
Beginning Balance, shares at Dec. 29, 2012		4,944
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other, shares		130
Repurchase of common stock, shares		(94)
Restricted stock unit withholdings, shares		(13)
Ending Balance, shares at Dec. 28, 2013		4,967
Beginning Balance at Dec. 29, 2012	$ 51,203	$ 19,464	$ (399)	$ 32,138
Components of comprehensive income, net of tax:
Net income	9,620			9,620
Other comprehensive income (loss)	1,642		1,642
Total comprehensive income	11,262
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other	1,593	1,593
Share-based compensation	1,117	1,117
Repurchase of common stock	(2,147)	(345)		(1,802)
Restricted stock unit withholdings	(293)	(293)		0
Cash dividends declared	(4,479)			(4,479)
Ending Balance at Dec. 28, 2013	$ 58,256	$ 21,536	1,243	35,477
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other, shares		125
Repurchase of common stock, shares		(332)
Restricted stock unit withholdings, shares		(12)
Ending Balance, shares at Dec. 27, 2014	4,748	4,748
Components of comprehensive income, net of tax:
Net income	$ 11,704			11,704
Other comprehensive income (loss)	(577)		(577)
Total comprehensive income	11,127
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other	1,787	$ 1,787
Share-based compensation	1,140	1,140
Temporary equity reclassification	(912)	(912)
Repurchase of common stock	(10,792)	(1,438)		(9,354)
Restricted stock unit withholdings	(332)	(332)		0
Cash dividends declared	(4,409)			(4,409)
Ending Balance at Dec. 27, 2014	$ 55,865	$ 21,781	666	33,418
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other, shares		87
Repurchase of common stock, shares		(96)
Restricted stock unit withholdings, shares		(14)
Ending Balance, shares at Dec. 26, 2015	4,725	4,725
Components of comprehensive income, net of tax:
Net income	$ 11,420			11,420
Other comprehensive income (loss)	(606)		(606)
Total comprehensive income	10,814
Proceeds from sales of common stock through employee equity incentive plans, net tax deficiency, and other	1,076	$ 1,076
Share-based compensation	1,314	1,314
Temporary equity reclassification	15	15
Repurchase of common stock	(3,001)	(453)		(2,548)
Restricted stock unit withholdings	(442)	(322)		(120)
Cash dividends declared	(4,556)			(4,556)
Ending Balance at Dec. 26, 2015	$ 61,085	$ 23,411	$ 60	$ 37,614

Consolidated Statements of Sto8

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Retained Earnings [Member]
Cash dividends declared per common share (in dollars per share)	$ 0.96	$ 0.90	$ 0.90

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 26, 2015
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	Note 1: Basis of Presentation We have a 52- or 53-week fiscal year that ends on the last Saturday in December. Fiscal years 2015 , 2014 , and 2013 were 52-week years. Fiscal year 2016 is a 53-week fiscal year, and the first quarter of 2016 will be a 14-week quarter. Our consolidated financial statements include the accounts of Intel Corporation (Intel) and our subsidiaries. We have eliminated intercompany accounts and transactions. We use the equity method to account for equity investments in instances in which we own common stock or similar interests and have the ability to exercise significant influence, but not control, over the investee. We have reclassified certain prior period amounts to conform to current period presentation. As a result of our integration of McAfee Inc. (McAfee) in the third quarter of 2015, the functional currency for operations previously acquired from McAfee was changed to the U.S. dollar, making the U.S. dollar the functional currency for Intel and our subsidiaries.

Accounting Policies

Accounting Policies	12 Months Ended
	Dec. 26, 2015
Accounting Policies [Abstract]
Accounting Policies	Note 2: Accounting Policies Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include: • the valuation of non-marketable equity investments and the determination of other-than-temporary impairments; • the determination of useful lives for our property, plant and equipment and the related timing of when depreciation should begin; • the valuation and allocation of assets acquired and liabilities assumed in connection with business combinations; • the valuation and recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles); • the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions); • the valuation of inventory; and • the recognition and measurement of loss contingencies. The actual results that we experience may differ materially from our estimates. Fair Value Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Substantially all of our liabilities are not measured and recorded at fair value. Fair Value Hierarchy The three levels of inputs that may be used to measure fair value are as follows: Level 1. Quoted prices in active markets for identical assets or liabilities. Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions. Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data. For further discussion of fair value, see " Note 4: Fair Value " and " Note 16: Retirement Benefit Plans ." Cash Equivalents We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. See " Note 4: Fair Value " for the instruments held as cash equivalents. Trading Assets Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets. Available-for-Sale Investments We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments. Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the "Other-Than-Temporary Impairment" section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include: • Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net. • Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net. Non-Marketable and Other Equity Investments Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as: • Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net. • Non-marketable cost method investments when the equity method does not apply. We record the realized gains or losses on the sale of equity method and non-marketable cost method investments in gains (losses) on equity investments, net. Other-Than-Temporary Impairment Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows: • Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss). • Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net. • Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including: • the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects; • the technological feasibility of the investee’s products and technologies; • the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes; • the management and governance structure of the investee; • factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and • the investee’s receipt of additional funding at a lower valuation. We record other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net. Derivative Financial Instruments Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally, our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities. Our accounting policies for derivative financial instruments are based on whether they meet the criteria for hedge accounting designation. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction or variability in the functional currency equivalent cash flows of a recognized asset or liability are examples of cash flow hedges. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities. A designated hedge with exposure to changes in the fair value of a recognized asset or liability that are attributable to the changes in the benchmark interest rate is one example of a fair value hedge. For derivatives with fair value hedge accounting designation, the gains and losses of the hedge as well as the offsetting gains and losses attributable to the changes in the benchmark interest rate on the underlying hedged item are recognized in earnings in the current period. Derivatives that we designated as fair value hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from financing activities. We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, which we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Realized gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities or investing activities, depending on the activity the exposure is most closely associated with. Measurement of Effectiveness • Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included, and effectiveness is measured using forward rates to value both the hedge contract and the hedged item. • Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. • Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item. If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see " Note 6: Derivative Financial Instruments ." Securities Lending We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment and financing transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged. Loans Receivable We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see " Note 4: Fair Value ." Inventories We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Raw materials $ 532 $ 462 Work in process 2,893 2,375 Finished goods 1,742 1,436 Total inventories $ 5,167 $ 4,273 Property, Plant and Equipment Property, plant and equipment, net at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Land and buildings $ 25,578 $ 22,989 Machinery and equipment 48,459 44,441 Construction in progress 9,359 12,279 Total property, plant and equipment, gross 83,396 79,709 Less: accumulated depreciation (51,538 ) (46,471 ) Total property, plant and equipment, net $ 31,858 $ 33,238 We compute depreciation for financial reporting purposes using the straight-line method. As of December 26, 2015 , substantially all of our depreciable property, plant and equipment assets were depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; and buildings, 10 to 25 years. Beginning in 2016, our machinery and equipment will be depreciated over 2 to 5 years. We capitalize a portion of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment. Included within construction in progress we have certain facilities on hold and not in use. These facilities are being held in a safe state, and we have plans to place them into service at a future date. Depreciation is not recognized on these assets and they are not eligible for capitalized interest when construction is on hold. The balance of such assets was approximately $ 3.4 billion as of December 26, 2015 (approximately $ 2.2 billion as of December 27, 2014 ). Goodwill We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets acquired. We assign the goodwill to our reporting units based on the relative expected fair value provided by the acquisition. We perform an annual impairment assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist , which includes evaluating qualitative and quantitative factors to assess the likelihood of an impairment of a reporting unit’s goodwill. We perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see " Note 10: Goodwill ." Identified Intangible Assets Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as "other intangible assets" that are not subject to amortization. Assets related to projects that have been completed are transferred from "other intangible assets" to "acquisition-related developed technology;" these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts. The estimated useful life ranges for all identified intangible assets that are subject to amortization as of December 26, 2015 were as follows: (In Years) Estimated Useful Life Acquisition-related developed technology 3 – 9 Acquisition-related customer relationships 5 – 11 Acquisition-related brands 5 – 8 Licensed technology and patents 2 – 17 We perform a quarterly review of significant finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets, which is calculated based on projected discounted net cash flows. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new, shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. For further discussion of identified intangible assets, see " Note 11: Identified Intangible Assets ." Product Warranty The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented. Revenue Recognition We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectability. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in our industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales. Revenue from license agreements on our McAfee products generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized. We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income. Advertising Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.8 billion in 2015 ( $1.8 billion in 2014 and $1.9 billion in 2013 ). Employee Equity Incentive Plans We have employee equity incentive plans, which are described more fully in " Note 18: Employee Equity Incentive Plans ." We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and RSUs with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award. Income Taxes We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized. We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see " Note 23: Income Taxes ."

Recent Accounting Standards

Recent Accounting Standards	12 Months Ended
	Dec. 26, 2015
Recent Accounting Standards [Abstract]
Recent Accounting Standards [Text Block]	Note 3: Recent Accounting Standards In May 2014, the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 9, 2015, the FASB agreed to delay the effective date by one year; accordingly, the new standard is effective for us beginning in the first quarter of 2018 and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements. In 2015, the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the first quarter of 2017; early adoption is permitted and we are evaluating whether we will early adopt. The amended standard may be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations. In 2015, the FASB issued an amended standard requiring that we recognize the effect on earnings of any adjustments identified during the measurement period after an acquisition in the same period the adjustment is identified, as opposed to the prior standard which required material adjustments be retrospectively adjusted. The amended standard is effective for us beginning in the first quarter of 2016. We do not expect that the adoption of this standard will have a significant impact on our consolidated financial statements. In January 2016, the FASB issued changes to the accounting for financial instruments that primarily affect equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. This standard is effective for us beginning in the first quarter of 2018; certain provisions allow for early adoption and we are evaluating whether we will elect to early adopt these provisions. The new standard should be applied by means of a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption, with certain exceptions. We have not yet determined the impact of the new standard on our consolidated financial statements. In 2015, we adopted an amended standard simplifying the presentation of debt issuance costs as a direct deduction from the carrying value of the debt liability rather than showing the debt issuance costs as an asset. We have applied the amendment retrospectively to the comparable period presented and it did not have a significant impact on our financial statements.

Fair Value

Fair Value	12 Months Ended
	Dec. 26, 2015
Fair Value Disclosures [Abstract]
Fair Value [Text Block]	Note 4: Fair Value Assets and Liabilities Measured and Recorded at Fair Value on a Recurring Basis Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: December 26, 2015 December 27, 2014 Fair Value Measured and Recorded at Reporting Date Using Total Fair Value Measured and Recorded at Reporting Date Using Total (In Millions) Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets Cash equivalents: Corporate debt $ — $ 1,829 $ — $ 1,829 $ — $ 48 $ — $ 48 Financial institution instruments 8,238 1,277 — 9,515 321 1,119 — 1,440 Government debt — 130 — 130 — — — — Reverse repurchase agreements — 2,368 — 2,368 — 268 — 268 Short-term investments: Corporate debt 336 764 20 1,120 363 412 31 806 Financial institution instruments 145 927 — 1,072 149 1,050 — 1,199 Government debt 65 425 — 490 252 173 — 425 Trading assets: Asset-backed securities — 275 94 369 — 766 58 824 Corporate debt 1,744 564 — 2,308 2,625 339 — 2,964 Financial institution instruments 930 701 — 1,631 1,146 613 — 1,759 Government debt 1,107 1,908 — 3,015 1,295 2,221 — 3,516 Other current assets: Derivative assets 32 412 1 445 — 559 2 561 Loans receivable — 137 — 137 — 505 — 505 Marketable equity securities 5,891 69 — 5,960 7,097 — — 7,097 Other long-term investments: Asset-backed securities — — 4 4 — 2 4 6 Corporate debt 407 801 — 1,208 453 728 13 1,194 Financial institution instruments 171 381 — 552 189 319 — 508 Government debt 79 48 — 127 75 240 — 315 Other long-term assets: Derivative assets — 30 10 40 — 35 22 57 Loans receivable — 342 — 342 — 216 — 216 Total assets measured and recorded at fair value 19,145 13,388 129 32,662 13,965 9,613 130 23,708 Liabilities Other accrued liabilities: Derivative liabilities 2 210 — 212 — 563 — 563 Other long-term liabilities: Derivative liabilities — 33 — 33 — 17 — 17 Total liabilities measured and recorded at fair value $ 2 $ 243 $ — $ 245 $ — $ 580 $ — $ 580 Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. For the year ended December 26, 2015 , we transferred corporate debt and financial institution instruments of approximately $628 million from Level 1 to Level 2 of the fair value hierarchy and approximately $403 million of financial institution instruments, corporate debt, and government debt from Level 2 to Level 1 ( $177 million of corporate debt, financial institution instruments, and government debt from Level 1 to Level 2 and $395 million from Level 2 to Level 1 during 2014 ). These transfers were based on changes in market activity for the underlying instruments. Our policy is to reflect transfers between the fair value hierarchy levels at the beginning of the quarter in which a change in circumstances resulted in the transfer. Investments in Debt Instruments Debt instruments reflected in the preceding table include investments such as asset-backed securities, corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents . We classify our debt instruments as Level 2 when we use observable market prices for identical instruments that are traded in less active markets. When observable market prices for identical instruments are not available, we price the debt instruments using our own models, such as a discounted cash flow model, or non-binding market consensus prices based on the proprietary valuation models of pricing providers or brokers. These valuation models incorporate a number of inputs, including non-binding and binding broker quotes; observable market prices for identical or similar instruments; and the internal assumptions of pricing providers or brokers that use observable market inputs and unobservable market inputs that we consider to be not significant. When we use non-binding market consensus prices, we corroborate them with quoted market prices for similar instruments or compare them to output from internally developed pricing models such as a discounted cash flow model. The discounted cash flow model uses observable market inputs, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. All significant inputs are derived from or corroborated with observable market data. The fair values of debt instruments classified as Level 3 are generally derived from discounted cash flow models, performed either by us or our pricing providers, using inputs that we are unable to corroborate with observable market data. We monitor and review the inputs and results of these valuation models to help ensure the fair value measurements are reasonable and consistent with market experience in similar asset classes. Fair Value Option for Loans Receivable We elected the fair value option for loans receivable when the interest rate or currency exchange rate risk was hedged at inception with a related derivative instrument. As of December 26, 2015 and December 27, 2014 , the fair value of our loans receivable for which we elected the fair value option did not significantly differ from the contractual principal balance based on the contractual currency. Loans receivable are classified within other current assets and other long-term assets. Fair value is determined using a discounted cash flow model, with all significant inputs derived from or corroborated with observable market data. Gains and losses from changes in fair value on the loans receivable and related derivative instruments, as well as interest income, are recorded in interest and other, net. During all periods presented, changes in the fair value of our loans receivable were largely offset by gains or losses on the related derivative instruments, resulting in an insignificant net impact on our consolidated statements of income. Gains and losses attributable to changes in credit risk are determined using observable credit default spreads for the issuer or comparable companies; these gains and losses were insignificant during all periods presented. We did not elect the fair value option for loans receivable when the interest rate or currency exchange rate risk was not hedged at inception with a related derivative instrument. Loans receivable not measured and recorded at fair value are included in the following "Financial Instruments Not Recorded at Fair Value on a Recurring Basis" section. Assets Measured and Recorded at Fair Value on a Non-Recurring Basis Our non-marketable equity investments, marketable equity method investments, and non-financial assets, such as intangible assets and property, plant and equipment, are recorded at fair value only if an impairment is recognized. Some of our non-marketable equity investments have been measured and recorded at fair value due to events or circumstances that significantly impacted the fair value of those investments, resulting in other-than-temporary impairments. We classified these investments as Level 3 because the valuations used unobservable inputs that were significant to the fair value measurements and required management judgment due to the absence of quoted market prices. Impairments recognized on non-marketable equity investments held as of December 26, 2015 were $160 million in 2015 ( $128 million in 2014 on non-marketable equity investments held as of December 27, 2014 and $106 million in 2013 on non-marketable equity investments held as of December 28, 2013 ). Financial Instruments Not Recorded at Fair Value on a Recurring Basis On a quarterly basis, we measure the fair value of our grants receivable, cost method loans receivable, non-marketable cost method investments, reverse repurchase agreements with original maturities greater than approximately three months, and indebtedness carried at amortized cost plus applicable hedge adjustments; however, the assets are recorded at fair value only when an impairment is recognized. The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: December 26, 2015 Carrying Amount Fair Value Measured Using Fair Value (In Millions) Level 1 Level 2 Level 3 Grants receivable $ 593 $ — $ 600 $ — $ 600 Loans receivable $ 315 $ — $ 315 $ — $ 315 Non-marketable cost method investments $ 2,933 $ — $ — $ 3,904 $ 3,904 Reverse repurchase agreements $ 1,000 $ — $ 1,000 $ — $ 1,000 Short-term debt $ 2,593 $ 1,513 $ 1,563 $ — $ 3,076 Long-term debt $ 20,036 $ 14,058 $ 6,835 $ — $ 20,893 NVIDIA Corporation cross-license agreement liability $ 199 $ — $ 200 $ — $ 200 December 27, 2014 Carrying Amount Fair Value Measured Using Fair Value (In Millions) Level 1 Level 2 Level 3 Grants receivable $ 676 $ — $ 679 $ — $ 679 Loans receivable $ 250 $ — $ 250 $ — $ 250 Non-marketable cost method investments $ 1,769 $ — $ — $ 2,599 $ 2,599 Reverse repurchase agreements $ 450 $ — $ 450 $ — $ 450 Short-term debt $ 1,580 $ — $ 2,145 $ — $ 2,145 Long-term debt $ 12,059 $ 11,467 $ 1,309 $ — $ 12,776 NVIDIA Corporation cross-license agreement liability $ 395 $ — $ 399 $ — $ 399 The fair value of our grants receivable is determined using a discounted cash flow model, which discounts future cash flows using an appropriate yield curve. As of December 26, 2015 and December 27, 2014 , the carrying amount of our grants receivable was classified within other current assets and other long-term assets, as applicable. The carrying amount and fair value of loans receivable exclude loans measured and recorded at fair value on a recurring basis. The fair value of our loans receivable and reverse repurchase agreements, including those held at fair value, is determined using a discounted cash flow model. All significant inputs in the models are derived from or corroborated with observable market data, such as LIBOR-based yield curves, currency spot and forward rates, and credit ratings. The credit quality of these assets remains high, with credit ratings of A+/A1 for most of our loans receivable and a substantial majority of our reverse repurchase agreements as of December 26, 2015 . As of December 26, 2015 , and December 27, 2014 , the unrealized loss position of our non-marketable cost method investments was insignificant . Our non-marketable cost method investments are valued using a qualitative and quantitative analysis of events or circumstances that impact the fair value of the investment. Qualitative analysis of our investments involves understanding our investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects; the technological feasibility of our investee’s products and technologies; the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes; and the management and governance structure of the investee. Quantitative assessments of the fair value of our investments are developed using the market and income approaches. The market approach includes the use of financial metrics and ratios of comparable public companies, such as revenue, earnings, comparable performance multiples, recent financing rounds, the terms of the investees’ issued interests, and the level of marketability of the investments. The selection of comparable companies requires management judgment and is based on a number of factors, including comparable companies’ sizes, growth rates, industries, and development stages. The income approach includes the use of a discounted cash flow model, which requires significant estimates regarding investees’ revenue, costs, and discount rates based on the risk profile of comparable companies. Estimates of revenue and costs are developed using available market, historical, and forecast data. We measure the fair value of our non-marketable cost method investments as close to the end of the period as feasible. The carrying amount and fair value of short-term debt exclude drafts payable. Our short-term debt recognized at amortized cost includes our 2009 junior subordinated convertible debentures due 2039 (2009 debentures) and our 2011 senior notes due 2016. During the fourth quarter of 2015 , the 2009 debentures were classified as short-term debt on the consolidated balance sheet and convertible at the option of the holder during the first quarter of 2016. For further information, see " Note 15: Borrowings ." Our long-term debt recognized at amortized cost is composed of our senior notes and our convertible debentures. The fair value of our senior notes is classified as Level 1 when we use quoted prices in active markets and Level 2 when the quoted prices are from less active markets or when other observable inputs are used to determine fair value. The fair value of our 2009 and 2005 convertible debentures is determined using discounted cash flow models with observable market inputs, and takes into consideration variables such as interest rate changes, comparable instruments, subordination discount, and credit-rating changes; it is, therefore, classified as Level 2. The NVIDIA Corporation (NVIDIA) cross-license agreement liability in the preceding table was incurred as a result of entering into a long-term patent cross-license agreement with NVIDIA in January 2011, pursuant to which we agreed to make payments to NVIDIA over six years. The carrying amount of the liability arising from the agreement was classified within other accrued liabilities and other long-term liabilities, based on the expected timing of the underlying payments ( $200 million due in each of January 2015 and 2016 treated as cash used for financing activities). The fair value is determined using a discounted cash flow model, which discounts future cash flows using our incremental borrowing rates.

Cash and Investments

Cash and Investments	12 Months Ended
	Dec. 26, 2015
Investments and Cash [Abstract]
Cash and Investments [Text Block]	Note 5: Cash and Investments Cash and investments at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Available-for-sale investments $ 22,007 $ 13,038 Cash 1,466 805 Equity method investments 1,590 1,446 Loans receivable 794 971 Non-marketable cost method investments 2,933 1,769 Reverse repurchase agreements 3,368 718 Trading assets 7,323 9,063 Total cash and investments $ 39,481 $ 27,810 Available-for-Sale Investments Available-for-sale investments at the end of each period were as follows: December 26, 2015 December 27, 2014 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Asset-backed securities $ 5 $ — $ (1 ) $ 4 $ 8 $ — $ (2 ) $ 6 Corporate debt 4,164 3 (10 ) 4,157 2,040 13 (5 ) 2,048 Financial institution instruments 11,140 1 (2 ) 11,139 3,146 2 (1 ) 3,147 Government debt 748 — (1 ) 747 741 — (1 ) 740 Marketable equity securities 3,254 2,706 — 5,960 3,318 3,779 — 7,097 Total available-for-sale investments $ 19,311 $ 2,710 $ (14 ) $ 22,007 $ 9,253 $ 3,794 $ (9 ) $ 13,038 Government debt includes instruments such as non-U.S. government bonds and U.S. agency securities. Financial institution instruments include instruments issued or managed by financial institutions in various forms, such as commercial paper, fixed and floating rate bonds, money market fund deposits, and time deposits. Substantially all time deposits were issued by institutions outside the U.S. as of December 26, 2015 and December 27, 2014 . For information on the unrealized holding gains (losses) on available-for-sale investments reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, see " Note 24: Other Comprehensive Income (Loss) ." During 2015 , we sold available-for-sale investments for proceeds of $2.2 billion , of which $144 million related to sales of cash and cash equivalents ( $1.7 billion in 2014 , of which $509 million related to sales of cash and cash equivalents; and $1.3 billion in 2013 , of which $339 million related to sales of cash and cash equivalents). The gross realized gains on sales of available-for-sale investments were $133 million in 2015 ( $136 million in 2014 and $146 million in 2013 ). We determine the cost of an investment sold on an average cost basis at the individual security level. Impairments recognized on available-for-sale investments were insignificant for all periods presented. The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 26, 2015 were as follows: (In Millions) Cost Fair Value Due in 1 year or less $ 5,896 $ 5,893 Due in 1–2 years 1,271 1,268 Due in 2–5 years 623 620 Instruments not due at a single maturity date 8,267 8,266 Total $ 16,057 $ 16,047 Equity Method Investments Equity method investments, classified within other long-term assets, at the end of each period were as follows: December 26, 2015 December 27, 2014 (Dollars In Millions) Carrying Value Ownership Percentage Carrying Value Ownership Percentage IM Flash Technologies, LLC $ 872 49 % $ 713 49 % Cloudera, Inc. 256 17 % 280 17 % Intel-GE Care Innovations, LLC 64 50 % 108 50 % Other equity method investments 398 345 Total $ 1,590 $ 1,446 IM Flash Technologies, LLC Since the inception of IM Flash Technologies, LLC (IMFT) in 2006, Micron Technology, Inc. (Micron) and Intel have jointly developed NAND flash memory and, most recently, 3D XPoint technology products. Intel also purchases jointly developed products directly from Micron under certain supply agreements. The IMFT operating agreement, most recently amended in January 2016, continues through 2024 unless earlier terminated under certain terms and conditions, and provides for certain buy-sell rights of the joint venture. Intel has the right to cause Micron to buy our interest in IMFT. If we exercise this right, Micron would set the closing date of the transaction within two years following such election and could elect to receive financing from us for one to two years. Subsequent to our put right, and commencing in January 2019, Micron has the right to call our interest in IMFT with the closing date to be effective within one year. IMFT is a variable interest entity, and all costs of IMFT are passed on to Micron and Intel through sale of products or services in proportional share of ownership. Intel's portion of IMFT costs, primarily related to product purchases and production-related services, was approximately $400 million in 2015 (approximately $400 million in 2014 and approximately $380 million in 2013 ). The amount due to IMFT for product purchases and services provided was approximately $20 million as of December 26, 2015 (approximately $60 million as of December 27, 2014 ). IMFT returned $6 million to Intel in 2014, which is reflected within investing activities on the consolidated statements of cash flows ( $45 million in 2013). IMFT depends on Micron and Intel for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in IMFT, which was $872 million as of December 26, 2015 . Except for the amount due to IMFT for product purchases and production-related services, we did not have any additional liabilities recognized on our consolidated balance sheets in connection with our interests in this joint venture as of December 26, 2015 . Our potential future losses could be higher than the carrying amount of our investment, as Intel and Micron are liable for other future operating costs or obligations of IMFT. Future cash calls could also increase our investment balance and the related exposure to loss. In addition, because we are currently committed to purchasing 49% of IMFT’s production output and production-related services, we may be required to purchase products at a cost in excess of realizable value. We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in IMFT using the equity method of accounting. Cloudera, Inc. During 2014, we invested in Cloudera, Inc. (Cloudera). Our fully diluted ownership interest in Cloudera is 17% as of December 26, 2015 . Our investment is accounted for under the equity and cost methods of accounting based on the rights associated with different instruments we own, and is classified within other long-term assets. The carrying value of our equity method investment was $256 million and of our cost method investment was $454 million as of December 26, 2015 ( $280 million for our equity method investment and $454 million for our cost method investment as of December 27, 2014 ). Intel-GE Care Innovations, LLC During 2011, Intel and General Electric Company (GE) formed Intel-GE Care Innovations, LLC (Care Innovations), an equally owned joint venture in the healthcare industry that focuses on independent living and delivery of health-related services by means of telecommunications. The company was formed by combining assets of GE Healthcare’s Home Health division and Intel’s Digital Health Group. Care Innovations is a variable interest entity and depends on Intel and GE for any additional cash needs. Our known maximum exposure to loss approximated the carrying value of our investment balance in Care Innovations, which was $64 million as of December 26, 2015 . Intel and GE equally share the power to direct all of Care Innovations' activities that most significantly impact its economic performance. We have determined that we do not have the characteristics of a consolidating investor in the variable interest entity and, therefore, we account for our interest in Care Innovations using the equity method of accounting. Clearwire Communications, LLC During 2013, we sold our interest in Clearwire Communications, LLC (Clearwire LLC), which we originally acquired in 2008, for proceeds of $328 million . These proceeds are included in other investing within investing activities on the consolidated statements of cash flows. We recognized a gain on the sale of our interest in Clearwire LLC of $328 million . For proceeds received and gains recognized for each investment, see " Note 20: Gains (Losses) on Equity Investments, Net ." Non-marketable cost method investments The carrying value of our non-marketable cost method investments was $2.9 billion as of December 26, 2015 ( $1.8 billion as of December 27, 2014 ), of which $454 million and $966 million related to our cost method investments in Cloudera and Beijing UniSpreadtrum Technology Ltd. (UniSpreadtrum), respectively. In 2015 , we recognized impairments of $164 million on non-marketable cost method investments, which is included within gains (losses) on equity investments, net on the consolidated statements of income ( $130 million in 2014 and $103 million in 2013 ). Investment in Beijing UniSpreadtrum Technology Ltd. During 2014, we entered into a series of agreements with Tsinghua Unigroup Ltd. (Tsinghua Unigroup), an operating subsidiary of Tsinghua Holdings Co. Ltd., to, among other things, jointly develop Intel architecture- and communications-based solutions for phones . We agreed to invest up to 9.0 billion Chinese yuan (approximately $1.5 billion as of the date of the agreement) for a minority stake of approximately 20% of UniSpreadtrum, a holding company under Tsinghua Unigroup. During 2015, we invested $966 million to complete the first phase of the equity investment. We have determined we will not have significant influence over the company and, therefore, we account for our interest using the cost method of accounting. Subject to regulatory approvals and other closing conditions, the second phase of the investment will require additional funding of approximately $500 million . Trading Assets As of December 26, 2015 , and December 27, 2014 , substantially all of our trading assets were marketable debt instruments. Net losses related to trading assets still held at the reporting date were $152 million in 2015 (net losses of $530 million in 2014 and net losses of $70 million in 2013 ). Net gains on the related derivatives were $137 million in 2015 (net gains of $525 million in 2014 and $86 million in 2013 ).

Derivative Financial Instrument

Derivative Financial Instruments	12 Months Ended
	Dec. 26, 2015
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments [Text Block]	Note 6: Derivative Financial Instruments Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. Currency Exchange Rate Risk We are exposed to currency exchange rate risk, and generally hedge our exposures with currency forward contracts, currency interest rate swaps, or currency options. Substantially all of our revenue is transacted in U.S. dollars. However, a significant portion of our operating expenditures and capital purchases is incurred in or exposed to other currencies, primarily the euro, the Chinese yuan, the Japanese yen, and the Israeli shekel . We have established balance sheet and forecasted transaction currency risk management programs to protect against fluctuations in the fair value and the volatility of the functional currency equivalent of future cash flows caused by changes in exchange rates. Our non-U.S.-dollar-denominated investments in debt instruments and loans receivable are generally hedged with offsetting currency forward contracts or currency interest rate swaps. We may also hedge currency risk arising from funding foreign currency-denominated forecasted investments. These programs reduce, but do not eliminate, the impact of currency exchange movements . Our currency risk management programs include: • Currency derivatives with cash flow hedge accounting designation that utilize currency forward contracts and currency options to hedge exposures to the variability in the U.S.-dollar equivalent of anticipated non-U.S.-dollar-denominated cash flows. These instruments generally mature within 12 months . For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. We utilize currency interest rate swaps to hedge exposures to the variability in the U.S.-dollar equivalent of coupon and principal payments associated with our non-U.S.-dollar-denominated indebtedness. • Currency derivatives without hedge accounting designation that utilize currency forward contracts or currency interest rate swaps to economically hedge the functional currency equivalent cash flows of recognized monetary assets and liabilities, non-U.S.-dollar-denominated debt instruments classified as trading assets, and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. A substantial majority of these instruments mature within 12 months . Changes in the functional currency equivalent cash flows of the underlying assets and liabilities are approximately offset by the changes in the fair value of the related derivatives. We record net gains or losses in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net, except for equity-related gains or losses, which we primarily record in gains (losses) on equity investments, net. Interest Rate Risk Our primary objective for holding investments in debt instruments is to preserve principal while maximizing yields. We generally swap the returns on our investments in fixed-rate debt instruments with remaining maturities longer than six months into U.S. dollar three-month LIBOR-based returns, unless management specifically approves otherwise. We may elect to swap fixed coupon payments on our debt issuances for floating rate coupon payments. These swaps are settled at various interest payment times involving cash payments at each interest and principal payment date, with the majority of the contracts having quarterly payments. Our interest rate risk management programs include: • Interest rate derivatives with cash flow hedge accounting designation that utilize interest rate swap agreements to modify the interest characteristics of debt instruments. For these derivatives, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss), and we reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. • Interest rate derivatives with fair value hedge accounting designation that utilize interest rate swap agreements to hedge against changes in fair value on certain fixed rate debt due to fluctuations in the benchmark interest rate. For these derivatives, we recognize gains and losses in interest and other, net, along with the offsetting gains and losses attributable to the changes in the benchmark interest rate on the underlying hedged items. • Interest rate derivatives without hedge accounting designation that utilize interest rate swaps and currency interest rate swaps in economic hedging transactions, including hedges of non-U.S.-dollar-denominated debt instruments classified as trading assets and hedges of non-U.S.-dollar-denominated loans receivable recognized at fair value. Floating interest rates on the swaps generally reset on a quarterly basis. Changes in the fair value of the debt instruments classified as trading assets and loans receivable recognized at fair value are generally offset by changes in the fair value of the related derivatives, both of which are recorded in interest and other, net. Equity Market Risk Our investments include marketable equity securities and equity derivative instruments. We typically do not attempt to reduce or eliminate our equity market exposure through hedging activities at the inception of our investments. Before we enter into hedge arrangements, we evaluate legal, market, and economic factors, as well as the expected timing of disposal, to determine whether hedging is appropriate. Our equity market risk management program may include equity derivatives with or without hedge accounting designation that utilize warrants, equity options, or other equity derivatives. We recognize changes in the fair value of such derivatives in gains (losses) on equity investments, net. We also utilize total return swaps to offset changes in liabilities related to the equity market risks of certain deferred compensation arrangements. Gains and losses from changes in fair value of these total return swaps are generally offset by the losses and gains on the related liabilities , both of which are recorded in cost of sales and operating expenses. Deferred compensation liabilities were $1.3 billion as of December 26, 2015 ( $1.2 billion as of December 27, 2014 ), and are included in other accrued liabilities. Commodity Price Risk We operate facilities that consume commodities and have established forecasted transaction risk management programs to protect against fluctuations in the fair value and the volatility of future cash flows caused by changes in commodity prices, such as those for natural gas. These programs reduce, but do not always eliminate, the impact of commodity price movements. Our commodity price risk management program may include commodity derivatives with cash flow hedge accounting designation that utilize commodity swap contracts to hedge future cash flow exposures to the variability in commodity prices. These instruments generally mature within 12 months. For these derivatives, we report the after-tax gain (loss) from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Volume of Derivative Activity Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Dec 28, Currency forwards $ 11,212 $ 15,578 $ 13,404 Currency interest rate swaps 5,509 5,446 4,377 Embedded debt derivatives 3,600 3,600 3,600 Interest rate swaps 5,212 1,347 1,377 Total return swaps 1,061 1,056 914 Other 61 49 67 Total $ 26,655 $ 27,076 $ 23,739 The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Dec 28, Chinese yuan $ 2,231 $ 3,097 $ 1,116 Euro 6,084 7,486 6,874 Israeli shekel 1,674 2,489 2,244 Japanese yen 2,663 3,779 4,116 Other 4,069 4,173 3,431 Total $ 16,721 $ 21,024 $ 17,781 During the fourth quarter of 2014, we entered into $1.5 billion of forward contracts to hedge our anticipated equity funding of the UniSpreadtrum investment. The hedges were designated as cash flow hedges and the related gains and losses attributable to changes in the spot rates were recognized in accumulated other comprehensive income (loss). Hedge gains and losses attributable to changes in the forward rates were recognized in interest and other, net. During 2015, we discontinued cash flow hedge accounting treatment for $478 million of forward contracts since we could no longer assert that funding is probable to occur within the initially specified timeline. Hedge losses accumulated in other comprehensive income and subsequently released to interest and other, net, related to these de-designated forward contracts were insignificant. During 2015, we entered into $4.4 billion of interest rate swap agreements to hedge against changes in the fair value attributable to the benchmark interest rates related to $4.4 billion of our outstanding senior notes. These hedges were designated as fair value hedges. During 2015, we entered into $577 million of currency interest rate swap agreements to hedge against the variability in the U.S.-dollar equivalent of coupon and principal payments associated with our non-U.S.-dollar-denominated indebtedness. These hedges were designated as cash flow hedges. Fair Value of Derivative Instruments in the Consolidated Balance Sheets The fair value of our derivative instruments at the end of each period were as follows: December 26, 2015 December 27, 2014 (In Millions) Other Current Assets Other Long-Term Assets Other Accrued Liabilities Other Long-Term Liabilities Other Current Assets Other Long-Term Assets Other Accrued Liabilities Other Long-Term Liabilities Derivatives designated as hedging instruments: Currency forwards $ 20 $ 3 $ 83 $ 2 $ 6 $ 1 $ 497 $ 9 Interest rate swaps — 1 — 14 — — — — Currency interest rate swaps — 7 — — — — — — Total derivatives designated as hedging instruments 20 11 83 16 6 1 497 9 Derivatives not designated as hedging instruments: Currency forwards 20 — 63 — 207 — 44 — Currency interest rate swaps 370 18 52 — 344 34 7 — Embedded debt derivatives — — — 17 — — 4 8 Interest rate swaps 2 — 12 — 3 — 11 — Total return swaps 32 — 2 — — — — — Other 1 11 — — 1 22 — — Total derivatives not designated as hedging instruments 425 29 129 17 555 56 66 8 Total derivatives $ 445 $ 40 $ 212 $ 33 $ 561 $ 57 $ 563 $ 17 Amounts Offset in the Consolidated Balance Sheets The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: December 26, 2015 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 482 $ — $ 482 $ (201 ) $ (188 ) $ 93 Reverse repurchase agreements 3,368 — 3,368 — (3,368 ) — Total assets 3,850 — 3,850 (201 ) (3,556 ) 93 Liabilities: Derivative liabilities subject to master netting arrangements 242 — 242 (201 ) (27 ) 14 Total liabilities $ 242 $ — $ 242 $ (201 ) $ (27 ) $ 14 December 27, 2014 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 559 $ — $ 559 $ (365 ) $ (78 ) $ 116 Reverse repurchase agreements 718 — 718 — (718 ) — Total assets 1,277 — 1,277 (365 ) (796 ) 116 Liabilities: Derivative liabilities subject to master netting arrangements 559 — 559 (365 ) (80 ) 114 Total liabilities $ 559 $ — $ 559 $ (365 ) $ (80 ) $ 114 We obtain and secure available collateral from counterparties against obligations, including securities lending transactions and reverse repurchase agreements, when we deem it appropriate. Derivatives in Cash Flow Hedging Relationships The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: Gains (Losses) Recognized in OCI on Derivatives (Effective Portion) Years Ended Dec 26, Dec 27, Dec 28, Currency forwards $ (305 ) $ (587 ) $ (167 ) Currency interest rate swaps and other 7 (2 ) 1 Total $ (298 ) $ (589 ) $ (166 ) Gains and losses on derivative instruments in cash flow hedging relationships related to hedge ineffectiveness and amounts excluded from effectiveness testing were insignificant during all periods presented in the preceding tables. Additionally, for all periods presented, there was an insignificant impact on results of operations from discontinued cash flow hedges, which arises when forecasted transactions are probable of not occurring. For information on the unrealized holding gains (losses) on derivatives reclassified out of accumulated other comprehensive income into the consolidated statements of income, see " Note 24: Other Comprehensive Income (Loss) ." Derivatives in Fair Value Hedging Relationships The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Statement of Income on Derivatives Years Ended Dec 26, Dec 27, Dec 28, Interest rate swap $ (13 ) $ — $ — Hedged item 13 — — Total $ — $ — $ — There was no ineffectiveness during all periods presented in the preceding table. Derivatives Not Designated as Hedging Instruments The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows: Years Ended Location of Gains (Losses) Recognized in Income on Derivatives Dec 26, Dec 27, Dec 28, Currency forwards Interest and other, net $ (50 ) $ 144 $ 44 Currency interest rate swaps Interest and other, net 346 456 29 Interest rate swaps Interest and other, net (6 ) (3 ) — Total return swaps Various (27 ) 68 140 Other Gains (losses) on equity investments, net (11 ) (6 ) 6 Other Interest and other, net (2 ) — — Total $ 250 $ 659 $ 219

Concentrations of Credit Risk

Concentrations of Credit Risk	12 Months Ended
	Dec. 26, 2015
Risks and Uncertainties [Abstract]
Concentrations of Credit Risk [Text Block]	Note 7: Concentrations of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist principally of investments in debt instruments, derivative financial instruments, loans receivable, reverse repurchase agreements, and trade receivables. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. We generally place investments with high-credit-quality counterparties and, by policy, we limit the amount of credit exposure to any one counterparty based on our analysis of that counterparty’s relative credit standing. Substantially all of our investments in debt instruments are in A/A2 or better rated issuances, and a substantial majority of the issuances are rated AA-/Aa3 or better . Our investment policy requires substantially all investments with original maturities at the time of investment of up to six months to be rated at least A-2/P-2 by Standard & Poor’s/Moody’s, and specifies a higher minimum rating for investments with longer maturities. For instance, investments with maturities of greater than three years generally require a minimum rating of AA-/Aa3 at the time of investment. Government regulations imposed on investment alternatives of our non-U.S. subsidiaries, or the absence of A-rated counterparties in certain countries, result in some minor exceptions. Credit-rating criteria for derivative instruments are similar to those for other investments. Due to master netting arrangements, the amounts subject to credit risk related to derivative instruments are generally limited to the amounts, if any, by which the counterparty’s obligations exceed our obligations with that counterparty. As of December 26, 2015 , our total credit exposure to any single counterparty, excluding money market funds invested in U.S. treasury and U.S. agency securities and reverse repurchase agreements collateralized by treasury and agency securities, did not exceed $500 million . To further reduce credit risk, we obtain and secure available collateral from counterparties against obligations, including securities lending transactions, when we deem it appropriate. A substantial majority of our trade receivables are derived from sales to original equipment manufacturers and original design manufacturers . We also have accounts receivable derived from sales to industrial and communications equipment manufacturers in the computing and communications industries . Hewlett-Packard Company, our largest customer in 2014, separated into HP Inc. and Hewlett Packard Enterprise Company on November 1, 2015. These entities, together with Dell Inc. and Lenovo Group Limited, represent our largest customers. Collectively, these customers accounted for 46% of net revenue for 2015 ( 46% for 2014 and 44% for 2013 ) and 49% of net accounts receivable as of December 26, 2015 ( 43% as of December 27, 2014 ). We believe that the net accounts receivable balances from these largest customers do not represent a significant credit risk, based on cash flow forecasts, balance sheet analysis, and past collection experience. We have adopted credit policies and standards intended to accommodate industry growth and inherent risk. We believe that credit risks are moderated by the financial stability of our major customers. We assess credit risk through quantitative and qualitative analysis. From this analysis, we establish shipping and credit limits, and determine whether we will seek to use one or more credit support protection devices, such as obtaining a parent guarantee, standby letter of credit, or credit insurance.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 26, 2015
Acquisitions [Abstract]
Acquisitions [Text Block]	Note 8: Acquisitions During 2015, we completed eight acquisitions qualifying as business combinations in exchange for aggregate consideration (net of cash acquired) of $1.0 billion , a substantial majority of which was cash consideration. Substantially all of the consideration was allocated to goodwill and other intangible assets, such as acquisition-related developed technology and acquisition-related customer relationships. Included in these acquisitions is our acquisition of Lantiq Semiconductor (Lantiq), intended to extend Intel's success in cable home gateways into DSL and fiber markets. We acquired Lantiq in the second quarter of 2015 for net cash consideration of $345 million , substantially all of which was allocated to goodwill and intangible assets, such as acquisition-related developed technology and acquisition-related customer relationships. The operating results of Lantiq are included in our Client Computing Group operating segment. During 2014, we completed eight acquisitions qualifying as business combinations in exchange for aggregate consideration of $963 million , substantially all cash consideration. A substantial majority of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets. Included in these acquisitions is our acquisition of the Axxia Networking Business (Axxia business) of Avago Technologies Limited, intended to accelerate growth in the mobile wireless base station business. We acquired the Axxia business in the fourth quarter of 2014 for net cash consideration of $650 million , substantially all of which was allocated to goodwill and acquisition-related developed technology intangible assets. The operating results of the Axxia business are included in our Data Center Group (DCG) operating segment. During 2013, we completed 12 acquisitions qualifying as business combinations in exchange for aggregate net cash consideration of $925 million . Most of the consideration was allocated to goodwill and acquisition-related developed technology intangible assets. Included in these acquisitions is our acquisition of Stonesoft Oyj (Stonesoft), intended to expand our network security solutions, specifically addressing next-generation firewall products. We acquired Stonesoft in the third quarter of 2013 for net cash consideration of $381 million , substantially all of which was allocated to goodwill and acquisition-related developed technology intangible assets. Stonesoft's operating results are included in our software and services operating segments. Acquisitions completed in 2015, 2014, and 2013, both individually and in the aggregate, were not significant to our results of operations. For information on the assignment of goodwill to our operating segments, see " Note 10: Goodwill " and for information on the classification of intangible assets, see " Note 11: Identified Intangible Assets ." Acquisition of Altera Corporation During the second quarter of 2015, we entered into a definitive agreement to acquire Altera Corporation (Altera) in an all-cash transaction. The transaction closed on December 28, 2015, subsequent to our fiscal 2015 year-end. Altera is a global semiconductor company that designs and sells programmable semiconductors and related products, including programmable logic devices, which incorporate field-programmable gate array (FPGAs) and complex programmable logic devices, and highly integrated System-on-Chip (SoC) devices. This acquisition is expected to expand our reach within the compute continuum, as the combination of our leading-edge products and manufacturing process with Altera's leading FPGA technology is expected to enable new classes of platforms that meet customer needs in the data center and Internet of Things market segments. Upon completion of the acquisition, each outstanding share of Altera common stock and, subject to certain exceptions, each share of Altera common stock underlying vested stock option awards, restricted stock unit awards and performance-based restricted stock unit awards were converted into the right to receive $ 54.00 per share in cash, without interest. During the third and fourth quarters of 2015, we issued $ 9.5 billion in aggregate principal amount of senior unsecured debt, and in the first quarter of 2016 we borrowed $4.0 billion against our short-term credit facility, in order to fund a portion of the total purchase price (net of cash acquired) of $ 14.5 billion . For more information on our indebtedness, see " Note 15: Borrowings ." Since the closing of this acquisition occurred subsequent to our fiscal year-end, the allocation of the purchase price to the underlying assets acquired and liabilities assumed is subject to a formal valuation process, which has not yet been completed. We will reflect the preliminary valuation of the net assets acquired and the operational results of Altera beginning December 28, 2015, the close date of the transaction, in our first quarter of 2016. The purchase price allocation will be finalized as soon as practicable within the measurement period, but not later than one year following the acquisition close date. Although the purchase price allocation for this acquisition and pro forma financial information is not yet available, we expect a substantial majority of the purchase price will be allocated to goodwill and acquisition-related developed technology and other identified intangible assets. Additionally, we assumed $ 1.5 billion of aggregate principal amount of Altera's outstanding indentures. Altera became a new Intel operating segment called the Programmable Solutions Group upon acquisition.

Divestitures

Divestitures	12 Months Ended
	Dec. 26, 2015
Divestitures [Abstract]
Divestitures [Text Block]	Note 9: Divestitures In 2015, we completed three separate divestiture transactions. As a result of these transactions, we received aggregate net cash consideration of $153 million , included within investing activities on the consolidated statements of cash flows, and recognized a gain within interest and other, net on the consolidated statements of income. During the first quarter of 2014, we completed the divestiture of the assets of Intel Media, a business division dedicated to the development of cloud TV products and services, to Verizon Communications Inc. As a result of the transaction, we received aggregate net cash consideration of $ 150 million , included within investing activities on the consolidated statements of cash flows, and recognized a gain within interest and other, net on the consolidated statements of income.

Goodwill

Goodwill	12 Months Ended
	Dec. 26, 2015
Goodwill [Abstract]
Goodwill [Text Block]	Note 10: Goodwill Goodwill activity for each period was as follows: (In Millions) Dec 27, Acquisitions Currency Exchange and Other Dec 26, Client Computing Group $ 3,708 $ 370 $ — $ 4,078 Data Center Group 2,376 28 — 2,404 Internet of Things Group 428 — — 428 Software and services operating segments 4,236 10 (206 ) 4,040 All other 113 269 — 382 Total $ 10,861 $ 677 $ (206 ) $ 11,332 (In Millions) Dec 28, Acquisitions Currency Exchange and Other Dec 27, Client Computing Group $ 3,689 $ 19 $ — $ 3,708 Data Center Group 1,969 407 — 2,376 Internet of Things Group 428 — — 428 Software and services operating segments 4,409 41 (214 ) 4,236 All other 18 113 (18 ) 113 Total $ 10,513 $ 580 $ (232 ) $ 10,861 During the first quarter of 2015, we combined the PC Client Group and Mobile and Communications Group to create the Client Computing Group (CCG). All prior-period amounts have been retrospectively adjusted to reflect this organizational structure. For further information, see " Note 26: Operating Segments and Geographic Information ." During the fourth quarters of 2015 , 2014 , and 2013 , we completed our annual impairment assessments and we concluded that goodwill was not impaired in any of these years. The accumulated impairment losses as of December 26, 2015 were $719 million : $365 million associated with CCG, $275 million associated with DCG, and $79 million associated with the Internet of Things Group.

Identified Intangible Assets

Identified Intangible Assets	12 Months Ended
	Dec. 26, 2015
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Identified Intangible Assets [Text Block]	Note 11: Identified Intangible Assets Identified intangible assets at the end of each period were as follows: December 26, 2015 (In Millions) Gross Assets Accumulated Amortization Net Acquisition-related developed technology $ 2,928 $ (2,276 ) $ 652 Acquisition-related customer relationships 1,738 (1,219 ) 519 Acquisition-related brands 59 (55 ) 4 Licensed technology and patents 3,017 (1,200 ) 1,817 Identified intangible assets subject to amortization 7,742 (4,750 ) 2,992 Acquisition-related brands 767 — 767 Other intangible assets 174 — 174 Identified intangible assets not subject to amortization 941 — 941 Total identified intangible assets $ 8,683 $ (4,750 ) $ 3,933 December 27, 2014 (In Millions) Gross Assets Accumulated Amortization Net Acquisition-related developed technology $ 3,009 $ (2,192 ) $ 817 Acquisition-related customer relationships 1,698 (1,001 ) 697 Acquisition-related brands 61 (49 ) 12 Licensed technology and patents 3,153 (1,224 ) 1,929 Identified intangible assets subject to amortization 7,921 (4,466 ) 3,455 Acquisition-related brands 788 — 788 Other intangible assets 203 — 203 Identified intangible assets not subject to amortization 991 — 991 Total identified intangible assets $ 8,912 $ (4,466 ) $ 4,446 As a result of our acquisitions and purchases of licensed technology and patents, identified intangible assets recorded for each period and their respective estimated weighted average useful life were as follows: December 26, 2015 December 27, 2014 Gross Assets (In Millions) Estimated Useful Life (In Years) Gross Assets (In Millions) Estimated Useful Life (In Years) Acquisition-related developed technology $ 238 6 $ 175 6 Acquisition-related customer relationships $ 110 11 $ 79 9 Licensed technology and patents $ 176 7 $ 93 8 All intangible assets acquired during 2015 are subject to amortization. During 2014 , we acquired other intangible assets of $197 million that were not subject to amortization. Amortization expenses, with presentation location on the consolidated statements of income, for each period were as follows: Years Ended Location Dec 26, Dec 27, Dec 28, Acquisition-related developed technology Cost of sales $ 343 $ 600 $ 576 Acquisition-related customer relationships Amortization of acquisition-related intangibles 258 284 279 Acquisition-related brands Amortization of acquisition-related intangibles 7 10 12 Licensed technology and patents Cost of sales 282 275 272 Other intangible assets Reduction of revenue — — 103 Total amortization expenses $ 890 $ 1,169 $ 1,242 Based on identified intangible assets that are subject to amortization as of December 26, 2015 (which do not include intangibles from the Altera acquisition), we expect future amortization expense for each period to be as follows: (In Millions) 2016 2017 2018 2019 2020 Acquisition-related developed technology $ 260 $ 115 $ 101 $ 98 $ 64 Acquisition-related customer relationships 229 143 42 25 22 Acquisition-related brands 3 — — — — Licensed technology and patents 282 239 187 186 174 Total future amortization expenses $ 774 $ 497 $ 330 $ 309 $ 260

Other Long-Term Assets

Other Long-Term Assets	12 Months Ended
	Dec. 26, 2015
Other Assets, Noncurrent Disclosure [Abstract]
Other Long-Term Assets [Text Block]	Note 12: Other Long-Term Assets Other long-term assets at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Equity method investments $ 1,590 $ 1,446 Non-marketable cost method investments 2,933 1,769 Non-current deferred tax assets 600 622 Pre-payments for property, plant and equipment 623 636 Loans receivable 642 416 Grants receivable 318 312 Reverse repurchase agreements 350 350 Other 679 954 Total other long-term assets $ 7,735 $ 6,505 As of December 26, 2015 , the carrying amount of our non-marketable cost method investments includes $966 million related to our investment in UniSpreadtrum. For further information, see " Note 5: Cash and Investments ." During 2015 , we received and transferred $213 million of equipment from pre-payments for property, plant and equipment to property, plant and equipment. Substantially all of the equipment was prepaid in 2012 and 2013 . We recognized the pre-payments within operating activities in the consolidated statement of cash flows when we paid for the equipment, and the receipt of the equipment is reflected as a non-cash transaction in the current period.

Restructuring and Asset Impairm

Restructuring and Asset Impairment Charges	12 Months Ended
	Dec. 26, 2015
Restructuring Costs and Asset Impairment Charges [Abstract]
Restructuring and Asset Impairment Charges [Text Block]	Note 13: Restructuring and Asset Impairment Charges Restructuring and asset impairment charges by program for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, 2015 restructuring program $ 264 $ — $ — 2013 restructuring program 90 295 240 Total restructuring and asset impairment charges $ 354 $ 295 $ 240 2015 Restructuring Program Beginning in the second quarter of 2015, management approved and commenced implementation of restructuring actions, primarily targeted workforce reductions, as we adjusted resources from areas of disinvestment to areas of investment. This program was substantially complete by the end of the 2015 . Restructuring and asset impairment charges for the 2015 restructuring program in 2015 were as follows: Years Ended Dec 26, Employee severance and benefit arrangements $ 250 Asset impairments and other restructuring charges 14 Total restructuring and asset impairment charges $ 264 Restructuring and asset impairment activities for the 2015 restructuring program in 2015 were as follows: (In Millions) Employee Severance and Benefits Asset Impairments and Other Total Accrued restructuring balance as of December 27, 2014 $ — $ — $ — Additional accruals 292 14 306 Adjustments (42 ) — (42 ) Cash payments (225 ) (1 ) (226 ) Non-cash settlements — (6 ) (6 ) Accrued restructuring balance as of December 26, 2015 $ 25 $ 7 $ 32 We recorded the additional accruals as restructuring and asset impairment charges in the consolidated statements of income and within the “all other” operating segments category. A substantial majority of the accrued restructuring balance as of December 26, 2015 is expected to be paid within the next 12 months, and was recorded as a current liability within accrued compensation and benefits on the consolidated balance sheets. Restructuring actions related to this program that were approved in 2015 impacted approximately 4,000 employees. 2013 Restructuring Program Beginning in the third quarter of 2013, management approved and commenced implementation of several restructuring actions, including targeted workforce reductions and the exit of certain businesses and facilities. These actions include the wind down of our 200mm wafer fabrication facility in Massachusetts, which ceased production in the first quarter of 2015, and the closure of our assembly and test facility in Costa Rica, which ceased production in the fourth quarter of 2014. These targeted reductions will enable us to better align our resources in areas providing the greatest benefit in the current business environment. This program was substantially complete by the end of 2015 . Restructuring and asset impairment charges for the 2013 restructuring program for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Employee severance and benefit arrangements $ 82 $ 265 $ 201 Asset impairments and other restructuring charges 8 30 39 Total restructuring and asset impairment charges $ 90 $ 295 $ 240 Restructuring and asset impairment activities for the 2013 restructuring program for each period were as follows: (In Millions) Employee Severance and Benefits Asset Impairments and Other Total Accrued restructuring balance as of December 28, 2013 $ 183 $ — $ 183 Additional accruals 252 31 283 Adjustments 13 (1 ) 12 Cash payments (327 ) (6 ) (333 ) Non-cash settlements — (13 ) (13 ) Accrued restructuring balance as of December 27, 2014 121 11 132 Additional accruals 101 9 110 Adjustments (19 ) (1 ) (20 ) Cash payments (171 ) (10 ) (181 ) Non-cash settlements — (3 ) (3 ) Accrued restructuring balance as of December 26, 2015 $ 32 $ 6 $ 38 We recorded the additional accruals and adjustments as restructuring and asset impairment charges in the consolidated statements of income and within the "all other" operating segments category. Substantially all of the accrued restructuring balance as of December 26, 2015 is expected to be paid within the next 12 months, and was recorded as a current liability within accrued compensation and benefits on the consolidated balance sheets. Restructuring actions related to this program that were approved in 2015 impacted approximately 940 employees. Since the third quarter of 2013, we have incurred a total of $625 million in restructuring and asset impairment charges. These charges include $548 million related to employee severance and benefit arrangements for approximately 8,500 employees, and $77 million in asset impairment charges and other restructuring charges.

Deferred Income

Deferred Income	12 Months Ended
	Dec. 26, 2015
Deferred Revenue [Abstract]
Deferred Income [Text Block]	Note 14: Deferred Income Deferred income at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Deferred income on shipments of components to distributors $ 920 $ 944 Deferred income from software, services, and other 1,268 1,261 Current deferred income 2,188 2,205 Non-current deferred income from software, services, and other 530 483 Total deferred income $ 2,718 $ 2,688 We classify non-current deferred income from software, services, and other within other long-term liabilities on the consolidated balance sheets.

Borrowings

Borrowings	12 Months Ended
	Dec. 26, 2015
Debt Disclosure [Abstract]
Borrowings [Text Block]	Note 15: Borrowings Short-Term Debt Our short-term debt at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Drafts payable $ 41 $ 16 Commercial paper — 500 Current portion of long-term debt 2,602 1,088 Less: debt issuance costs associated with the current portion of long-term debt (9 ) (8 ) Total short-term debt $ 2,634 $ 1,596 We have an ongoing authorization from our Board of Directors to borrow up to $5.0 billion , which our Board of Directors increased in 2015 from $3.0 billion , under our commercial paper program. Maximum borrowings under our commercial paper program in 2015 were $900 million ( $2.4 billion in 2014 ). We had no outstanding commercial paper as of December 26, 2015 ( $500 million as of December 27, 2014 ). Our commercial paper was rated A-1+ by Standard & Poor’s and P-1 by Moody’s as of December 26, 2015 . On December 21, 2015 we entered into a short-term credit facility to borrow up to $5.0 billion in order to facilitate the settlement of our acquisition of Altera. There were no borrowings outstanding under this credit facility as of December 26, 2015 and it was closed in January 2016. Long-Term Debt Our indebtedness is carried at amortized cost plus applicable hedge adjustments. Our long-term debt at the end of each period was as follows: (In Millions) Maturity Date Stated Interest Rate Dec 26, Dec 27, Fourth quarter 2015 debt issuance of $915 million Senior notes December 2045 4.70 % $ 908 $ — Fourth quarter 2015 Australian dollar-denominated debt issuance of A$800 million Senior notes 1 December 2019 3.25 % 181 — Senior notes 1 December 2022 4.00 % 397 — Third quarter 2015 debt issuance of $1.0 billion Senior notes August 2045 4.90 % 1,009 — Third quarter 2015 debt issuance of $7.0 billion Senior notes July 2020 2.45 % 1,748 — Senior notes July 2022 3.10 % 996 — Senior notes July 2025 3.70 % 2,247 — Senior notes July 2045 4.90 % 1,998 — 2012 debt issuance of $6.2 billion Senior notes December 2017 1.35 % 2,999 2,998 Senior notes December 2022 2.70 % 1,492 1,495 Senior notes December 2032 4.00 % 744 744 Senior notes December 2042 4.25 % 924 924 2011 debt issuance of $5.0 billion Senior notes October 2016 1.95 % 1,499 1,499 Senior notes October 2021 3.30 % 1,997 1,997 Senior notes October 2041 4.80 % 1,490 1,490 2009 debt issuance of $2.0 billion Junior subordinated convertible debentures August 2039 3.25 % 1,103 1,088 2005 debt issuance of $1.6 billion Junior subordinated convertible debentures December 2035 2.95 % 975 960 Long-term debt 22,707 13,195 Less: current portion of long-term debt (2,602 ) (1,088 ) Less: debt issuance costs (69 ) (48 ) Total long-term debt $ 20,036 $ 12,059 1 To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $577 million , which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see " Note 6: Derivative Financial Instruments ." Senior Notes During 2015, we issued a total of $9.5 billion aggregate principal amount of senior unsecured notes to fund a portion of the cash consideration for our acquisition of Altera. The acquisition of Altera closed on December 28, 2015, subsequent to our fiscal 2015 year-end. For more information on the closing of our Altera acquisition, see " Note 8: Acquisitions ." All of our senior notes pay a fixed rate of interest semiannually. A portion of our fixed coupon payments related to our senior notes have been swapped for floating rate coupon payments. For more information on our interest rate swaps, see " Note 6: Derivative Financial Instruments ." We may redeem the notes prior to their maturity at our option at specified redemption prices and subject to certain restrictions. The notes rank equally in right of payment with all of our other existing and future senior unsecured indebtedness and will effectively rank junior to all liabilities of our subsidiaries. Convertible Debentures In 2009 and 2005, we issued junior subordinated convertible debentures due 2039 (2009 debentures) and 2035 (2005 debentures), respectively. Both the 2009 and 2005 debentures pay a fixed rate of interest semiannually. 2009 Debentures 2005 Debentures Annual stated coupon interest rate 3.25 % 2.95 % Annual effective interest rate 7.20 % 6.45 % The effective interest rate is based on the rate, at inception, for a similar instrument that does not have a conversion feature. 2009 Debentures. The 2009 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events, commencing on August 1, 2019. After such date, if the 10 -day average trading price of $1,000 principal amount of the bond immediately preceding any six -month interest period is less than or equal to $650 or greater than or equal to $1,500 , we are required to pay contingent 0.25% or 0.50% annual interest, respectively. The fair value of the related contingent interest embedded derivative was $13 million as of December 26, 2015 ( $8 million as of December 27, 2014 ). The 2009 debentures are convertible, subject to certain conditions. Holders can surrender the 2009 debentures for conversion if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during the 30 consecutive trading-day period ending on the last trading day of the preceding fiscal quarter. We will settle any conversion of the 2009 debentures in cash up to the face value, and any amount in excess of face value will be settled in cash or stock at our option. On or after August 5, 2019, we can redeem, for cash, all or part of the 2009 debentures for the principal amount, plus any accrued and unpaid interest, if the closing price of Intel common stock has been at least 150% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period. In addition, if certain events occur in the future, the indentures governing the 2009 debentures provide that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. The 2009 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that the 2009 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments. As such, the embedded conversion options are not accounted for separately as derivative liabilities. 2005 Debentures. The 2005 debentures have a contingent interest component that requires us to pay interest based on certain thresholds or for certain events. If the 10 -day average trading price of $1,000 principal amount of the bond immediately preceding any six -month interest period is less than or equal to $800 or greater than or equal to $1,300 , we are required to pay contingent 0.25% or 0.40% annual interest, respectively. As of December 26, 2015 , we did not meet either contingent interest threshold. The fair value of the related contingent interest embedded derivative was $4 million as of December 26, 2015 ( $4 million as of December 27, 2014 ). The 2005 debentures are convertible into shares of our common stock. Holders can surrender the 2005 debentures for conversion at any time. We can settle any conversion of the 2005 debentures in cash or stock at our option. The 2005 debentures will become redeemable if the closing price of Intel common stock has been at least 130% of the conversion price then in effect for at least 20 trading days during any 30 consecutive trading-day period. Once this condition has been met, we can redeem, for cash, all or part of the 2005 debentures for the principal amount, plus any accrued and unpaid interest. In addition, if certain events occur in the future, the indentures governing the 2005 debentures provide that each holder of the debentures can, for a pre-defined period of time, require us to repurchase the holder’s debentures for the principal amount plus any accrued and unpaid interest. The 2005 debentures are subordinated in right of payment to any existing and future senior debt and to the other liabilities of our subsidiaries. We have concluded that the 2005 debentures are not conventional convertible debt instruments and that the embedded stock conversion options qualify as derivatives. In addition, we have concluded that the embedded conversion options would be classified in stockholders’ equity if they were freestanding derivative instruments. As such, the embedded conversion options are not accounted for separately as derivative liabilities. 2009 Debentures 2005 Debentures (In Millions, Except Per Share Amounts) Dec 26, Dec 27, Dec 26, Dec 27, Outstanding principal $ 2,000 $ 2,000 $ 1,600 $ 1,600 Equity component (including temporary equity) carrying amount $ 613 $ 613 $ 466 $ 466 Unamortized discount $ 897 $ 912 $ 625 $ 640 Net debt carrying amount $ 1,103 $ 1,088 $ 975 $ 960 Conversion rate (shares of common stock per $1,000 principal amount of debentures) 46.58 46.06 35.82 34.95 Effective conversion price (per share of common stock) $ 21.47 $ 21.71 $ 27.92 $ 28.61 In the preceding table, the remaining amortization periods for the unamortized discounts for the 2009 and 2005 debentures are approximately 24 and 20 years, respectively, as of December 26, 2015 . The conversion rate adjusts for certain events outlined in the indentures governing the 2009 and 2005 debentures, such as quarterly dividend distributions in excess of $0.14 and $0.10 per share for the 2009 and 2005 debentures, respectively, but it does not adjust for accrued interest. In addition, the conversion rate will increase for a holder of either the 2009 or 2005 debentures who elects to convert the debentures in connection with certain share exchanges, mergers, or consolidations involving Intel. During the fourth quarter of 2015 , the closing stock price conversion right condition of the 2009 debentures continued to be met and the debentures will be convertible at the option of the holders during the first quarter of 2016 . As a result, the $1.1 billion carrying amount of the 2009 debentures was classified as short-term debt on our consolidated balance sheet as of December 26, 2015 ( $1.1 billion as of December 27, 2014 ). The excess of the amount of cash payable if converted over the carrying amount of the 2009 debentures of $897 million has been classified as temporary equity on our consolidated balance sheet as of December 26, 2015 ( $912 million as of December 27, 2014 ). In future periods, if the closing stock price conversion right condition is no longer met, all outstanding 2009 debentures would be reclassified to long-term debt and the temporary equity would be reclassified to stockholders’ equity on our consolidated balance sheet. Debt Maturities Our aggregate debt maturities based on outstanding principal as of December 26, 2015 , by year payable, were as follows: (In Millions) 2016 $ 1,500 2017 3,000 2018 — 2019 181 2020 1,750 2021 and thereafter 17,845 Total $ 24,276 In the preceding table, the 2009 debentures are classified based on their stated maturity date, regardless of their classification on the consolidated balance sheet .

Retirement Benefit Plans

Retirement Benefit Plans	12 Months Ended
	Dec. 26, 2015
Compensation and Retirement Disclosure [Abstract]
Retirement Benefit Plans [Text Block]	Note 16: Retirement Benefit Plans Retirement Contribution Plans We provide tax-qualified retirement contribution plans for the benefit of eligible employees, former employees, and retirees in the U.S. and certain other countries. The plans are designed to provide employees with an accumulation of funds for retirement on a tax-deferred basis. Employees hired prior to January 1, 2011 are eligible for and receive discretionary employer contributions in the U.S. Intel Retirement Contribution Plan. Employees hired on or after January 1, 2011 receive discretionary employer contributions in the Intel 401(k) Savings Plan, which are participant-directed. Our Chief Executive Officer (CEO) determines the annual discretionary employer contribution amounts for the U.S. Intel Retirement Contribution Plan and the Intel 401(k) Savings Plan under delegation of authority from our Board of Directors, pursuant to the terms of the plans. Effective January 1, 2015, the U.S. Intel Retirement Contribution plan assets and future discretionary employer contributions are participant-directed. For the benefit of eligible U.S. employees, we also provide a non-tax-qualified supplemental deferred compensation plan for certain highly compensated employees. This plan is designed to permit certain discretionary employer contributions and to permit employees to defer a portion of compensation in addition to their Intel 401(k) Savings Plan deferrals. This plan is unfunded. We expensed $337 million for the qualified and non-qualified U.S. retirement contribution plans in 2015 ( $286 million in 2014 and $298 million in 2013 ). In the first quarter of 2016 , we funded $318 million for the 2015 contributions to the qualified U.S. retirement contribution plans. Pension and Postretirement Benefit Plans U.S. Pension Benefits. For employees hired prior to January 1, 2011, we provide a tax-qualified defined-benefit pension plan, the U.S. Intel Minimum Pension Plan, for eligible employees, former employees, and retirees in the U.S. Beginning on January 1, 2015, future benefit accruals in the U.S. Intel Minimum Pension Plan were frozen to all employees at or above a specific grade level, and generally covering all highly compensated employees in the plan. Starting in 2016, the impacted employees will receive discretionary employer contributions in the Intel 401(k) Savings Plan, instead of the Retirement Contribution plan. This change was contingent on receiving a favorable private letter ruling from the U.S. Internal Revenue Service (IRS), which we received in October 2014. As a result, our projected benefit obligation was reduced by $1.1 billion in 2014, most of which was also included as a change in actuarial valuation on the consolidated statements of comprehensive income. The U.S. Intel Minimum Pension Plan benefit is determined by a participant’s years of service and final average compensation, as defined by the plan document. The plan generates a minimum pension benefit if the participants’ U.S. Intel Minimum Pension Plan benefit exceeds the annuitized value of their U.S. Intel Retirement Contribution Plan benefit. If participant balances in the U.S. Intel Retirement Contribution Plan do not grow sufficiently, the projected benefit obligation of the U.S. Intel Minimum Pension Plan could increase significantly. Consistent with applicable law, assets of the U.S. Intel Minimum Pension Plan are held in trust, solely for the benefit of plan participants, and are not available for general corporate purposes. Non-U.S. Pension Benefits. We also provide defined-benefit pension plans in certain other countries, most significantly Ireland, Israel, and Germany. Consistent with the requirements of local law, we deposit funds for certain plans with insurance companies, with third-party trustees, or into government-managed accounts, and/or accrue for the unfunded portion of the obligation. The Ireland pension plan and one of our Germany pension plans were closed to employees hired on or after June 20, 2012 and January 1, 2014, respectively. U.S. Postretirement Medical Benefits. Upon retirement, eligible U.S. employees who were hired prior to January 1, 2014 are credited with a defined dollar amount, based on years of service, into a U.S. Sheltered Employee Retirement Medical Account (SERMA). These credits can be used to pay all or a portion of the cost to purchase coverage in the retiree’s choice of medical plan. If the available credits are not sufficient to pay the entire cost of the coverage, the remaining cost is the retiree’s responsibility. Employees hired on or after January 1, 2014 are not eligible to earn a SERMA benefit. Funding Policy. Our practice is to fund the various pension plans in amounts sufficient to meet the minimum requirements of applicable local laws and regulations. Additional funding may be provided as deemed appropriate. Funding for the U.S. postretirement medical benefits plan is discretionary under applicable laws and regulations, and is reviewed annually; additional funding may be provided as deemed appropriate. Depending on the design of the plan, local customs, and market circumstances, the liabilities of a plan may exceed qualified plan assets. Benefit Obligation and Plan Assets The vested benefit obligation for a defined benefit pension plan is the actuarial present value of the vested benefits to which the employee is currently entitled based on the employee's expected date of separation or retirement. The changes in the projected benefit obligations and plan assets at the end of each period for the plans described above were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Beginning projected benefit obligation $ 892 $ 1,137 $ 2,423 $ 1,695 $ 546 $ 509 Service cost 18 88 128 104 30 26 Interest cost 33 49 63 66 21 23 Actuarial (gain) loss 126 760 (250 ) 767 (21 ) 10 Currency exchange rate changes — — (190 ) (254 ) — — Plan curtailments — (1,083 ) — — — — Other (79 ) (59 ) (34 ) 45 (16 ) (22 ) Ending projected benefit obligation $ 990 $ 892 $ 2,140 $ 2,423 $ 560 $ 546 U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Beginning fair value of plan assets $ 623 $ 649 $ 1,017 $ 1,005 $ 427 $ 395 Actual return on plan assets (4 ) 30 42 80 6 33 Employer contributions 90 — 72 73 1 — Currency exchange rate changes — — (66 ) (114 ) — — Other (82 ) (56 ) (54 ) (27 ) (24 ) (1 ) Ending fair value of plan assets $ 627 $ 623 $ 1,011 $ 1,017 $ 410 $ 427 The amounts recognized on the consolidated balance sheets at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Other long-term assets $ — $ — $ 15 $ 14 $ — $ — Other long-term liabilities (363 ) (269 ) (1,144 ) (1,420 ) (150 ) (119 ) Accumulated other comprehensive loss (income), before tax 158 1 908 1,217 39 33 Net amount recognized $ (205 ) $ (268 ) $ (221 ) $ (189 ) $ (111 ) $ (86 ) The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits Years Ended Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Net prior service credit (cost) $ — $ — $ (12 ) $ (13 ) $ (43 ) $ (48 ) Net actuarial gain (loss) (158 ) (1 ) (896 ) (1,204 ) 4 15 Accumulated other comprehensive income (loss), before tax $ (158 ) $ (1 ) $ (908 ) $ (1,217 ) $ (39 ) $ (33 ) We use a corridor approach to amortize actuarial gains and losses. Under this approach, net actuarial gains or losses in excess of 10% of the larger of the projected benefit obligation or the fair value of plan assets are amortized on a straight-line basis. The period of amortization is the average remaining service of active participants who are expected to receive benefits under the plans. As of December 26, 2015 , the accumulated benefit obligation was $899 million for the U.S. Intel Minimum Pension Plan ( $808 million as of December 27, 2014 ) and $1.6 billion for the non-U.S. defined-benefit pension plans ( $1.7 billion as of December 27, 2014 ). Included in the aggregate data in the following tables are the amounts applicable to our pension plans with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations $ 899 $ 808 $ 1,239 $ 1,344 Plan assets $ 627 $ 623 $ 645 $ 616 Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations $ 990 $ 892 $ 2,079 $ 2,361 Plan assets $ 627 $ 623 $ 934 $ 941 On a worldwide basis, our pension and postretirement benefit plans were 55% funded as of December 26, 2015 . The U.S. Intel Minimum Pension Plan, which accounts for 27% of the worldwide pension and postretirement benefit obligations, was 63% funded. Funded status is not indicative of our ability to pay ongoing pension benefits or of our obligation to fund retirement trusts. Required pension funding for U.S. retirement plans is determined in accordance with the Employee Retirement Income Security Act (ERISA), which sets required minimum contributions. Cumulative company funding to the U.S. Intel Minimum Pension Plan currently exceeds the minimum ERISA funding requirements. Assumptions Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Discount rate 4.0 % 3.8 % 3.1 % 2.7 % 4.1 % 4.1 % Rate of compensation increase 3.7 % 3.8 % 3.8 % 4.0 % n/a n/a Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits 2015 2014 2013 2015 2014 2013 2015 2014 2013 Discount rate 3.8 % 4.6 % 3.9 % 2.8 % 4.0 % 4.2 % 3.9 % 4.6 % 4.2 % Expected long-term rate of return on plan assets 6.1 % 5.4 % 4.5 % 5.7 % 5.7 % 5.2 % 7.4 % 7.4 % 7.7 % Rate of compensation increase 3.8 % 3.8 % 4.1 % 4.0 % 4.1 % 4.3 % n/a n/a n/a For the U.S. plans, we developed the discount rate by calculating the benefit payment streams by year to determine when benefit payments will be due. We then matched the benefit payment streams by year to the AA corporate bond rates to match the timing and amount of the expected benefit payments and discounted back to the measurement date to determine the appropriate discount rate. For the non-U.S. plans, we used two approaches to develop the discount rate. In certain countries, we used a model consisting of a theoretical bond portfolio for which the timing and amount of cash flows approximated the estimated benefit payments of our pension plans. In other countries, we analyzed current market long-term bond rates and matched the bond maturity with the average duration of the pension liabilities. The expected long-term rate of return on plan assets assumptions takes into consideration both duration and risk of the investment portfolios, and is developed through consensus and building-block methodologies. The consensus methodology includes unadjusted estimates by the fund manager on future market expectations by broad asset classes and geography. The building-block approach determines the rates of return implied by historical risk premiums across asset classes. In addition, we analyze rates of return relevant to the country where each plan is in effect and the investments applicable to the plan, expectations of future returns, local actuarial projections, and the projected long-term rates of return from external investment managers. The expected long-term rate of return on plan assets shown for the non-U.S. plan assets is weighted to reflect each country’s relative portion of the non-U.S. plan assets. Net Periodic Benefit Cost In 2015 , the net periodic benefit cost for U.S. pension benefits, non-U.S. pension benefits, and U.S. postretirement medical benefits was $26 million ( $36 million in 2014 and $230 million in 2013 ), $198 million ( $165 million in 2014 and $116 million in 2013 ) and $26 million ( $17 million in 2014 and $77 million in 2013 ), respectively. The decrease in the U.S. net periodic pension benefit cost in 2014 compared to 2013 is primarily attributed to the one-time curtailment gain related to the freeze of future benefit accruals and lower recognized net actuarial losses. U.S. Pension Plan Assets In general, the investment strategy for U.S. Intel Minimum Pension Plan assets is to maximize risk-adjusted returns, taking into consideration the investment horizon and expected volatility to help ensure that there are sufficient assets available to pay pension benefits as they come due. The allocation to each asset class will fluctuate with market conditions, such as volatility and liquidity concerns, and will typically be rebalanced when outside the target ranges, which were 55% for equity investments and 45% for fixed-income investments in 2015 . For 2016 , the expected long-term rate of return for the U.S. Intel Minimum Pension Plan assets is 5.6% . U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period: December 26, 2015 Dec 27, Fair Value Measured at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Total Equity securities $ 54 $ 314 $ — $ 368 $ 347 Fixed income 16 201 38 255 254 Other investments 4 — — 4 20 Total assets measured at fair value $ 74 $ 515 $ 38 $ 627 $ 621 Cash — 2 Total U.S. pension plan assets at fair value $ 627 $ 623 A substantial majority of the fixed income investments in the preceding table are asset-backed securities, corporate debt, and government debt. Government debt includes instruments such as non-U.S. government securities, U.S. agency securities, and U.S. treasury securities. Non-U.S. Plan Assets The investments of the non-U.S. plans are managed by insurance companies, pension funds, or third-party trustees, consistent with regulations or market practice of the country where the assets are invested. The investment manager makes investment decisions within the guidelines set by Intel or local regulations. The investment manager evaluates performance by comparing the actual rate of return to the return on similar assets. Investments managed by qualified insurance companies or pension funds under standard contracts follow local regulations, and we are not actively involved in their investment strategies. For the assets that we have discretion to set investment guidelines, the assets are invested in developed country equity investments and fixed-income investments, either through index funds or direct investment. In general, the investment strategy is designed to accumulate a diversified portfolio among markets, asset classes, or individual securities to reduce market risk and to help ensure that the pension assets are available to pay benefits as they come due. The target allocation of the non-U.S. plan assets that we have control over is 50% equity investments and 50% fixed-income investments. For 2016 , the average expected long-term rate of return for the non-U.S. plan assets is 5.3% . Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period: December 26, 2015 Dec 27, Fair Value Measured at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Total Equity securities $ 274 $ 56 $ 15 $ 345 $ 521 Fixed income — 610 34 644 476 Total assets measured at fair value $ 274 $ 666 $ 49 $ 989 $ 997 Cash 22 20 Total non-U.S. plan assets at fair value $ 1,011 $ 1,017 Substantially all of the equity investments in the preceding table are invested in a diversified mix of equities of developed countries, including the U.S., and emerging markets throughout the world. The majority of the fixed income investments in the preceding table are investments held by insurance companies and insurance contracts that are managed by qualified insurance companies. We do not have control over the target allocation or visibility of the investment strategies of those investments. Insurance contracts and investments held by insurance companies made up 33% of total non-U.S. plan assets as of December 26, 2015 ( 35% as of December 27, 2014 ). U.S. Postretirement Medical Plan Assets In general, the investment strategy for U.S. postretirement medical benefits plan assets is to invest primarily in liquid assets, due to the level of expected future benefit payments. The assets are invested solely in a tax-aware global equity portfolio, which is actively managed by an external investment manager. The tax-aware global equity portfolio is composed of a diversified mix of equities in developed countries, including the U.S., and emerging markets throughout the world. For 2016 , the expected long-term rate of return for the U.S. postretirement medical benefits plan assets is 7% . As of December 26, 2015 , substantially all of the U.S. postretirement medical benefits plan assets were invested in exchange-traded equity securities and were measured at fair value using Level 1 inputs. Concentrations of Risk We manage a variety of risks, including credit, liquidity, and market risks, across our plan assets through our investment managers. We define a concentration of risk as an undiversified exposure to one of the aforementioned risks that unnecessarily increases the exposure to a loss of plan assets. We monitor exposure to such risks in both the U.S. and non-U.S. plans by monitoring the magnitude of the risk in each plan and diversifying our exposure to such risks across a variety of counterparties, instruments, and markets. As of December 26, 2015 , we did not have concentrations of risk in any single entity, manager, counterparty, sector, industry, or country. Funding Expectations Under applicable law for the U.S. Intel Minimum Pension Plan, we are required to contribute a minimum of approximately $10 million during 2016 . Our expected required funding for the non-U.S. plans during 2016 is approximately $58 million . Estimated Future Benefit Payments Estimated benefit payments over the next 10 fiscal years are as follows: (In Millions) U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits 2016 $ 57 $ 26 $ 19 2017 $ 61 $ 28 $ 21 2018 $ 69 $ 31 $ 24 2019 $ 70 $ 34 $ 27 2020 $ 70 $ 37 $ 31 2021-2025 $ 362 $ 251 $ 214

Commitments

Commitments	12 Months Ended
	Dec. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments [Text Block]	Note 17: Commitments A portion of our capital equipment and certain facilities are under operating leases that expire at various dates through 2030 . Additionally, portions of our real property are under leases that expire at various dates through 2062 . Rental expense was $253 million in 2015 ( $257 million in 2014 and $270 million in 2013 ). Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 26, 2015 : (In Millions) 2016 $ 234 2017 209 2018 167 2019 144 2020 120 2021 and thereafter 326 Total $ 1,200 Commitments for construction or purchase of property, plant and equipment totaled $5.7 billion as of December 26, 2015 ( $3.5 billion as of December 27, 2014 ), a majority of which will be due within the next 12 months. Other purchase obligations and commitments totaled approximately $4.0 billion as of December 26, 2015 (approximately $2.5 billion as of December 27, 2014 ). Other purchase obligations and commitments include payments due under various types of licenses and agreements to purchase goods or services, as well as payments due under non-contingent funding obligations. Funding obligations include agreements to fund various projects with other companies. In addition, we have various contractual commitments with Micron and IMFT. For further information on these contractual commitments, see " Note 5: Cash and Investments ." During 2012, we entered into a series of agreements with ASML Holding N.V. (ASML) intended to accelerate the development of extreme ultraviolet lithography projects and deep ultraviolet immersion lithography projects, including generic developments applicable to both 300mm and 450mm. Certain of these agreements were amended in 2014. Under the amended agreements, Intel agreed to provide R&D funding totaling €829 million over five years and committed to advance purchase orders for a specified number of tools from ASML. Our remaining obligation, contingent upon ASML achieving certain milestones, is approximately €367 million , or $403 million , as of December 26, 2015 . As our obligation is contingent upon ASML achieving certain milestones, we have excluded this obligation from other purchase obligations and commitments.

Employee Equity Incentive Plans

Employee Equity Incentive Plans	12 Months Ended
	Dec. 26, 2015
Employee Benefits and Share-based Compensation [Abstract]
Employee Equity Incentive Plans [Text Block]	Note 18: Employee Equity Incentive Plans Our equity incentive plans are broad-based, long-term programs intended to attract and retain talented employees and align stockholder and employee interests. In May 2015, stockholders approved an extension of the expiration date of the 2006 Equity Incentive Plan (the 2006 Plan) to June 2018 and approved an additional 34 million shares for issuance. Under the 2006 Plan, 753 million shares of common stock are available for issuance as equity awards to employees and non-employee directors through June 2018. As of December 26, 2015 , 258.4 million shares of common stock remained available for issuance under the 2006 Plan. Going forward, we may assume the equity incentive plans and the outstanding equity awards of certain acquired companies. Once they are assumed, we do not grant additional shares of common stock under those plans. The stock options and RSUs assumed generally retain their terms and conditions as they were originally granted. We grant restricted stock units with both a market condition and a service condition (market-based restricted stock units), referred to in our 2015 Proxy Statement as outperformance stock units (OSUs), to a group of senior officers, employees, and non-employee directors. For OSUs granted in 2015 , the number of shares of our common stock to be received at vesting will range from 0% to 200% of the target amount, based on total stockholder return (TSR) on our common stock measured against the benchmark TSR of a peer group over a three -year period. TSR is a measure of stock price appreciation plus any dividends paid in this performance period. As of December 26, 2015 , 4.7 million OSUs were outstanding. These OSUs accrue dividend equivalents and generally vest three years and one month from the grant date. RSU and option awards generally vest over four years from the grant date. Stock options generally expire seven years from the date of grant. In May 2015, stockholders approved an extension of the expiration date of the 2006 Stock Purchase Plan to August 2021. The 2006 Stock Purchase Plan allows eligible employees to purchase shares of our common stock at 85% of the value of our common stock on specific dates. Under the 2006 Stock Purchase Plan, 373 million shares of common stock are available for issuance through August 2021. As of December 26, 2015 , 181.3 million shares of common stock were available for issuance under the 2006 Stock Purchase Plan. Share-Based Compensation Share-based compensation recognized in 2015 was $1.3 billion ( $1.1 billion in 2014 and $1.1 billion in 2013 ). On a quarterly basis, we assess changes to our estimate of expected equity award forfeitures based on our review of recent forfeiture activity and expected future employee turnover. We recognize the effect of adjustments made to the forfeiture rates, if any, in the period that we change the forfeiture estimate. The effect of forfeiture rate adjustments in all periods presented was not significant. The total share-based compensation cost capitalized as part of inventory as of December 26, 2015 was $49 million ( $39 million as of December 27, 2014 and $38 million as of December 28, 2013 ). During 2015 , the tax benefit that we realized for the tax deduction from share-based awards totaled $533 million ( $555 million in 2014 and $385 million in 2013 ). We estimate the fair value of RSUs with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our shares of common stock prior to vesting. We estimate the fair value of OSUs using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of RSU grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows: Dec 26, Dec 27, Dec 28, Estimated values $ 31.63 $ 25.40 $ 21.45 Risk-free interest rate 0.6 % 0.5 % 0.2 % Dividend yield 2.9 % 3.3 % 3.8 % Volatility 27 % 23 % 25 % We use the Black-Scholes option pricing model to estimate the fair value of options granted under the 2006 Plan and rights to acquire shares of common stock granted under the 2006 Stock Purchase Plan. No options were granted in 2015 . We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows: Stock Options Stock Purchase Plan Dec 26, Dec 27, Dec 28, Dec 26, Dec 27, Dec 28, Estimated values n/a $ 3.61 $ 3.11 $ 6.56 $ 5.87 $ 4.52 Expected life (in years) n/a 5.1 5.2 0.5 0.5 0.5 Risk-free interest rate n/a 1.7 % 0.8 % 0.1 % 0.1 % 0.1 % Dividend yield n/a 3.6 % 3.9 % 3.1 % 3.2 % 4.0 % Volatility n/a 23 % 25 % 25 % 22 % 22 % We base the expected volatility on implied volatility because we have determined that implied volatility is more reflective of market conditions and a better indicator of expected volatility than historical volatility. We use historical option exercise data as the basis for determining expected life, as we believe that historical data provides a reasonable basis upon which to estimate the expected life input for valuing options using the Black-Scholes model. Restricted Stock Unit Awards Restricted stock unit activity for each period was as follows: Number of RSUs (In Millions) Weighted Average Grant-Date Fair Value December 29, 2012 109.3 $ 22.03 Granted 53.4 $ 21.45 Vested (44.5 ) $ 20.21 Forfeited (4.9 ) $ 22.06 December 28, 2013 113.3 $ 22.47 Granted 57.2 $ 25.40 Vested (42.5 ) $ 22.33 Forfeited (8.6 ) $ 22.94 December 27, 2014 119.4 $ 23.89 Granted 42.4 $ 31.63 Vested (46.6 ) $ 23.61 Forfeited (7.8 ) $ 25.76 December 26, 2015 107.4 $ 26.93 Expected to vest as of December 26, 2015 102.5 $ 26.93 The aggregate fair value of awards that vested in 2015 was $1.5 billion ( $1.1 billion in 2014 and $1.0 billion in 2013 ), which represents the market value of our common stock on the date that the RSUs vested. The grant-date fair value of awards that vested in 2015 was $1.1 billion ( $949 million in 2014 and $899 million in 2013 ). The number of RSUs vested includes shares of common stock that we withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements. RSUs that are expected to vest are net of estimated future forfeitures. As of December 26, 2015 , there was $1.8 billion in unrecognized compensation costs related to RSUs granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of 1.2 years . Stock Option Awards As of December 26, 2015 , options outstanding that have vested and are expected to vest were as follows: Number of Options (In Millions) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (In Years) Aggregate Intrinsic Value (In Millions) Vested 43.8 $ 21.07 1.8 $ 609 Expected to vest 9.6 $ 24.07 4.1 $ 104 Total 53.4 $ 21.61 2.2 $ 713 Aggregate intrinsic value represents the difference between the exercise price and $34.98 , the closing price of our common stock on December 24, 2015 , as reported on The NASDAQ Global Select Market, for all in-the-money options outstanding. Options outstanding that are expected to vest are net of estimated future option forfeitures. Options with a fair value of $42 million completed vesting in 2015 ( $68 million in 2014 and $186 million in 2013 ). As of December 26, 2015 , there was $13 million in unrecognized compensation costs related to stock options granted under our equity incentive plans. We expect to recognize those costs over a weighted average period of approximately eight months . Stock option activity for each period was as follows: Number of Options (In Millions) Weighted Average Exercise Price December 29, 2012 202.8 $ 20.20 Granted 20.1 $ 22.99 Exercised (65.0 ) $ 18.76 Cancelled and forfeited (3.0 ) $ 22.58 Expired (1.9 ) $ 22.56 December 28, 2013 153.0 $ 21.10 Granted 0.6 $ 25.34 Exercised (63.7 ) $ 19.87 Cancelled and forfeited (2.7 ) $ 23.70 Expired (9.9 ) $ 27.00 December 27, 2014 77.3 $ 21.30 Granted — $ — Exercised (21.9 ) $ 20.34 Cancelled and forfeited (1.1 ) $ 23.23 Expired (0.1 ) $ 20.87 December 26, 2015 54.2 $ 21.65 Options exercisable as of: December 28, 2013 111.5 $ 20.25 December 27, 2014 54.7 $ 20.29 December 26, 2015 43.8 $ 21.07 The aggregate intrinsic value of stock option exercises in 2015 was $284 million ( $611 million in 2014 and $265 million in 2013 ), which represents the difference between the exercise price and the value of our common stock at the time of exercise. No stock options were granted during 2015 . As of December 26, 2015 , outstanding options and exercisable options information, by range of exercise prices, was as follows: Outstanding Options Exercisable Options Range of Exercise Prices Number of Shares (In Millions) Weighted Average Remaining Contractual Life (In Years) Weighted Average Exercise Price Number of Shares (In Millions) Weighted Average Exercise Price $ 1.82 - $ 15.00 0.4 2.9 $ 11.70 0.4 $ 11.70 $ 15.01 - $ 20.00 21.7 0.8 $ 18.48 21.7 $ 18.48 $ 20.01 - $ 25.00 24.7 3.1 $ 22.92 16.9 $ 22.86 $ 25.01 - $ 27.42 7.4 3.3 $ 27.15 4.8 $ 27.23 Total 54.2 2.2 $ 21.65 43.8 $ 21.07 These options will expire if they are not exercised by specific dates through April 2021 . Option exercise prices for options exercised during the three-year period ended December 26, 2015 ranged from $1.12 to $27.42 . Stock Purchase Plan Approximately 77% of our employees were participating in our 2006 Stock Purchase Plan as of December 26, 2015 ( 76% in 2014 and 76% in 2013 ). Employees purchased 15.8 million shares of common stock in 2015 for $421 million under the 2006 Stock Purchase Plan ( 19.4 million shares of common stock for $393 million in 2014 and 20.5 million shares of common stock for $369 million in 2013 ). As of December 26, 2015 , unrecognized share-based compensation costs related to rights to acquire shares of common stock under our stock purchase plan totaled $14 million . We expect to recognize those costs over a period of approximately two months .

Common Stock Repurchases

Common Stock Repurchases	12 Months Ended
	Dec. 26, 2015
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	Note 19: Common Stock Repurchases Common Stock Repurchase Program We have an ongoing authorization, originally approved by our Board of Directors in 2005, and subsequently amended, to repurchase up to $65.0 billion in shares of our common stock in open market or negotiated transactions. As of December 26, 2015 , $9.4 billion remained available for repurchase under the existing repurchase authorization limit. During 2015 , we repurchased 95.7 million shares of common stock at a cost of $3.0 billion ( 332.4 million shares of common stock at a cost of $10.8 billion in 2014 and 94.1 million shares of common stock at a cost of $2.1 billion in 2013 ). We have repurchased 4.8 billion shares of common stock at a cost of $104.9 billion since the program began in 1990. Restricted Stock Unit Withholdings We grant RSUs pursuant to the 2006 Plan. For the majority of RSUs granted, the number of shares of common stock issued on the date the RSUs vest is net of the minimum statutory withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. In our consolidated financial statements, we treat shares of common stock withheld for tax purposes on behalf of our employees in connection with the vesting of RSUs as common stock repurchases because they reduce the number of shares that would have been issued upon vesting. These withheld shares of common stock are not considered common stock repurchases under our authorized common stock repurchase plan . During 2015 , we withheld 13.5 million shares of common stock to satisfy $442 million ( 12.0 million shares of common stock to satisfy $332 million in 2014 and 13.1 million shares of common stock to satisfy $293 million in 2013 ) of employees’ tax obligations.

Gains (Losses) on Equity Invest

Gains (Losses) on Equity Investments, Net	12 Months Ended
	Dec. 26, 2015
Gains (Losses) on Equity Investments, Net [Abstract]
Gains (Losses) on Equity Investments, Net [Text Block]	Note 20: Gains (Losses) on Equity Investments, Net The components of gains (losses) on equity investments, net for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Share of equity method investee losses, net $ (95 ) $ (69 ) $ (69 ) Impairments (185 ) (146 ) (123 ) Gains on sales, net 145 422 515 Dividends 52 57 46 Other, net 398 147 102 Total gains (losses) on equity investments, net $ 315 $ 411 $ 471 The substantial majority of other, net for 2015 resulted from gains on third-party merger transactions, and the majority of gains on sales, net for 2014 resulted from gains on private equity sales. During 2013, we sold our shares in Clearwire Corporation, which had been accounted for as available-for-sale marketable equity securities, and our interest in Clearwire LLC, which had been accounted for as an equity method investment. We received proceeds of $142 million on the sale of our shares in Clearwire Corporation and $328 million on the sale of our interest in Clearwire LLC. The proceeds received on the sale of our shares in Clearwire Corporation and our interest in Clearwire LLC are included in "sales of available-for-sale investments" and "other investing," respectively, within investing activities on the consolidated statements of cash flows. During 2013, we recognized gains of $111 million on the sale of our shares in Clearwire Corporation and $328 million on the sale of our interest in Clearwire LLC. The total gain of $439 million on these transactions is included in "gains (losses) on equity investments, net" on the consolidated statements of income.

Interest and Other, Net

Interest and Other, Net	12 Months Ended
	Dec. 26, 2015
Interest and Other, Net [Abstract]
Interest and Other, Net [Text Block]	Note 21: Interest and Other, Net The components of interest and other, net for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Interest income $ 124 $ 141 $ 104 Interest expense (337 ) (192 ) (244 ) Other, net 108 94 (11 ) Total interest and other, net $ (105 ) $ 43 $ (151 ) Interest expense in the preceding table is net of $258 million of interest capitalized in 2015 ( $276 million in 2014 and $246 million in 2013 ). During 2015, we recognized an interest and other, net loss primarily due to higher interest expense, which includes the 2015 issuances of our $9.5 billion aggregate principal amount of senior unsecured notes. For further information on these transactions, see " Note 15: Borrowings ." This was partially offset by divestiture gains recognized in 2015. For further information on these transactions, see " Note 9: Divestitures ." During 2014, we completed the divestiture of our Intel Media assets. As a result of the transaction, we recognized a gain within "other, net" in the preceding table. For further information, see " Note 9: Divestitures ."

Earnings Per Share

Earnings Per Share	12 Months Ended
	Dec. 26, 2015
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	Note 22: Earnings Per Share We computed our basic and diluted earnings per share of common stock for each period as follows: Years Ended Dec 26, Dec 27, Dec 28, Net income available to common stockholders $ 11,420 $ 11,704 $ 9,620 Weighted average shares of common stock outstanding—basic 4,742 4,901 4,970 Dilutive effect of employee equity incentive plans 64 75 68 Dilutive effect of convertible debt 88 80 59 Weighted average shares of common stock outstanding—diluted 4,894 5,056 5,097 Basic earnings per share of common stock $ 2.41 $ 2.39 $ 1.94 Diluted earnings per share of common stock $ 2.33 $ 2.31 $ 1.89 We computed basic earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding during the period. We computed diluted earnings per share of common stock using net income available to common stockholders and the weighted average number of shares of common stock outstanding plus potentially dilutive shares of common stock outstanding during the period. Net income available to participating securities was insignificant for all periods presented. Potentially dilutive shares of common stock from employee incentive plans are determined by applying the treasury stock method to the assumed exercise of outstanding stock options, the assumed vesting of outstanding RSUs, and the assumed issuance of common stock under the stock purchase plan. Potentially dilutive shares of common stock for our 2005 debentures are determined by applying the if-converted method. However, as our 2009 debentures require settlement of the principal amount of the debt in cash upon conversion, with the conversion premium paid in cash or stock at our option, potentially dilutive shares of common stock are determined by applying the treasury stock method. For further discussion on the specific conversion features of our 2005 and 2009 debentures, see " Note 15: Borrowings ." In 2015 , we excluded on average 2 million outstanding stock options and RSUs from the computation of diluted earnings per share of common stock because these shares of common stock would have been anti-dilutive ( 10 million in 2014 and 55 million in 2013 ). These options could potentially be included in the diluted earnings per share of common stock calculation in the future if the average market value of the shares of common stock increases and is greater than the exercise price of these options. In all years presented, we included our 2009 debentures in the calculation of diluted earnings per share of common stock because the average market price was above the conversion price. We could potentially exclude the 2009 debentures in the future if the average market price is below the conversion price.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 26, 2015
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	Note 23: Income Taxes Income Tax Provision Income before taxes and the provision for taxes consisted of the following: Years Ended Dec 26, Dec 27, Dec 28, Income before taxes: U.S. $ 8,800 $ 11,565 $ 9,374 Non-U.S. 5,412 4,236 3,237 Total income before taxes 14,212 15,801 12,611 Provision for taxes: Current: Federal 2,828 3,374 2,730 State 40 38 68 Non-U.S. 842 969 716 Total current provision for taxes 3,710 4,381 3,514 Deferred: Federal (862 ) (263 ) (412 ) Other (56 ) (21 ) (111 ) Total deferred provision for taxes (918 ) (284 ) (523 ) Total provision for taxes $ 2,792 $ 4,097 $ 2,991 Effective tax rate 19.6 % 25.9 % 23.7 % The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows: Years Ended Dec 26, Dec 27, Dec 28, Statutory federal income tax rate 35.0 % 35.0 % 35.0 % Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates (7.9 ) (6.1 ) (5.8 ) Settlements, effective settlements, and related remeasurements (2.9 ) — — Domestic manufacturing deduction benefit (2.0 ) (2.1 ) (2.1 ) Research and development tax credits (1.7 ) (1.7 ) (3.5 ) Other (0.9 ) 0.8 0.1 Effective tax rate 19.6 % 25.9 % 23.7 % Most of the decrease in our effective tax rate in 2015 compared to 2014 was driven by one-time items, a higher proportion of our income from lower taxed jurisdictions, and our decision to indefinitely reinvest certain prior years’ non-U.S. earnings positively impacted our effective income tax rate. A substantial majority of the increase in our effective tax rate between 2014 and 2013 was driven by the reenacted U.S. R&D tax credit in 2013 containing two years' worth of R&D tax credits. The U.S. R&D tax credit was reenacted in the fourth quarter of 2014 retroactive for the full year. It was also reenacted in the first quarter of 2013 retroactive to the beginning of 2012. Income in certain non-U.S. countries is fully exempt from income taxes for a limited period of time due to eligible activities and certain capital investment actions. These full tax exemptions expire at various dates through 2023 ; however, the exemptions in certain countries are eligible for renewal. In 2015 , the tax benefit attributable to tax holidays was $85 million ( $166 million for 2014 and $213 million for 2013 ) with a $0.02 impact on diluted earnings per share ( $0.03 for 2014 and $0.04 for 2013 ). During 2015 , net income tax benefits attributable to equity-based compensation transactions that were allocated to stockholders’ equity totaled $172 million (net benefits of $103 million in 2014 and net benefits of $3 million in 2013 ). Deferred and Current Income Taxes Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Deferred tax assets: Accrued compensation and other benefits $ 931 $ 982 Share-based compensation 424 438 Deferred income 694 691 Inventory 598 339 State credits and net operating losses 613 519 Other, net 760 715 Gross deferred tax assets 4,020 3,684 Valuation allowance (701 ) (595 ) Total deferred tax assets 3,319 3,089 Deferred tax liabilities: Property, plant and equipment (505 ) (1,171 ) Licenses and intangibles (563 ) (576 ) Convertible debt (1,042 ) (977 ) Unrealized gains on investments and derivatives (717 ) (1,017 ) Investment in non-U.S. subsidiaries (37 ) (252 ) Other, net (358 ) (291 ) Total deferred tax liabilities (3,222 ) (4,284 ) Net deferred tax assets (liabilities) 97 (1,195 ) Reported as: Current deferred tax assets 2,036 1,958 Non-current deferred tax assets 600 622 Non-current deferred tax liabilities (2,539 ) (3,775 ) Net deferred tax assets (liabilities) $ 97 $ (1,195 ) Non-current deferred tax assets are included within other long-term assets on the consolidated balance sheets. The valuation allowance is based on our assessment that it is more likely than not that certain deferred tax assets will not be realized in the foreseeable future. The valuation allowance as of December 26, 2015 included allowances related to unrealized state credit carryforwards of $607 million and matters related to our non-U.S. subsidiaries of $94 million . As of December 26, 2015 , our federal, state, and non-U.S. net operating loss carryforwards for income tax purposes were $171 million , $101 million , and $384 million , respectively. A majority of the non-U.S. net operating loss carryforwards have no expiration date. The remaining non-U.S., as well as the U.S. federal and state net operating loss carryforwards, expire at various dates through 2035 . A significant amount of the net operating loss carryforwards in the U.S. relates to acquisitions and, as a result, is limited in the amount that can be recognized in any one year. The non-U.S. net operating loss carryforwards include $218 million that is not likely to be recovered and has been reduced by a valuation allowance. As of December 26, 2015 , we had not recognized U.S. deferred income taxes on a cumulative total of $26.9 billion of undistributed earnings for certain non-U.S. subsidiaries and $1.8 billion of other basis differences of our investments in certain non-U.S. subsidiaries, primarily related to McAfee. Determining the unrecognized deferred tax liability related to investments in these non-U.S. subsidiaries that are indefinitely reinvested is not practicable. We currently intend to indefinitely reinvest those earnings and other basis differences in operations outside the U.S. Current income taxes receivable of $468 million as of December 26, 2015 ( $79 million as of December 27, 2014 ) is included in other current assets. Current income taxes payable of $272 million as of December 26, 2015 ( $443 million as of December 27, 2014 ) is included in other accrued liabilities. Long-term income taxes payable of $114 million as of December 26, 2015 ( $262 million as of December 27, 2014 ) is included in other long-term liabilities, which includes uncertain tax positions, reduced by the associated federal deduction for state taxes and non-U.S. tax credits, and may also include other long-term tax liabilities that are not uncertain but have not yet been paid. Uncertain Tax Positions The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Beginning gross unrecognized tax benefits $ 577 $ 207 $ 189 Settlements and effective settlements with tax authorities and related remeasurements (452 ) (220 ) (2 ) Increases in balances related to tax positions taken during prior periods 4 173 21 Decreases in balances related to tax positions taken during prior periods (34 ) (1 ) (9 ) Increases in balances related to tax positions taken during current period 6 418 8 Ending gross unrecognized tax benefits $ 101 $ 577 $ 207 The related tax benefit for settlements, effective settlements, and remeasurements is $419 million for 2015 ( insignificant in 2014 and 2013 ). If the remaining balance of $101 million of unrecognized tax benefits as of December 26, 2015 ( $577 million as of December 27, 2014 ) were recognized in a future period, it would result in a tax benefit of $32 million ( $485 million as of December 27, 2014 ) and a reduction in the effective tax rate. During all years presented, we recognized interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. Interest and penalties related to unrecognized tax benefits were insignificant in 2015 ( $21 million in 2014 and insignificant in 2013 ). As of December 26, 2015 , we had $34 million of accrued interest and penalties related to unrecognized tax benefits ( $44 million as of December 27, 2014 ). Our tax policy is to comply with the laws, regulations, and filing requirements of all jurisdictions in which we conduct business. We regularly engage in discussions and negotiations with tax authorities regarding tax matters in various jurisdictions. Although the timing of the resolutions and/or closures of audits is highly uncertain, it is reasonably possible that certain U.S. federal and non-U.S. tax audits may be concluded within the next 12 months, which could significantly increase or decrease the balance of our gross unrecognized tax benefits. However, the estimated impact of income tax expense and net income is not expected to be significant. We file federal, state, and non-U.S. tax returns. For state and non-U.S. tax returns, we are generally no longer subject to tax examinations for years prior to 2002 . For federal tax returns, we are no longer subject to tax examination for years prior to 2009 .

Other Comprehensive Income (Los

Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 26, 2015
Equity [Abstract]
Other Comprehensive Income (Loss) [Text Block]	Note 24: Other Comprehensive Income (Loss) The components of other comprehensive income (loss) and related tax effects for each period were as follows: December 26, 2015 December 27, 2014 December 28, 2013 Years Ended Before Tax Tax Net of Tax Before Tax Tax Net of Tax Before Tax Tax Net of Tax Change in unrealized holding gains (losses) on available-for-sale investments $ (999 ) $ 350 $ (649 ) $ 1,029 $ (359 ) $ 670 $ 1,963 $ (687 ) $ 1,276 Less: adjustment for (gains) losses on available-for-sale investments included in net income (93 ) 32 (61 ) (142 ) 49 (93 ) (146 ) 51 (95 ) Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income — (18 ) (18 ) — (41 ) (41 ) — (26 ) (26 ) Change in unrealized holding gains (losses) on derivatives (298 ) 93 (205 ) (589 ) 160 (429 ) (166 ) 76 (90 ) Less: adjustment for (gains) losses on derivatives included in net income 522 (160 ) 362 13 (11 ) 2 30 (29 ) 1 Change in net prior service (costs) credits (2 ) 1 (1 ) (42 ) 5 (37 ) 17 (2 ) 15 Less: adjustment for amortization of net prior service costs (credits) 10 (2 ) 8 6 (2 ) 4 4 (1 ) 3 Change in actuarial gains (losses) 73 7 80 (433 ) 3 (430 ) 725 (275 ) 450 Less: adjustment for amortization of actuarial (gains) losses 67 (19 ) 48 37 (9 ) 28 101 (31 ) 70 Change in net foreign currency translation adjustment (187 ) 17 (170 ) (275 ) 24 (251 ) 45 (7 ) 38 Other comprehensive income (loss) $ (907 ) $ 301 $ (606 ) $ (396 ) $ (181 ) $ (577 ) $ 2,573 $ (931 ) $ 1,642 In prior periods, we recorded a reversal of a portion of our deferred tax asset valuation allowance attributed to changes in unrealized holding gains on our available-for-sale investments. This amount is reduced and included in our provision for taxes as these investments mature or are sold, and is included in the preceding table as an adjustment for (gains) losses on deferred tax asset valuation allowance included in net income. The change in actuarial valuation in 2014 in the preceding table includes $1.4 billion in actuarial losses arising during the year offset by a $1.0 billion reduction in losses due to a freeze of future benefit accruals in the U.S. Intel Minimum Pension Plan. For further information, see " Note 16: Retirement Benefit Plans ." The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows: (In Millions) Unrealized Holding Gains (Losses) on Available-for-Sale Investments Deferred Tax Asset Valuation Allowance Unrealized Holding Gains (Losses) on Derivatives Prior Service Credits (Costs) Actuarial Gains (Losses) Foreign Currency Translation Adjustment Total December 28, 2013 $ 1,882 $ 67 $ 4 $ (14 ) $ (602 ) $ (94 ) $ 1,243 Other comprehensive income (loss) before reclassifications 1,029 — (589 ) (42 ) (433 ) (275 ) (310 ) Amounts reclassified out of accumulated other comprehensive income (loss) (142 ) — 13 6 37 — (86 ) Tax effects (310 ) (41 ) 149 3 (6 ) 24 (181 ) Other comprehensive income (loss) 577 (41 ) (427 ) (33 ) (402 ) (251 ) (577 ) December 27, 2014 2,459 26 (423 ) (47 ) (1,004 ) (345 ) 666 Other comprehensive income (loss) before reclassifications (999 ) — (298 ) (2 ) 73 (187 ) (1,413 ) Amounts reclassified out of accumulated other comprehensive income (loss) (93 ) — 522 10 67 — 506 Tax effects 382 (18 ) (67 ) (1 ) (12 ) 17 301 Other comprehensive income (loss) (710 ) (18 ) 157 7 128 (170 ) (606 ) December 26, 2015 $ 1,749 $ 8 $ (266 ) $ (40 ) $ (876 ) $ (515 ) $ 60 The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, with presentation location, for each period were as follows: Income Before Taxes Impact for Years Ended (In Millions) Comprehensive Income Components Dec 26, Dec 27, Dec 28, Location Unrealized holding gains (losses) on available-for-sale investments: $ 2 $ 10 $ 8 Interest and other, net 91 132 138 Gains (losses) on equity investments, net 93 142 146 Unrealized holding gains (losses) on derivatives: Currency forwards (290 ) (31 ) (61 ) Cost of Sales (177 ) 18 30 Research and development (46 ) 2 — Marketing, general and administrative Other instruments — (2 ) 1 Cost of Sales (9 ) — — Interest and other, net (522 ) (13 ) (30 ) Amortization of pension and postretirement benefit components: Prior service credits (costs) (10 ) (6 ) (4 ) Actuarial gains (losses) (67 ) (37 ) (101 ) (77 ) (43 ) (105 ) Total amounts reclassified out of accumulated other comprehensive income (loss) $ (506 ) $ 86 $ 11 The amortization of pension and postretirement benefit components are included in the computation of net periodic benefit cost. For further information, see " Note 16: Retirement Benefit Plans ." The estimated net prior service costs and net actuarial losses for the defined-benefit plans that will be amortized from accumulated other comprehensive income (loss) into net periodic benefit cost during 2016 are $7 million and $42 million , respectively. We estimate that we will reclassify approximately $185 million (before taxes) of net derivative losses included in accumulated other comprehensive income (loss) into earnings within the next 12 months.

Contingencies

Contingencies	12 Months Ended
	Dec. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
Contingencies [Text Block]	Note 25: Contingencies Legal Proceedings We are a party to various legal proceedings, including those noted in this section. Although management at present believes that the ultimate outcome of these proceedings, individually and in the aggregate, will not materially harm our financial position, results of operations, cash flows, or overall trends, legal proceedings and related government investigations are subject to inherent uncertainties, and unfavorable rulings or other events could occur. Unfavorable resolutions could include substantial monetary damages. In addition, in matters for which injunctive relief or other conduct remedies are sought, unfavorable resolutions could include an injunction or other order prohibiting us from selling one or more products at all or in particular ways, precluding particular business practices, or requiring other remedies. An unfavorable outcome may result in a material adverse impact on our business, results of operations, financial position, and overall trends. We might also conclude that settling one or more such matters is in the best interests of our stockholders, employees, and customers, and any such settlement could include substantial payments. Except as specifically described below, we have not concluded that settlement of any of the legal proceedings noted in this section is appropriate at this time. Government Competition Matters and Related Consumer Class Actions A number of proceedings generally have challenged and continue to challenge certain of our competitive practices. The allegations in these proceedings vary and are described in more detail in the following paragraphs. In general, they contend that we improperly conditioned price rebates and other discounts on our microprocessors on exclusive or near-exclusive dealing by some of our customers; and they allege that our software compiler business unfairly preferred Intel microprocessors over competing microprocessors and that, through the use of our compilers and other means, we have caused the dissemination of inaccurate and misleading benchmark results concerning our microprocessors. Based on the procedural posture of the various remaining competition matters, which we describe in the following paragraphs, our investment of resources to explain and defend our position has declined as compared to the period 2005-2011. Nonetheless, certain of the matters remain active, and these challenges could continue for a number of years, potentially requiring us to invest additional resources. We believe that we compete lawfully and that our marketing, business, intellectual property, and other challenged practices benefit our customers and our stockholders, and we will continue to conduct a vigorous defense in the remaining proceedings. In 2001, the European Commission (EC) commenced an investigation regarding claims by Advanced Micro Devices, Inc. (AMD) that we used unfair business practices to persuade customers to buy our microprocessors. We received numerous requests for information and documents from the EC and we responded to each of those requests. The EC issued a Statement of Objections in July 2007 and held a hearing on that Statement in March 2008. The EC issued a Supplemental Statement of Objections in July 2008. In May 2009, the EC issued a decision finding that we had violated Article 82 of the EC Treaty and Article 54 of the European Economic Area Agreement. In general, the EC found that we violated Article 82 (later renumbered as Article 102 by a new treaty) by offering alleged "conditional rebates and payments" that required our customers to purchase all or most of their x86 microprocessors from us. The EC also found that we violated Article 82 by making alleged "payments to prevent sales of specific rival products." The EC imposed a fine in the amount of €1.1 billion ( $1.4 billion as of May 2009), which we subsequently paid during the third quarter of 2009, and ordered us to "immediately bring to an end the infringement referred to in" the EC decision. The EC decision contained no specific direction on whether or how we should modify our business practices. Instead, the decision stated that we should "cease and desist" from further conduct that, in the EC's opinion, would violate applicable law. We took steps, which are subject to the EC's ongoing review, to comply with that decision pending appeal. We had discussions with the EC to better understand the decision and to explain changes to our business practices. We appealed the EC decision to the Court of First Instance (which has been renamed the General Court) in July 2009. The hearing of our appeal took place in July 2012. In June 2014, the General Court rejected our appeal in its entirety. In August 2014, we filed an appeal with the European Court of Justice. On November 11, 2014, Intervener Association for Competitive Technologies filed comments in support of Intel’s grounds of appeal. The EC and interveners filed briefs in November 2014, we filed a reply in February 2015, and the EC filed a rejoinder in April 2015. The Court of Justice is likely to hold oral argument and issue its decision in 2016. At least 82 separate class-action lawsuits have been filed in the U.S. District Courts for the Northern District of California, Southern District of California, District of Idaho, District of Nebraska, District of New Mexico, District of Maine, and District of Delaware, as well as in various California, Kansas, and Tennessee state courts. These actions generally repeat the allegations made in a now-settled lawsuit filed against us by AMD in June 2005 in the U.S. District Court for the District of Delaware (AMD litigation). Like the AMD litigation, these class-action lawsuits allege that we engaged in various actions in violation of the Sherman Act and other laws by, among other things: providing discounts and rebates to our manufacturer and distributor customers conditioned on exclusive or near-exclusive dealing that allegedly unfairly interfered with AMD's ability to sell its microprocessors; interfering with certain AMD product launches; and interfering with AMD's participation in certain industry standards-setting groups. The class actions allege various consumer injuries, including that consumers in various states have been injured by paying higher prices for computers containing our microprocessors. We dispute these class-action claims and intend to defend the lawsuits vigorously. All of the federal and state class actions other than the California class actions were transferred by the Multidistrict Litigation Panel to the U.S. District Court in Delaware for all pre-trial proceedings and discovery (MDL proceedings). The Delaware district court appointed a Special Master to address issues in the MDL proceedings, as assigned by the court. In January 2010, the plaintiffs in the Delaware action filed a motion for sanctions for our alleged failure to preserve evidence. This motion largely copies a motion previously filed by AMD in the AMD litigation, which has settled. The plaintiffs in the MDL proceedings also moved for certification of a class of members who purchased certain personal computers containing products sold by us. In July 2010, the Special Master issued a Report and Recommendation (Report) denying the motion to certify a class. The MDL plaintiffs filed objections to the Special Master's Report, and a hearing on those objections was held before the district court in July 2013. In July 2014, the district court affirmed the Special Master's ruling and issued an order denying the MDL plaintiffs' motion for class certification. In August 2014, plaintiffs filed a petition for interlocutory appeal of the district court's decision with the U.S. Court of Appeals for the Third Circuit, which the Third Circuit denied in October 2014. In December 2014, Intel filed a motion for summary judgment on the claims of the remaining individual plaintiffs. We subsequently negotiated a settlement of the claims and the case was dismissed in September 2015. All California class actions have been consolidated in the Superior Court of California in Santa Clara County. The plaintiffs in the California actions moved for class certification, which we are in the process of opposing. At our request, the court in the California actions agreed to delay ruling on this motion until after the Delaware district court ruled on the similar motion in the MDL proceedings. The plaintiffs asked the court for leave to retain a new expert and to amend their previous motion for class certification. The court granted plaintiffs’ request in February 2015 and the hearing on plaintiffs’ amended class certification motion took place in January 2016; we are awaiting the court's decision. Given the procedural posture and the nature of these cases, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from these matters. In re High Tech Employee Antitrust Litigation Between May and July 2011, former employees of Intel, Adobe Systems Incorporated, Apple Inc., Google Inc., Intuit Inc., Lucasfilm Ltd., and Pixar filed antitrust class-action lawsuits in the California Superior Courts alleging that these companies had entered into a conspiracy to suppress the compensation of their employees. The lawsuits were removed to the United States District Court for the Northern District of California and in September 2011 the plaintiffs filed a consolidated amended complaint, captioned In re High Tech Employee Antitrust Litigation . The plaintiffs’ allegations reference the 2009 and 2010 investigation by the Department of Justice (DOJ) into employment practices in the technology industry, as well as the DOJ’s complaints and subsequent stipulated final judgments with the seven companies named as defendants in the lawsuits. The plaintiffs allege that the defendants entered into certain unlawful agreements not to cold call employees of particular other defendants and that there was an overarching conspiracy among the defendants. Plaintiffs assert one such agreement specific to Intel, namely that Intel and Google entered into an agreement starting in 2005, not to cold call each other's employees. Plaintiffs assert claims under Section 1 of the Sherman Antitrust Act and Section 4 of the Clayton Antitrust Act and seek a declaration that the defendants’ alleged actions violated the antitrust laws, damages trebled as provided for by law under the Sherman Act or Clayton Act, restitution and disgorgement, and attorneys’ fees and costs. In October 2013, the district court certified a class consisting of approximately 65,000 current or former employees of the seven defendants and set the matter for trial in late May 2014. The so-called "technical class" consists of a group of current and former technical, creative, and R&D employees at each of the defendants. In January 2014, Intel filed a motion for summary judgment, which the court denied in March 2014. In April 2014, Intel, Adobe, Apple, and Google reached an agreement with plaintiffs to settle this lawsuit, but in August 2014, the district court denied preliminary approval of the settlement. In September 2014, defendants filed a petition for writ of mandamus asking the U.S. Court of Appeals for the Ninth Circuit to reverse the district court’s decision. The Ninth Circuit ordered briefing and scheduled a March 2015 hearing date on the writ petition. Defendants have withdrawn the petition for writ of mandamus in light of the settlement agreement discussed below. In January 2015, Intel, Adobe, Apple, and Google reached a second agreement with plaintiffs to settle this lawsuit, which the court preliminarily approved in March 2015. The court held a final fairness hearing in July 2015, and in September 2015, gave its final approval of the settlement and entered final judgment in the lawsuit. We made our settlement payment in October 2015, which we accrued for in our operating expenses for 2014. Although we disputed the plaintiffs’ claims, we agreed to settle the lawsuit to avoid the uncertainties, expenses, and diversion of resources from continued litigation. In re Intel Corporation Shareholder Derivative Litigation regarding High Tech Employee Antitrust Litigation In March 2014, the Police Retirement System of St. Louis (PRSSL) filed a shareholder derivative action in the Superior Court of California in Santa Clara County against Intel, certain current and former members of our Board of Directors and a current officer. The complaint alleges that the defendants breached their duties to the company by participating in, or allowing, alleged antitrust violations, which were alleged in In re High Tech Employee Antitrust Litigation . In March 2014, a second plaintiff, Barbara Templeton, filed a substantially similar derivative suit in the same court. In May 2014, a third shareholder, Robert Achermann, filed a substantially similar derivative action in the same court. The court consolidated the three actions into one, which is captioned In re Intel Corporation Shareholder Derivative Litigation . Plaintiffs filed a consolidated complaint in July 2014. In August 2015, the court granted our motion to dismiss the consolidated complaint. The plaintiffs thereafter filed a motion for reconsideration and a motion for new trial, both of which the court denied in October 2015. In November 2015, plaintiffs PRSSL and Templeton appealed the court's decision. In June 2015, the International Brotherhood of Electrical Workers (IBEW) filed a shareholder derivative action in the Chancery Court in Delaware against Intel, certain current and former members of our Board of Directors, and a current officer. The lawsuit makes allegations that are substantially similar to those in the California shareholder derivative litigation described above, but contain additional allegations regarding breach of the duty of disclosure surrounding the In re High Tech Employee Antitrust Litigation and that the Intel 2013 and 2014 proxy statements were false and misleading in that they misrepresented the effectiveness of the Board’s oversight of compliance issues at Intel and the Board’s compliance with Intel’s Code of Conduct and Board of Director Guidelines on Significant Corporate Governance Issues. In October 2015, the court stayed the IBEW lawsuit for six months pending further developments in the California case. Lehman Brothers Holdings Inc. and Lehman Brothers OTC Derivatives Inc. v. Intel In May 2013, Lehman Brothers OTC Derivatives Inc. (LOTC) and Lehman Brothers Holdings Inc. (LBHI) filed an adversary complaint in the United States Bankruptcy Court in the Southern District of New York asserting claims against us arising from a 2008 contract between Intel and LOTC. Under the terms of the 2008 contract, we prepaid $1.0 billion to LOTC, in exchange for which LOTC was required to deliver to us on or before September 29, 2008, quantities of Intel common stock and cash determined by a formula set forth in the contract. LOTC's performance under the contract was secured by $1.0 billion of cash collateral. Under the terms of the contract, LOTC was obligated to deliver approximately 50 million shares of our common stock to us on September 29, 2008. LOTC failed to deliver any Intel common stock or cash, and we exercised our right of setoff against the $1.0 billion collateral. LOTC and LBHI acknowledge in their complaint that we were entitled to set off our losses against the collateral, but they assert that we withheld collateral in excess of our losses that should have been returned to LOTC. The complaint asserts a claim for breach of contract, a claim for turnover under section 542(a) of the Bankruptcy Code, and a claim for violation of the automatic stay under section 362(a)(3) of the Bankruptcy Code. The complaint does not expressly quantify the amount of damages claimed, but does assert multiple theories of damages that impliedly seek up to $312 million of alleged excess collateral, plus interest at LIBOR plus 13.5% , compounded daily. In June 2013, we filed a motion to dismiss plaintiffs' bankruptcy claims and for a determination that the breach of contract claim is "non-core" under the Bankruptcy Code. The bankruptcy court granted our motion in its entirety in December 2013. In May 2014, the United States District Court for the Southern District of New York denied our request that it withdraw its reference of plaintiffs' adversary complaint to the bankruptcy court. In January 2015, Intel and the plaintiffs filed competing motions for summary judgment. Plaintiffs' motion requested judgment against Intel "in the amount of no less than" $129 million , plus interest. In September 2015, the bankruptcy court ruled in favor of Intel and issued proposed findings of fact and conclusions of law recommending that the district court deny plaintiffs’ motion for summary judgment and grant Intel’s motion for summary judgment. In October 2015, plaintiffs voluntarily dismissed the lawsuit with prejudice. McAfee, Inc. Shareholder Litigation On August 19, 2010, we announced that we had agreed to acquire all of the common stock of McAfee, Inc. (McAfee) for $48.00 per share. Four McAfee shareholders filed putative class-action lawsuits in Santa Clara County, California Superior Court challenging the proposed transaction. The cases were ordered consolidated in September 2010. Plaintiffs filed an amended complaint that named former McAfee board members, McAfee, and Intel as defendants, and alleged that the McAfee board members breached their fiduciary duties and that McAfee and Intel aided and abetted those breaches of duty. The complaint requested rescission of the merger agreement, such other equitable relief as the court may deem proper, and an award of damages in an unspecified amount. In June 2012, the plaintiffs’ damages expert asserted that the value of a McAfee share for the purposes of assessing damages should be $62.08 . In January 2012, the court certified the action as a class action, appointed the Central Pension Laborers’ Fund to act as the class representative, and scheduled trial to begin in January 2013. In March 2012, defendants filed a petition with the California Court of Appeal for a writ of mandate to reverse the class certification order; the petition was denied in June 2012. In March 2012, at defendants’ request, the court held that plaintiffs were not entitled to a jury trial, and ordered a bench trial. In April 2012, plaintiffs filed a petition with the California Court of Appeal for a writ of mandate to reverse that order, which the court of appeal denied in July 2012. In August 2012, defendants filed a motion for summary judgment. The trial court granted that motion in November 2012, and entered final judgment in the case in February 2013. In April 2013, plaintiffs appealed the final judgment. Intel, McAfee, and McAfee’s board of directors filed an opposition to plaintiff’s appeal in December 2014. Because the resolution of the appeal may materially impact the scope and nature of the proceeding, we are unable to make a reasonable estimate of the potential loss or range of losses, if any, arising from this matter. We dispute the class-action claims and intend to continue to defend the lawsuit vigorously.

Operating Segments and Geograph

Operating Segments and Geographic Information	12 Months Ended
	Dec. 26, 2015
Segment Reporting [Abstract]
Operating Segments and Geographic Information [Text Block]	Note 26: Operating Segments and Geographic Information Our operating segments in effect as of December 26, 2015 included: • Client Computing Group • All other • Data Center Group • Non-Volatile Memory Solutions Group • Internet of Things Group • New Devices Group • Software and services operating segments • Intel Security Group • Software and Services Group During the first quarter of 2015, we combined the PC Client Group and Mobile and Communications Group to create the Client Computing Group (CCG). This change in our organizational structure reflects our strategy to address all aspects of the client computing market segment and utilize our intellectual property to offer compelling customer solutions for a wide range of end-user devices. All prior-period amounts have been retrospectively adjusted to reflect the way we internally manage and monitor segment performance starting in fiscal year 2015, and include other minor reorganizations. Additionally, in the fourth quarter of 2015 we renamed the McAfee operating segment as the Intel Security Group. The Chief Operating Decision Maker (CODM) is our CEO. The CODM allocates resources to and assesses the performance of each operating segment using information about its revenue and operating income (loss). We manage our business activities primarily based on a product segmentation basis. CCG and the Data Center Group (DCG) are our reportable operating segments. The Internet of Things Group and the aggregated "software and services operating segments," as shown in the preceding operating segment list, do not meet the quantitative thresholds to qualify as reportable operating segments; however, we have elected to disclose the results of these non-reportable operating segments. Our Non-Volatile Memory Solutions Group (NSG) and New Devices Group operating segments do not meet the quantitative thresholds to qualify as reportable segments and their combined results are included within the "all other" category. Revenue for our reportable and aggregated non-reportable operating segments is primarily related to the following product lines: • Client Computing Group . Includes platforms designed for notebooks (including Ultrabook devices), 2 in 1 systems, desktops (including all-in-ones and high-end enthusiast PCs), tablets, phones, wireless and wired connectivity products, and mobile communication components. • Data Center Group. Includes platforms designed for the enterprise, cloud, communications infrastructure, and technical computing segments. • Internet of Things Group. Includes platforms designed for Internet of Things market segments, including retail, transportation, industrial, and buildings and home use, along with a broad range of other market segments. • Software and services operating segments. Includes software products designed to deliver innovative solutions that secure computers, mobile devices, and networks, and software products and services that promote Intel architecture as the platform of choice for software development. We have sales and marketing, manufacturing, engineering, finance, and administration groups. Expenses for these groups are generally allocated to the operating segments, and the expenses are included in the following operating results. The "all other" category includes revenue and expenses such as: • results of operations from our NSG and New Devices Group; • amounts included within restructuring and asset impairment charges; • a portion of employee benefits, compensation, and other expenses not allocated to the operating segments; • divested businesses for which discrete operating results are not regularly reviewed by our CODM; • results of operations of start-up businesses that support our initiatives, including our foundry business; and • acquisition-related costs, including amortization and any impairment of acquisition-related intangibles and goodwill. The CODM does not evaluate operating segments using discrete asset information. Based on the interchangeable nature of our manufacturing and assembly and test assets, most of the related depreciation expense is not directly identifiable within our operating segments, as it is included in overhead cost pools and subsequently absorbed into inventory as each product passes through our manufacturing process. As our products are then sold across multiple operating segments, it is impracticable to determine the total depreciation expense included as a component of each operating segment’s operating income (loss) results. Operating segments do not record inter-segment revenue. We do not allocate gains and losses from equity investments, interest and other income, or taxes to operating segments. Although the CODM uses operating income to evaluate the segments, operating costs included in one segment may benefit other segments. Except for these differences, the accounting policies for segment reporting are the same as for Intel as a whole. Net revenue and operating income (loss) for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Net revenue: Client Computing Group Platform $ 30,654 $ 33,210 $ 32,385 Other 1,565 1,662 2,260 32,219 34,872 34,645 Data Center Group Platform 14,882 13,366 11,219 Other 1,095 1,021 944 15,977 14,387 12,163 Internet of Things Platform 1,976 1,814 1,485 Other 322 328 316 2,298 2,142 1,801 Software and services operating segments 2,167 2,216 2,188 All other 2,694 2,253 1,911 Total net revenue $ 55,355 $ 55,870 $ 52,708 Operating income (loss): Client Computing Group $ 8,165 $ 10,323 $ 8,708 Data Center Group 7,844 7,390 5,456 Internet of Things Group 515 583 532 Software and services operating segments 210 81 57 All other (2,732 ) (3,030 ) (2,462 ) Total operating income $ 14,002 $ 15,347 $ 12,291 Hewlett-Packard Company , our largest customer in 2014, separated into HP Inc. and Hewlett Packard Enterprise Company on November 1, 2015. These entities collectively accounted for 18% of our net revenue in 2015 ( 18% in 2014 and 17% in 2013 ). Dell Inc. accounted for 15% of our net revenue ( 16% in 2014 and 15% in 2013 ), and Lenovo Group Limited accounted for 13% of our net revenue ( 12% in 2014 and 12% in 2013 ). A majority of the revenue from these customers was from the sale of platforms and other components by the CCG and DCG operating segments. Net revenue by country as presented below is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows: Years Ended Dec 26, Dec 27, Dec 28, China (including Hong Kong) $ 11,679 $ 11,197 $ 9,890 Singapore 11,544 11,573 10,997 United States 11,121 9,828 9,091 Taiwan 10,661 8,955 8,888 Other countries 10,350 14,317 13,842 Total net revenue $ 55,355 $ 55,870 $ 52,708 Revenue from unaffiliated customers outside the U.S. totaled $44.2 billion in 2015 ( $46.0 billion in 2014 and $43.6 billion in 2013 ). Net property, plant and equipment by country at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Dec 28, United States $ 22,611 $ 24,020 $ 23,624 Ireland 5,789 5,433 2,986 Israel 1,661 1,957 2,667 Other countries 1,797 1,828 2,151 Total property, plant and equipment, net $ 31,858 $ 33,238 $ 31,428 Net property, plant and equipment outside the U.S. totaled $9.2 billion as of December 26, 2015 ( $9.2 billion as of December 27, 2014 and $7.8 billion as of December 28, 2013 ).

Valuation and Qualifying Accoun

Valuation and Qualifying Accounts	12 Months Ended
	Dec. 26, 2015
Valuation and Qualifying Accounts [Abstract]
SCHEDULE II-VALUATION AND QUALIFYING ACCOUNTS [Text Block]	INTEL CORPORATION SCHEDULE II—VALUATION AND QUALIFYING ACCOUNTS Years Ended Balance at Beginning of Year Additions Charged to Expenses/ Other Accounts Net (Deductions) Recoveries Balance at End of Year Allowance for doubtful receivables December 26, 2015 $ 38 $ 12 $ (10 ) $ 40 December 27, 2014 $ 38 $ 10 $ (10 ) $ 38 December 28, 2013 $ 38 $ 5 $ (5 ) $ 38 Valuation allowance for deferred tax assets December 26, 2015 $ 595 $ 190 $ (84 ) $ 701 December 27, 2014 $ 456 $ 128 $ 11 $ 595 December 28, 2013 $ 389 $ 88 $ (21 ) $ 456 Deductions in allowance for doubtful receivables represent uncollectible accounts written off, net of recoveries.

Accounting Policies (Policies)

Accounting Policies (Policies)	12 Months Ended
	Dec. 26, 2015
Accounting Policies [Abstract]
Use of Estimates [Policy Text Block]	Use of Estimates The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles requires us to make estimates and judgments that affect the amounts reported in our consolidated financial statements and the accompanying notes. The accounting estimates that require our most significant, difficult, and subjective judgments include: • the valuation of non-marketable equity investments and the determination of other-than-temporary impairments; • the determination of useful lives for our property, plant and equipment and the related timing of when depreciation should begin; • the valuation and allocation of assets acquired and liabilities assumed in connection with business combinations; • the valuation and recoverability of long-lived assets (property, plant and equipment; goodwill; and identified intangibles); • the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions); • the valuation of inventory; and • the recognition and measurement of loss contingencies. The actual results that we experience may differ materially from our estimates.
Fair Value [Policy Text Block]	Fair Value Fair value is the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. When determining fair value, we consider the principal or most advantageous market in which we would transact, and we consider assumptions that market participants would use when pricing the asset or liability. Our financial assets are measured and recorded at fair value, except for cost method investments, cost method loans receivable, equity method investments, grants receivable, and reverse repurchase agreements with original maturities greater than approximately three months. Substantially all of our liabilities are not measured and recorded at fair value. Fair Value Hierarchy The three levels of inputs that may be used to measure fair value are as follows: Level 1. Quoted prices in active markets for identical assets or liabilities. Level 2. Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities, quoted prices in less active markets, or model-derived valuations in which all significant inputs are observable or can be derived principally from or corroborated with observable market data for substantially the full term of the assets or liabilities. Level 2 inputs also include non-binding market consensus prices that can be corroborated with observable market data, as well as quoted prices that were adjusted for security-specific restrictions. Level 3. Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of assets or liabilities. Level 3 inputs also include non-binding market consensus prices or non-binding broker quotes that we were unable to corroborate with observable market data. For further discussion of fair value, see " Note 4: Fair Value " and " Note 16: Retirement Benefit Plans ."
Cash Equivalents [Policy Text Block]	Cash Equivalents We consider all highly liquid debt investments with original maturities from the date of purchase of approximately three months or less as cash equivalents. Cash equivalents can include investments such as corporate debt, financial institution instruments, government debt, and reverse repurchase agreements classified as cash equivalents. See " Note 4: Fair Value " for the instruments held as cash equivalents.
Trading Assets [Policy Text Block]	Trading Assets Marketable debt instruments are generally designated as trading assets when a market risk is economically hedged at inception with a related derivative instrument, or when the marketable debt instrument itself is used to economically hedge foreign exchange rate risk from remeasurement. Investments designated as trading assets are reported at fair value. The gains or losses of these investments arising from changes in fair value due to interest rate and currency market fluctuations and credit market volatility, largely offset by losses or gains on the related derivative instruments and balance sheet remeasurement, are recorded in interest and other, net. We also designate certain floating-rate securitized financial instruments, primarily asset-backed securities, as trading assets.
Available-for-Sale Investments [Policy Text Block]	Available-for-Sale Investments We consider all liquid available-for-sale debt instruments with original maturities from the date of purchase of approximately three months or less to be cash and cash equivalents. Available-for-sale debt instruments with original maturities at the date of purchase greater than approximately three months and remaining maturities of less than one year are classified as short-term investments. Available-for-sale debt instruments with remaining maturities beyond one year are classified as other long-term investments. Investments that we designate as available-for-sale are reported at fair value, with unrealized gains and losses, net of tax, recorded in accumulated other comprehensive income (loss), except as noted in the "Other-Than-Temporary Impairment" section that follows. We determine the cost of the investment sold based on an average cost basis at the individual security level. Our available-for-sale investments include: • Marketable debt instruments when the interest rate and foreign currency risks are not hedged at the inception of the investment or when our criteria for designation as trading assets are not met. We generally hold these debt instruments to generate a return commensurate with the U.S.-dollar three-month LIBOR. We record the interest income and realized gains and losses on the sale of these instruments in interest and other, net. • Marketable equity securities when there is no plan to sell or hedge the investment at the time of original classification. We acquire these equity investments to promote business and strategic objectives. To the extent that these investments continue to have strategic value, we typically do not attempt to reduce or eliminate the equity market risks through hedging activities. We record the realized gains or losses on the sale or exchange of marketable equity securities in gains (losses) on equity investments, net.
Non-Marketable and Other Equity Investments [Policy Text Block]	Non-Marketable and Other Equity Investments Our non-marketable equity and other equity investments are included in other long-term assets. We account for non-marketable equity and other equity investments for which we do not have control over the investee as: • Equity method investments when we have the ability to exercise significant influence, but not control, over the investee. Equity method investments include marketable and non-marketable investments. Our proportionate share of the income or loss is recognized on a one-quarter lag and is recorded in gains (losses) on equity investments, net. • Non-marketable cost method investments when the equity method does not apply. We record the realized gains or losses on the sale of equity method and non-marketable cost method investments in gains (losses) on equity investments, net.
Other-Than-Temporary Impairment [Policy Text Block]	Other-Than-Temporary Impairment Our available-for-sale investments and non-marketable and other equity investments are subject to a periodic impairment review. Investments are considered impaired when the fair value is below the investment’s adjusted cost basis. Impairments affect earnings as follows: • Marketable debt instruments when the fair value is below amortized cost and we intend to sell the instrument, or when it is more likely than not that we will be required to sell the instrument before recovery of its amortized cost basis, or when we do not expect to recover the entire amortized cost basis of the instrument (that is, a credit loss exists). When we do not expect to recover the entire amortized cost basis of the instrument, we separate other-than-temporary impairments into amounts representing credit losses, which are recognized in interest and other, net, and amounts related to all other factors, which are recognized in other comprehensive income (loss). • Marketable equity securities based on the specific facts and circumstances present at the time of assessment, which include the consideration of general market conditions, the duration and extent to which the fair value is below cost, and our ability and intent to hold the investment for a sufficient period of time to allow for recovery of value in the foreseeable future. We also consider specific adverse conditions related to the financial health of, and the business outlook for, the investee, which may include industry and sector performance, changes in technology, operational and financing cash flow factors, and changes in the investee’s credit rating. We record other-than-temporary impairments on marketable equity securities and marketable equity method investments in gains (losses) on equity investments, net. • Non-marketable equity investments based on our assessment of the severity and duration of the impairment, and qualitative and quantitative analysis, including: • the investee’s revenue and earnings trends relative to pre-defined milestones and overall business prospects; • the technological feasibility of the investee’s products and technologies; • the general market conditions in the investee’s industry or geographic area, including adverse regulatory or economic changes; • the management and governance structure of the investee; • factors related to the investee’s ability to remain in business, such as the investee’s liquidity and debt ratios, and the rate at which the investee is using its cash; and • the investee’s receipt of additional funding at a lower valuation. We record other-than-temporary impairments for non-marketable cost method investments and equity method investments in gains (losses) on equity investments, net.
Derivative Financial Instruments [Policy Text Block]	Derivative Financial Instruments Our primary objective for holding derivative financial instruments is to manage currency exchange rate risk and interest rate risk, and, to a lesser extent, equity market risk, commodity price risk, and credit risk. When possible, we enter into master netting arrangements with counterparties to mitigate credit risk in derivative transactions. A master netting arrangement may allow counterparties to net settle amounts owed to each other as a result of multiple, separate derivative transactions. Generally, our master netting agreements allow for net settlement in case of certain triggering events such as bankruptcy or default of one of the counterparties to the transaction. We may also elect to exchange cash collateral with certain of our counterparties on a regular basis. For presentation on our consolidated balance sheets, we do not offset fair value amounts recognized for derivative instruments under master netting arrangements. Our derivative financial instruments are recorded at fair value and are included in other current assets, other long-term assets, other accrued liabilities, or other long-term liabilities. Our accounting policies for derivative financial instruments are based on whether they meet the criteria for hedge accounting designation. A designated hedge with exposure to variability in the functional currency equivalent of the future foreign currency cash flows of a forecasted transaction or variability in the functional currency equivalent cash flows of a recognized asset or liability are examples of cash flow hedges. The criteria for designating a derivative as a cash flow hedge include the assessment of the instrument’s effectiveness in risk reduction, matching of the derivative instrument to its underlying transaction, and the assessment of the probability that the underlying transaction will occur. For derivatives with cash flow hedge accounting designation, we report the after-tax gain or loss from the effective portion of the hedge as a component of accumulated other comprehensive income (loss) and reclassify it into earnings in the same period or periods in which the hedged transaction affects earnings, and in the same line item on the consolidated statements of income as the impact of the hedged transaction. Derivatives that we designate as cash flow hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from operating activities. A designated hedge with exposure to changes in the fair value of a recognized asset or liability that are attributable to the changes in the benchmark interest rate is one example of a fair value hedge. For derivatives with fair value hedge accounting designation, the gains and losses of the hedge as well as the offsetting gains and losses attributable to the changes in the benchmark interest rate on the underlying hedged item are recognized in earnings in the current period. Derivatives that we designated as fair value hedges are classified in the consolidated statements of cash flows in the same section as the underlying item, primarily within cash flows from financing activities. We recognize gains and losses from changes in fair value of derivatives that are not designated as hedges for accounting purposes in the line item on the consolidated statements of income most closely associated with the related exposures, primarily in interest and other, net and gains (losses) on equity investments, net. As part of our strategic investment program, we also acquire equity derivative instruments, such as equity conversion rights associated with debt instruments, which we do not designate as hedging instruments. We recognize the gains or losses from changes in fair value of these equity derivative instruments in gains (losses) on equity investments, net. Realized gains and losses from derivatives not designated as hedges are classified in the consolidated statements of cash flows within cash flows from operating activities or investing activities, depending on the activity the exposure is most closely associated with. Measurement of Effectiveness • Effectiveness for forwards is generally measured by comparing the cumulative change in the fair value of the hedge contract with the cumulative change in the fair value of the forecasted cash flows of the hedged item. For currency forward contracts used in cash flow hedging strategies related to capital purchases, forward points are excluded, and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. For currency forward contracts used in cash flow hedging strategies related to operating expenditures, forward points are included, and effectiveness is measured using forward rates to value both the hedge contract and the hedged item. • Effectiveness for options is generally measured by comparing the cumulative change in the intrinsic value of the hedge contract with the cumulative change in the intrinsic value of an option instrument representing the hedged risks in the hedged item. Time value is excluded and effectiveness is measured using spot rates to value both the hedge contract and the hedged item. • Effectiveness for interest rate swaps and commodity swaps is generally measured by comparing the cumulative change in fair value of the swap with the cumulative change in the fair value of the hedged item. If a cash flow hedge is discontinued because it is probable that the original hedged transaction will not occur as previously anticipated, the cumulative unrealized gain or loss on the related derivative is reclassified from accumulated other comprehensive income (loss) into earnings. Subsequent gains or losses on the related derivative instrument are recognized in interest and other, net in each period until the instrument matures, is terminated, is re-designated as a qualified cash flow hedge, or is sold. Ineffective portions of cash flow hedges, as well as amounts excluded from the assessment of effectiveness, are recognized in earnings in interest and other, net. For further discussion of our derivative instruments and risk management programs, see " Note 6: Derivative Financial Instruments ."
Securities Lending [Policy Text Block]	Securities Lending We may enter into securities lending agreements with financial institutions, generally to facilitate hedging and certain investment and financing transactions. Selected securities may be loaned, secured by collateral in the form of cash or securities. The loaned securities continue to be carried as investment assets on our consolidated balance sheets. For lending agreements collateralized by cash and cash equivalents, collateral is recorded as an asset with a corresponding liability. For lending agreements collateralized by other securities, we do not record the collateral as an asset or a liability, unless the collateral is repledged.
Loans Receivable [Policy Text Block]	Loans Receivable We make loans to third parties that are classified within other current assets or other long-term assets. We may elect the fair value option for loans when the interest rate or foreign currency exchange rate risk is economically hedged at inception with a related derivative instrument. We record the gains or losses on these loans arising from changes in fair value due to interest rate, currency, and counterparty credit changes, largely offset by losses or gains on the related derivative instruments, in interest and other, net. Loans that are denominated in U.S. dollars and have a floating-rate coupon are carried at amortized cost. We measure interest income for all loans receivable using the interest method, which is based on the effective yield of the loans rather than the stated coupon rate. For further discussion of our loans receivable, see " Note 4: Fair Value ."
Inventories [Policy Text Block]	Inventories We compute inventory cost on a first-in, first-out basis. Costs incurred to manufacture our products are included in the valuation of inventory beginning in the quarter in which a product meets the technical criteria to qualify for sale to customers. Prior to qualification for sale, costs that do not meet the criteria for research and development (R&D) are included in cost of sales in the period incurred. Inventories at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Raw materials $ 532 $ 462 Work in process 2,893 2,375 Finished goods 1,742 1,436 Total inventories $ 5,167 $ 4,273
Property, Plant and Equipment [Policy Text Block]	Property, Plant and Equipment Property, plant and equipment, net at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Land and buildings $ 25,578 $ 22,989 Machinery and equipment 48,459 44,441 Construction in progress 9,359 12,279 Total property, plant and equipment, gross 83,396 79,709 Less: accumulated depreciation (51,538 ) (46,471 ) Total property, plant and equipment, net $ 31,858 $ 33,238 We compute depreciation for financial reporting purposes using the straight-line method. As of December 26, 2015 , substantially all of our depreciable property, plant and equipment assets were depreciated over the following estimated useful lives: machinery and equipment, 2 to 4 years; and buildings, 10 to 25 years. Beginning in 2016, our machinery and equipment will be depreciated over 2 to 5 years. We capitalize a portion of interest on borrowings related to eligible capital expenditures. Capitalized interest is added to the cost of qualified assets and depreciated over the estimated useful lives of the assets. We record capital-related government grants earned as a reduction to property, plant and equipment. Included within construction in progress we have certain facilities on hold and not in use. These facilities are being held in a safe state, and we have plans to place them into service at a future date. Depreciation is not recognized on these assets and they are not eligible for capitalized interest when construction is on hold. The balance of such assets was approximately $ 3.4 billion as of December 26, 2015 (approximately $ 2.2 billion as of December 27, 2014 ).
Goodwill [Policy Text Block]	Goodwill We record goodwill when the purchase price of an acquisition exceeds the fair value of the net tangible and identified intangible assets acquired. We assign the goodwill to our reporting units based on the relative expected fair value provided by the acquisition. We perform an annual impairment assessment in the fourth quarter of each year, or more frequently if indicators of potential impairment exist , which includes evaluating qualitative and quantitative factors to assess the likelihood of an impairment of a reporting unit’s goodwill. We perform impairment tests using a fair value approach when necessary. The reporting unit’s carrying value used in an impairment test represents the assignment of various assets and liabilities, excluding certain corporate assets and liabilities, such as cash, investments, and debt. For further discussion of goodwill, see " Note 10: Goodwill ."
Identified Intangible Assets [Policy Text Block]	Identified Intangible Assets Licensed technology and patents are generally amortized on a straight-line basis over the periods of benefit. We amortize all acquisition-related intangible assets that are subject to amortization over their estimated useful life based on economic benefit. Acquisition-related in-process R&D assets represent the fair value of incomplete R&D projects that had not reached technological feasibility as of the date of acquisition; initially, these are classified as "other intangible assets" that are not subject to amortization. Assets related to projects that have been completed are transferred from "other intangible assets" to "acquisition-related developed technology;" these are subject to amortization, while assets related to projects that have been abandoned are impaired and expensed to R&D. In the quarter following the period in which identified intangible assets become fully amortized, we remove the fully amortized balances from the gross asset and accumulated amortization amounts. The estimated useful life ranges for all identified intangible assets that are subject to amortization as of December 26, 2015 were as follows: (In Years) Estimated Useful Life Acquisition-related developed technology 3 – 9 Acquisition-related customer relationships 5 – 11 Acquisition-related brands 5 – 8 Licensed technology and patents 2 – 17 We perform a quarterly review of significant finite-lived identified intangible assets to determine whether facts and circumstances indicate that the useful life is shorter than we had originally estimated or that the carrying amount of assets may not be recoverable. If such facts and circumstances exist, we assess recoverability by comparing the projected undiscounted net cash flows associated with the related asset or group of assets over their remaining lives against their respective carrying amounts. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets, which is calculated based on projected discounted net cash flows. If an asset’s useful life is shorter than originally estimated, we accelerate the rate of amortization and amortize the remaining carrying value over the new, shorter useful life. We perform an annual impairment assessment in the fourth quarter of each year for indefinite-lived intangible assets, or more frequently if indicators of potential impairment exist, to determine whether it is more likely than not that the carrying value of the assets may not be recoverable. If necessary, a quantitative impairment test is performed to compare the fair value of the indefinite-lived intangible asset with its carrying value. Impairments, if any, are based on the excess of the carrying amount over the fair value of those assets. For further discussion of identified intangible assets, see " Note 11: Identified Intangible Assets ."
Product Warranty [Policy Text Block]	Product Warranty The vast majority of our products are sold with a limited warranty on product quality and a limited indemnification for customers against intellectual property rights infringement claims related to our products. The accrual and the related expense for known product warranty issues were not significant during the periods presented. Due to product testing, the short time typically between product shipment and the detection and correction of product failures, and the historical rate of payments on indemnification claims, the accrual and related expense for estimated incurred but unidentified issues were not significant during the periods presented.
Revenue Recognition [Policy Text Block]	Revenue Recognition We recognize net product revenue when the earnings process is complete, as evidenced by an agreement with the customer, delivery has occurred, and acceptance, if applicable, as well as fixed pricing and probable collectability. We record pricing allowances, including discounts based on contractual arrangements with customers, when we recognize revenue as a reduction to both accounts receivable and net revenue. Because of frequent sales price reductions and rapid technology obsolescence in our industry, we defer product revenue and related costs of sales from component sales made to distributors under agreements allowing price protection or right of return until the distributors sell the merchandise. The right of return granted generally consists of a stock rotation program in which distributors are able to exchange certain products based on the number of qualified purchases made by the distributor. Under the price protection program, we give distributors credits for the difference between the original price paid and the current price that we offer. We include shipping charges billed to customers in net revenue, and include the related shipping costs in cost of sales. Revenue from license agreements on our McAfee products generally includes service and support agreements for which the related revenue is deferred and recognized ratably over the performance period. Revenue derived from online subscription products is deferred and recognized ratably over the performance period. Professional services revenue is recognized as services are performed or, if required, upon customer acceptance. For arrangements with multiple elements, including software licenses, maintenance, and/or services, revenue is allocated across the separately identified deliverables and may be recognized or deferred. When vendor-specific objective evidence does not exist for undelivered elements such as maintenance and support, the entire arrangement fee is recognized ratably over the performance period. Direct costs, such as costs related to revenue-sharing and royalty arrangements associated with license arrangements, as well as component costs associated with product revenue and sales commissions, are deferred and amortized over the same period that the related revenue is recognized. We record deferred revenue offset by the related cost of sales on our consolidated balance sheets as deferred income.
Advertising [Policy Text Block]	Advertising Cooperative advertising programs reimburse customers for marketing activities for certain of our products, subject to defined criteria. We accrue cooperative advertising obligations and record the costs at the same time that the related revenue is recognized. We record cooperative advertising costs as marketing, general and administrative (MG&A) expenses to the extent that an advertising benefit separate from the revenue transaction can be identified and the fair value of that advertising benefit received is determinable. We record any excess in cash paid to customers over the fair value of the advertising benefit we receive as a reduction in revenue. Advertising costs, including direct marketing costs, recorded within MG&A expenses were $1.8 billion in 2015 ( $1.8 billion in 2014 and $1.9 billion in 2013 ).
Employee Equity Incentive Plans [Policy Text Block]	Employee Equity Incentive Plans We have employee equity incentive plans, which are described more fully in " Note 18: Employee Equity Incentive Plans ." We use the straight-line attribution method to recognize share-based compensation over the service period of the award. Upon exercise, cancellation, forfeiture, or expiration of stock options, or upon vesting or forfeiture of restricted stock units (RSUs), we eliminate deferred tax assets for options and RSUs with multiple vesting dates for each vesting period on a first-in, first-out basis as if each vesting period were a separate award.
Income Taxes [Policy Text Block]	Income Taxes We compute the provision for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating losses and tax credit carryforwards. We measure deferred tax assets and liabilities using the currently enacted tax rates that apply to taxable income in effect for the years in which those tax assets are expected to be realized or settled. We record a valuation allowance to reduce deferred tax assets to the amount that it is believed more likely than not to be realized. We recognize tax benefits from uncertain tax positions only if that tax position is more likely than not to be sustained on examination by the taxing authorities, based on the technical merits of the position. We then measure the tax benefits recognized in the financial statements from such positions based on the largest benefit that has a greater than 50% likelihood of being realized upon ultimate settlement. We recognize interest and penalties related to unrecognized tax benefits within the provision for taxes on the consolidated statements of income. For more information about income taxes, see " Note 23: Income Taxes ."

Accounting Policies (Tables)

Accounting Policies (Tables)	12 Months Ended
	Dec. 26, 2015
Accounting Policies [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Raw materials $ 532 $ 462 Work in process 2,893 2,375 Finished goods 1,742 1,436 Total inventories $ 5,167 $ 4,273
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Land and buildings $ 25,578 $ 22,989 Machinery and equipment 48,459 44,441 Construction in progress 9,359 12,279 Total property, plant and equipment, gross 83,396 79,709 Less: accumulated depreciation (51,538 ) (46,471 ) Total property, plant and equipment, net $ 31,858 $ 33,238
Schedule Of Useful Life Ranges For Identified Intangible Assets [Table Text Block]	The estimated useful life ranges for all identified intangible assets that are subject to amortization as of December 26, 2015 were as follows: (In Years) Estimated Useful Life Acquisition-related developed technology 3 – 9 Acquisition-related customer relationships 5 – 11 Acquisition-related brands 5 – 8 Licensed technology and patents 2 – 17

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 26, 2015
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured and recorded at fair value on a recurring basis at the end of each period were as follows: December 26, 2015 December 27, 2014 Fair Value Measured and Recorded at Reporting Date Using Total Fair Value Measured and Recorded at Reporting Date Using Total (In Millions) Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 Assets Cash equivalents: Corporate debt $ — $ 1,829 $ — $ 1,829 $ — $ 48 $ — $ 48 Financial institution instruments 8,238 1,277 — 9,515 321 1,119 — 1,440 Government debt — 130 — 130 — — — — Reverse repurchase agreements — 2,368 — 2,368 — 268 — 268 Short-term investments: Corporate debt 336 764 20 1,120 363 412 31 806 Financial institution instruments 145 927 — 1,072 149 1,050 — 1,199 Government debt 65 425 — 490 252 173 — 425 Trading assets: Asset-backed securities — 275 94 369 — 766 58 824 Corporate debt 1,744 564 — 2,308 2,625 339 — 2,964 Financial institution instruments 930 701 — 1,631 1,146 613 — 1,759 Government debt 1,107 1,908 — 3,015 1,295 2,221 — 3,516 Other current assets: Derivative assets 32 412 1 445 — 559 2 561 Loans receivable — 137 — 137 — 505 — 505 Marketable equity securities 5,891 69 — 5,960 7,097 — — 7,097 Other long-term investments: Asset-backed securities — — 4 4 — 2 4 6 Corporate debt 407 801 — 1,208 453 728 13 1,194 Financial institution instruments 171 381 — 552 189 319 — 508 Government debt 79 48 — 127 75 240 — 315 Other long-term assets: Derivative assets — 30 10 40 — 35 22 57 Loans receivable — 342 — 342 — 216 — 216 Total assets measured and recorded at fair value 19,145 13,388 129 32,662 13,965 9,613 130 23,708 Liabilities Other accrued liabilities: Derivative liabilities 2 210 — 212 — 563 — 563 Other long-term liabilities: Derivative liabilities — 33 — 33 — 17 — 17 Total liabilities measured and recorded at fair value $ 2 $ 243 $ — $ 245 $ — $ 580 $ — $ 580
Financial Instruments Not Recorded At Fair Value On Recurring Basis [Table Text Block]	The carrying amounts and fair values of financial instruments not recorded at fair value on a recurring basis at the end of each period were as follows: December 26, 2015 Carrying Amount Fair Value Measured Using Fair Value (In Millions) Level 1 Level 2 Level 3 Grants receivable $ 593 $ — $ 600 $ — $ 600 Loans receivable $ 315 $ — $ 315 $ — $ 315 Non-marketable cost method investments $ 2,933 $ — $ — $ 3,904 $ 3,904 Reverse repurchase agreements $ 1,000 $ — $ 1,000 $ — $ 1,000 Short-term debt $ 2,593 $ 1,513 $ 1,563 $ — $ 3,076 Long-term debt $ 20,036 $ 14,058 $ 6,835 $ — $ 20,893 NVIDIA Corporation cross-license agreement liability $ 199 $ — $ 200 $ — $ 200 December 27, 2014 Carrying Amount Fair Value Measured Using Fair Value (In Millions) Level 1 Level 2 Level 3 Grants receivable $ 676 $ — $ 679 $ — $ 679 Loans receivable $ 250 $ — $ 250 $ — $ 250 Non-marketable cost method investments $ 1,769 $ — $ — $ 2,599 $ 2,599 Reverse repurchase agreements $ 450 $ — $ 450 $ — $ 450 Short-term debt $ 1,580 $ — $ 2,145 $ — $ 2,145 Long-term debt $ 12,059 $ 11,467 $ 1,309 $ — $ 12,776 NVIDIA Corporation cross-license agreement liability $ 395 $ — $ 399 $ — $ 399

Cash and Investments (Tables)

Cash and Investments (Tables)	12 Months Ended
	Dec. 26, 2015
Investments and Cash [Abstract]
Schedule of Total Cash and Investments [Table Text Block]	Cash and investments at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Available-for-sale investments $ 22,007 $ 13,038 Cash 1,466 805 Equity method investments 1,590 1,446 Loans receivable 794 971 Non-marketable cost method investments 2,933 1,769 Reverse repurchase agreements 3,368 718 Trading assets 7,323 9,063 Total cash and investments $ 39,481 $ 27,810
Schedule of Available-for-sale Securities [Line Items]
Schedule of Available-for-sale Securities Reconciliation [Table Text Block]	Available-for-sale investments at the end of each period were as follows: December 26, 2015 December 27, 2014 (In Millions) Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Adjusted Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value Asset-backed securities $ 5 $ — $ (1 ) $ 4 $ 8 $ — $ (2 ) $ 6 Corporate debt 4,164 3 (10 ) 4,157 2,040 13 (5 ) 2,048 Financial institution instruments 11,140 1 (2 ) 11,139 3,146 2 (1 ) 3,147 Government debt 748 — (1 ) 747 741 — (1 ) 740 Marketable equity securities 3,254 2,706 — 5,960 3,318 3,779 — 7,097 Total available-for-sale investments $ 19,311 $ 2,710 $ (14 ) $ 22,007 $ 9,253 $ 3,794 $ (9 ) $ 13,038
Equity Method Investments [Table Text Block]	Equity method investments, classified within other long-term assets, at the end of each period were as follows: December 26, 2015 December 27, 2014 (Dollars In Millions) Carrying Value Ownership Percentage Carrying Value Ownership Percentage IM Flash Technologies, LLC $ 872 49 % $ 713 49 % Cloudera, Inc. 256 17 % 280 17 % Intel-GE Care Innovations, LLC 64 50 % 108 50 % Other equity method investments 398 345 Total $ 1,590 $ 1,446
Available-for-sale Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Investments Classified by Contractual Maturity Date [Table Text Block]	The amortized cost and fair value of available-for-sale debt investments, by contractual maturity, as of December 26, 2015 were as follows: (In Millions) Cost Fair Value Due in 1 year or less $ 5,896 $ 5,893 Due in 1–2 years 1,271 1,268 Due in 2–5 years 623 620 Instruments not due at a single maturity date 8,267 8,266 Total $ 16,057 $ 16,047

Derivative Financial Instrume40

Derivative Financial Instruments (Tables)	12 Months Ended
	Dec. 26, 2015
Derivative [Line Items]
Schedule of Notional Amounts of Outstanding Derivative Positions [Table Text Block]	Total gross notional amounts for outstanding derivatives (recorded at fair value) at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Dec 28, Currency forwards $ 11,212 $ 15,578 $ 13,404 Currency interest rate swaps 5,509 5,446 4,377 Embedded debt derivatives 3,600 3,600 3,600 Interest rate swaps 5,212 1,347 1,377 Total return swaps 1,061 1,056 914 Other 61 49 67 Total $ 26,655 $ 27,076 $ 23,739 The gross notional amounts for currency forwards and currency interest rate swaps (presented by currency) at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Dec 28, Chinese yuan $ 2,231 $ 3,097 $ 1,116 Euro 6,084 7,486 6,874 Israeli shekel 1,674 2,489 2,244 Japanese yen 2,663 3,779 4,116 Other 4,069 4,173 3,431 Total $ 16,721 $ 21,024 $ 17,781
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]	The fair value of our derivative instruments at the end of each period were as follows: December 26, 2015 December 27, 2014 (In Millions) Other Current Assets Other Long-Term Assets Other Accrued Liabilities Other Long-Term Liabilities Other Current Assets Other Long-Term Assets Other Accrued Liabilities Other Long-Term Liabilities Derivatives designated as hedging instruments: Currency forwards $ 20 $ 3 $ 83 $ 2 $ 6 $ 1 $ 497 $ 9 Interest rate swaps — 1 — 14 — — — — Currency interest rate swaps — 7 — — — — — — Total derivatives designated as hedging instruments 20 11 83 16 6 1 497 9 Derivatives not designated as hedging instruments: Currency forwards 20 — 63 — 207 — 44 — Currency interest rate swaps 370 18 52 — 344 34 7 — Embedded debt derivatives — — — 17 — — 4 8 Interest rate swaps 2 — 12 — 3 — 11 — Total return swaps 32 — 2 — — — — — Other 1 11 — — 1 22 — — Total derivatives not designated as hedging instruments 425 29 129 17 555 56 66 8 Total derivatives $ 445 $ 40 $ 212 $ 33 $ 561 $ 57 $ 563 $ 17
Offsetting Assets And Liabilities [Table Text Block]	The gross amounts of our derivative instruments and reverse repurchase agreements subject to master netting arrangements with various counterparties, and cash and non-cash collateral posted under such agreements at the end of each period were as follows: December 26, 2015 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 482 $ — $ 482 $ (201 ) $ (188 ) $ 93 Reverse repurchase agreements 3,368 — 3,368 — (3,368 ) — Total assets 3,850 — 3,850 (201 ) (3,556 ) 93 Liabilities: Derivative liabilities subject to master netting arrangements 242 — 242 (201 ) (27 ) 14 Total liabilities $ 242 $ — $ 242 $ (201 ) $ (27 ) $ 14 December 27, 2014 Gross Amounts Not Offset in the Balance Sheet (In Millions) Gross Amounts Recognized Gross Amounts Offset in the Balance Sheet Net Amounts Presented in the Balance Sheet Financial Instruments Cash and Non-Cash Collateral Received or Pledged Net Amount Assets: Derivative assets subject to master netting arrangements $ 559 $ — $ 559 $ (365 ) $ (78 ) $ 116 Reverse repurchase agreements 718 — 718 — (718 ) — Total assets 1,277 — 1,277 (365 ) (796 ) 116 Liabilities: Derivative liabilities subject to master netting arrangements 559 — 559 (365 ) (80 ) 114 Total liabilities $ 559 $ — $ 559 $ (365 ) $ (80 ) $ 114
Schedule Of Derivative Instruments In Cash Flow Hedging Relationships [Table Text Block]	The before-tax gains (losses), attributed to the effective portion of cash flow hedges, recognized in other comprehensive income (loss) for each period were as follows: Gains (Losses) Recognized in OCI on Derivatives (Effective Portion) Years Ended Dec 26, Dec 27, Dec 28, Currency forwards $ (305 ) $ (587 ) $ (167 ) Currency interest rate swaps and other 7 (2 ) 1 Total $ (298 ) $ (589 ) $ (166 )
Not Designated as Hedging Instrument [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments not designated as hedging instruments on the consolidated statements of income for each period were as follows: Years Ended Location of Gains (Losses) Recognized in Income on Derivatives Dec 26, Dec 27, Dec 28, Currency forwards Interest and other, net $ (50 ) $ 144 $ 44 Currency interest rate swaps Interest and other, net 346 456 29 Interest rate swaps Interest and other, net (6 ) (3 ) — Total return swaps Various (27 ) 68 140 Other Gains (losses) on equity investments, net (11 ) (6 ) 6 Other Interest and other, net (2 ) — — Total $ 250 $ 659 $ 219
Interest and other, net [Member] | Fair Value Hedging [Member]
Derivative [Line Items]
Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]	The effects of derivative instruments designated as fair value hedges, recognized in interest and other, net for each period were as follows: Gains (Losses) Recognized in Statement of Income on Derivatives Years Ended Dec 26, Dec 27, Dec 28, Interest rate swap $ (13 ) $ — $ — Hedged item 13 — — Total $ — $ — $ —

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 26, 2015
Goodwill [Abstract]
Schedule of Goodwill [Table Text Block]	Goodwill activity for each period was as follows: (In Millions) Dec 27, Acquisitions Currency Exchange and Other Dec 26, Client Computing Group $ 3,708 $ 370 $ — $ 4,078 Data Center Group 2,376 28 — 2,404 Internet of Things Group 428 — — 428 Software and services operating segments 4,236 10 (206 ) 4,040 All other 113 269 — 382 Total $ 10,861 $ 677 $ (206 ) $ 11,332 (In Millions) Dec 28, Acquisitions Currency Exchange and Other Dec 27, Client Computing Group $ 3,689 $ 19 $ — $ 3,708 Data Center Group 1,969 407 — 2,376 Internet of Things Group 428 — — 428 Software and services operating segments 4,409 41 (214 ) 4,236 All other 18 113 (18 ) 113 Total $ 10,513 $ 580 $ (232 ) $ 10,861

Identified Intangible Assets (T

Identified Intangible Assets (Tables)	12 Months Ended
	Dec. 26, 2015
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Schedule Of Intangible Assets By Major Class [Table Text Block]	Identified intangible assets at the end of each period were as follows: December 26, 2015 (In Millions) Gross Assets Accumulated Amortization Net Acquisition-related developed technology $ 2,928 $ (2,276 ) $ 652 Acquisition-related customer relationships 1,738 (1,219 ) 519 Acquisition-related brands 59 (55 ) 4 Licensed technology and patents 3,017 (1,200 ) 1,817 Identified intangible assets subject to amortization 7,742 (4,750 ) 2,992 Acquisition-related brands 767 — 767 Other intangible assets 174 — 174 Identified intangible assets not subject to amortization 941 — 941 Total identified intangible assets $ 8,683 $ (4,750 ) $ 3,933 December 27, 2014 (In Millions) Gross Assets Accumulated Amortization Net Acquisition-related developed technology $ 3,009 $ (2,192 ) $ 817 Acquisition-related customer relationships 1,698 (1,001 ) 697 Acquisition-related brands 61 (49 ) 12 Licensed technology and patents 3,153 (1,224 ) 1,929 Identified intangible assets subject to amortization 7,921 (4,466 ) 3,455 Acquisition-related brands 788 — 788 Other intangible assets 203 — 203 Identified intangible assets not subject to amortization 991 — 991 Total identified intangible assets $ 8,912 $ (4,466 ) $ 4,446
Schedule of Acquired Finite-Lived Intangible Assets by Major Class [Table Text Block]	As a result of our acquisitions and purchases of licensed technology and patents, identified intangible assets recorded for each period and their respective estimated weighted average useful life were as follows: December 26, 2015 December 27, 2014 Gross Assets (In Millions) Estimated Useful Life (In Years) Gross Assets (In Millions) Estimated Useful Life (In Years) Acquisition-related developed technology $ 238 6 $ 175 6 Acquisition-related customer relationships $ 110 11 $ 79 9 Licensed technology and patents $ 176 7 $ 93 8
Finite-lived Intangible Assets Amortization Expense [Table Text Block]	Amortization expenses, with presentation location on the consolidated statements of income, for each period were as follows: Years Ended Location Dec 26, Dec 27, Dec 28, Acquisition-related developed technology Cost of sales $ 343 $ 600 $ 576 Acquisition-related customer relationships Amortization of acquisition-related intangibles 258 284 279 Acquisition-related brands Amortization of acquisition-related intangibles 7 10 12 Licensed technology and patents Cost of sales 282 275 272 Other intangible assets Reduction of revenue — — 103 Total amortization expenses $ 890 $ 1,169 $ 1,242
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Based on identified intangible assets that are subject to amortization as of December 26, 2015 (which do not include intangibles from the Altera acquisition), we expect future amortization expense for each period to be as follows: (In Millions) 2016 2017 2018 2019 2020 Acquisition-related developed technology $ 260 $ 115 $ 101 $ 98 $ 64 Acquisition-related customer relationships 229 143 42 25 22 Acquisition-related brands 3 — — — — Licensed technology and patents 282 239 187 186 174 Total future amortization expenses $ 774 $ 497 $ 330 $ 309 $ 260

Other Long-Term Assets (Tables)

Other Long-Term Assets (Tables)	12 Months Ended
	Dec. 26, 2015
Other Assets, Noncurrent Disclosure [Abstract]
Schedule of Other Assets, Noncurrent [Table Text Block]	Other long-term assets at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Equity method investments $ 1,590 $ 1,446 Non-marketable cost method investments 2,933 1,769 Non-current deferred tax assets 600 622 Pre-payments for property, plant and equipment 623 636 Loans receivable 642 416 Grants receivable 318 312 Reverse repurchase agreements 350 350 Other 679 954 Total other long-term assets $ 7,735 $ 6,505

Restructuring And Asset Impai44

Restructuring And Asset Impairment Charges (Tables)	12 Months Ended
	Dec. 26, 2015
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Costs [Table Text Block]	Restructuring and asset impairment charges by program for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, 2015 restructuring program $ 264 $ — $ — 2013 restructuring program 90 295 240 Total restructuring and asset impairment charges $ 354 $ 295 $ 240
2015 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Restructuring and asset impairment activities for the 2015 restructuring program in 2015 were as follows: (In Millions) Employee Severance and Benefits Asset Impairments and Other Total Accrued restructuring balance as of December 27, 2014 $ — $ — $ — Additional accruals 292 14 306 Adjustments (42 ) — (42 ) Cash payments (225 ) (1 ) (226 ) Non-cash settlements — (6 ) (6 ) Accrued restructuring balance as of December 26, 2015 $ 25 $ 7 $ 32
Restructuring and Related Costs [Table Text Block]	Restructuring and asset impairment charges for the 2015 restructuring program in 2015 were as follows: Years Ended Dec 26, Employee severance and benefit arrangements $ 250 Asset impairments and other restructuring charges 14 Total restructuring and asset impairment charges $ 264
2013 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Schedule of Restructuring Reserve by Type of Cost [Table Text Block]	Restructuring and asset impairment activities for the 2013 restructuring program for each period were as follows: (In Millions) Employee Severance and Benefits Asset Impairments and Other Total Accrued restructuring balance as of December 28, 2013 $ 183 $ — $ 183 Additional accruals 252 31 283 Adjustments 13 (1 ) 12 Cash payments (327 ) (6 ) (333 ) Non-cash settlements — (13 ) (13 ) Accrued restructuring balance as of December 27, 2014 121 11 132 Additional accruals 101 9 110 Adjustments (19 ) (1 ) (20 ) Cash payments (171 ) (10 ) (181 ) Non-cash settlements — (3 ) (3 ) Accrued restructuring balance as of December 26, 2015 $ 32 $ 6 $ 38
Restructuring and Related Costs [Table Text Block]	Restructuring and asset impairment charges for the 2013 restructuring program for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Employee severance and benefit arrangements $ 82 $ 265 $ 201 Asset impairments and other restructuring charges 8 30 39 Total restructuring and asset impairment charges $ 90 $ 295 $ 240

Deferred Income (Tables)

Deferred Income (Tables)	12 Months Ended
	Dec. 26, 2015
Deferred Revenue [Abstract]
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Deferred income at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Deferred income on shipments of components to distributors $ 920 $ 944 Deferred income from software, services, and other 1,268 1,261 Current deferred income 2,188 2,205 Non-current deferred income from software, services, and other 530 483 Total deferred income $ 2,718 $ 2,688

Borrowings (Tables)

Borrowings (Tables)	12 Months Ended
	Dec. 26, 2015
Debt Disclosure [Abstract]
Schedule of Short-term Debt [Table Text Block]	Our short-term debt at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Drafts payable $ 41 $ 16 Commercial paper — 500 Current portion of long-term debt 2,602 1,088 Less: debt issuance costs associated with the current portion of long-term debt (9 ) (8 ) Total short-term debt $ 2,634 $ 1,596
Schedule of Long-term Debt Instruments [Table Text Block]	Our long-term debt at the end of each period was as follows: (In Millions) Maturity Date Stated Interest Rate Dec 26, Dec 27, Fourth quarter 2015 debt issuance of $915 million Senior notes December 2045 4.70 % $ 908 $ — Fourth quarter 2015 Australian dollar-denominated debt issuance of A$800 million Senior notes 1 December 2019 3.25 % 181 — Senior notes 1 December 2022 4.00 % 397 — Third quarter 2015 debt issuance of $1.0 billion Senior notes August 2045 4.90 % 1,009 — Third quarter 2015 debt issuance of $7.0 billion Senior notes July 2020 2.45 % 1,748 — Senior notes July 2022 3.10 % 996 — Senior notes July 2025 3.70 % 2,247 — Senior notes July 2045 4.90 % 1,998 — 2012 debt issuance of $6.2 billion Senior notes December 2017 1.35 % 2,999 2,998 Senior notes December 2022 2.70 % 1,492 1,495 Senior notes December 2032 4.00 % 744 744 Senior notes December 2042 4.25 % 924 924 2011 debt issuance of $5.0 billion Senior notes October 2016 1.95 % 1,499 1,499 Senior notes October 2021 3.30 % 1,997 1,997 Senior notes October 2041 4.80 % 1,490 1,490 2009 debt issuance of $2.0 billion Junior subordinated convertible debentures August 2039 3.25 % 1,103 1,088 2005 debt issuance of $1.6 billion Junior subordinated convertible debentures December 2035 2.95 % 975 960 Long-term debt 22,707 13,195 Less: current portion of long-term debt (2,602 ) (1,088 ) Less: debt issuance costs (69 ) (48 ) Total long-term debt $ 20,036 $ 12,059 1 To manage foreign currency risk associated with the Australian-dollar-denominated notes issued in 2015, we entered into currency interest rate swaps with an aggregate notional amount of $577 million , which effectively converted these notes to U.S.-dollar-denominated notes. For further discussion on our currency interest rate swaps, see " Note 6: Derivative Financial Instruments ."
Convertible Debentures Interest Rates [Table Text Block]	2009 Debentures 2005 Debentures Annual stated coupon interest rate 3.25 % 2.95 % Annual effective interest rate 7.20 % 6.45 %
Convertible Debentures Other Details [Table Text Block]	2009 Debentures 2005 Debentures (In Millions, Except Per Share Amounts) Dec 26, Dec 27, Dec 26, Dec 27, Outstanding principal $ 2,000 $ 2,000 $ 1,600 $ 1,600 Equity component (including temporary equity) carrying amount $ 613 $ 613 $ 466 $ 466 Unamortized discount $ 897 $ 912 $ 625 $ 640 Net debt carrying amount $ 1,103 $ 1,088 $ 975 $ 960 Conversion rate (shares of common stock per $1,000 principal amount of debentures) 46.58 46.06 35.82 34.95 Effective conversion price (per share of common stock) $ 21.47 $ 21.71 $ 27.92 $ 28.61
Schedule of Maturities of Long-term Debt [Table Text Block]	Our aggregate debt maturities based on outstanding principal as of December 26, 2015 , by year payable, were as follows: (In Millions) 2016 $ 1,500 2017 3,000 2018 — 2019 181 2020 1,750 2021 and thereafter 17,845 Total $ 24,276

Retirement Benefit Plans (Table

Retirement Benefit Plans (Tables)	12 Months Ended
	Dec. 26, 2015
Defined Benefit Plan Disclosure [Line Items]
Schedule of Changes in Projected Benefit Obligations [Table Text Block]	The vested benefit obligation for a defined benefit pension plan is the actuarial present value of the vested benefits to which the employee is currently entitled based on the employee's expected date of separation or retirement. The changes in the projected benefit obligations and plan assets at the end of each period for the plans described above were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Beginning projected benefit obligation $ 892 $ 1,137 $ 2,423 $ 1,695 $ 546 $ 509 Service cost 18 88 128 104 30 26 Interest cost 33 49 63 66 21 23 Actuarial (gain) loss 126 760 (250 ) 767 (21 ) 10 Currency exchange rate changes — — (190 ) (254 ) — — Plan curtailments — (1,083 ) — — — — Other (79 ) (59 ) (34 ) 45 (16 ) (22 ) Ending projected benefit obligation $ 990 $ 892 $ 2,140 $ 2,423 $ 560 $ 546
Schedule of Changes in Fair Value of Plan Assets [Table Text Block]	U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Beginning fair value of plan assets $ 623 $ 649 $ 1,017 $ 1,005 $ 427 $ 395 Actual return on plan assets (4 ) 30 42 80 6 33 Employer contributions 90 — 72 73 1 — Currency exchange rate changes — — (66 ) (114 ) — — Other (82 ) (56 ) (54 ) (27 ) (24 ) (1 ) Ending fair value of plan assets $ 627 $ 623 $ 1,011 $ 1,017 $ 410 $ 427
Schedule of Amounts Recognized in Balance Sheet [Table Text Block]	The amounts recognized on the consolidated balance sheets at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Other long-term assets $ — $ — $ 15 $ 14 $ — $ — Other long-term liabilities (363 ) (269 ) (1,144 ) (1,420 ) (150 ) (119 ) Accumulated other comprehensive loss (income), before tax 158 1 908 1,217 39 33 Net amount recognized $ (205 ) $ (268 ) $ (221 ) $ (189 ) $ (111 ) $ (86 )
Schedule of Net Periodic Benefit Cost Not yet Recognized [Table Text Block]	The amounts recorded in accumulated other comprehensive income (loss) before taxes at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits Years Ended Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Net prior service credit (cost) $ — $ — $ (12 ) $ (13 ) $ (43 ) $ (48 ) Net actuarial gain (loss) (158 ) (1 ) (896 ) (1,204 ) 4 15 Accumulated other comprehensive income (loss), before tax $ (158 ) $ (1 ) $ (908 ) $ (1,217 ) $ (39 ) $ (33 )
Schedule of Benefit Obligations in Excess of Fair Value of Plan Assets [Table Text Block]	As of December 26, 2015 , the accumulated benefit obligation was $899 million for the U.S. Intel Minimum Pension Plan ( $808 million as of December 27, 2014 ) and $1.6 billion for the non-U.S. defined-benefit pension plans ( $1.7 billion as of December 27, 2014 ). Included in the aggregate data in the following tables are the amounts applicable to our pension plans with accumulated benefit obligations in excess of plan assets, as well as plans with projected benefit obligations in excess of plan assets. Amounts related to such plans at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits (In Millions) Dec 26, Dec 27, Dec 26, Dec 27, Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations $ 899 $ 808 $ 1,239 $ 1,344 Plan assets $ 627 $ 623 $ 645 $ 616 Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations $ 990 $ 892 $ 2,079 $ 2,361 Plan assets $ 627 $ 623 $ 934 $ 941
Schedule of Assumptions Used [Table Text Block]	Weighted average actuarial assumptions used to determine benefit obligations for the plans at the end of each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits Dec 26, Dec 27, Dec 26, Dec 27, Dec 26, Dec 27, Discount rate 4.0 % 3.8 % 3.1 % 2.7 % 4.1 % 4.1 % Rate of compensation increase 3.7 % 3.8 % 3.8 % 4.0 % n/a n/a Weighted average actuarial assumptions used to determine costs for the plans for each period were as follows: U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits 2015 2014 2013 2015 2014 2013 2015 2014 2013 Discount rate 3.8 % 4.6 % 3.9 % 2.8 % 4.0 % 4.2 % 3.9 % 4.6 % 4.2 % Expected long-term rate of return on plan assets 6.1 % 5.4 % 4.5 % 5.7 % 5.7 % 5.2 % 7.4 % 7.4 % 7.7 % Rate of compensation increase 3.8 % 3.8 % 4.1 % 4.0 % 4.1 % 4.3 % n/a n/a n/a
Schedule of Expected Benefit Payments [Table Text Block]	Estimated benefit payments over the next 10 fiscal years are as follows: (In Millions) U.S. Pension Benefits Non-U.S. Pension Benefits U.S. Postretirement Medical Benefits 2016 $ 57 $ 26 $ 19 2017 $ 61 $ 28 $ 21 2018 $ 69 $ 31 $ 24 2019 $ 70 $ 34 $ 27 2020 $ 70 $ 37 $ 31 2021-2025 $ 362 $ 251 $ 214
U.S. Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Allocation of Plan Assets [Table Text Block]	U.S. Intel Minimum Pension Plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period: December 26, 2015 Dec 27, Fair Value Measured at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Total Equity securities $ 54 $ 314 $ — $ 368 $ 347 Fixed income 16 201 38 255 254 Other investments 4 — — 4 20 Total assets measured at fair value $ 74 $ 515 $ 38 $ 627 $ 621 Cash — 2 Total U.S. pension plan assets at fair value $ 627 $ 623
Non-U.S. Pension Benefits [Member]
Defined Benefit Plan Disclosure [Line Items]
Schedule of Allocation of Plan Assets [Table Text Block]	Non-U.S. plan assets measured at fair value on a recurring basis consisted of the following investment categories at the end of each period: December 26, 2015 Dec 27, Fair Value Measured at Reporting Date Using (In Millions) Level 1 Level 2 Level 3 Total Total Equity securities $ 274 $ 56 $ 15 $ 345 $ 521 Fixed income — 610 34 644 476 Total assets measured at fair value $ 274 $ 666 $ 49 $ 989 $ 997 Cash 22 20 Total non-U.S. plan assets at fair value $ 1,011 $ 1,017

Commitments (Tables)

Commitments (Tables)	12 Months Ended
	Dec. 26, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]	Minimum rental commitments under all non-cancelable leases with an initial term in excess of one year were as follows as of December 26, 2015 : (In Millions) 2016 $ 234 2017 209 2018 167 2019 144 2020 120 2021 and thereafter 326 Total $ 1,200

Employee Equity Incentive Pla49

Employee Equity Incentive Plans (Tables)	12 Months Ended
	Dec. 26, 2015
Employee Benefits and Share-based Compensation [Abstract]
Restricted Stock Units Estimated Values And Weighted Average Assumptions [Table Text Block]	We estimate the fair value of RSUs with time-based vesting using the value of our common stock on the date of grant, reduced by the present value of dividends expected to be paid on our shares of common stock prior to vesting. We estimate the fair value of OSUs using a Monte Carlo simulation model on the date of grant. We based the weighted average estimated value of RSU grants, as well as the weighted average assumptions that we used in calculating the fair value, on estimates at the date of grant, for each period as follows: Dec 26, Dec 27, Dec 28, Estimated values $ 31.63 $ 25.40 $ 21.45 Risk-free interest rate 0.6 % 0.5 % 0.2 % Dividend yield 2.9 % 3.3 % 3.8 % Volatility 27 % 23 % 25 %
Stock Options And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Table Text Block]	We use the Black-Scholes option pricing model to estimate the fair value of options granted under the 2006 Plan and rights to acquire shares of common stock granted under the 2006 Stock Purchase Plan. No options were granted in 2015 . We based the weighted average estimated value of employee stock option grants and rights granted under the stock purchase plan, as well as the weighted average assumptions used in calculating the fair value, on estimates at the date of grant, for each period as follows: Stock Options Stock Purchase Plan Dec 26, Dec 27, Dec 28, Dec 26, Dec 27, Dec 28, Estimated values n/a $ 3.61 $ 3.11 $ 6.56 $ 5.87 $ 4.52 Expected life (in years) n/a 5.1 5.2 0.5 0.5 0.5 Risk-free interest rate n/a 1.7 % 0.8 % 0.1 % 0.1 % 0.1 % Dividend yield n/a 3.6 % 3.9 % 3.1 % 3.2 % 4.0 % Volatility n/a 23 % 25 % 25 % 22 % 22 %
Schedule of Share-based Compensation, Restricted Stock Units Award Activity [Table Text Block]	Restricted stock unit activity for each period was as follows: Number of RSUs (In Millions) Weighted Average Grant-Date Fair Value December 29, 2012 109.3 $ 22.03 Granted 53.4 $ 21.45 Vested (44.5 ) $ 20.21 Forfeited (4.9 ) $ 22.06 December 28, 2013 113.3 $ 22.47 Granted 57.2 $ 25.40 Vested (42.5 ) $ 22.33 Forfeited (8.6 ) $ 22.94 December 27, 2014 119.4 $ 23.89 Granted 42.4 $ 31.63 Vested (46.6 ) $ 23.61 Forfeited (7.8 ) $ 25.76 December 26, 2015 107.4 $ 26.93 Expected to vest as of December 26, 2015 102.5 $ 26.93
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	As of December 26, 2015 , options outstanding that have vested and are expected to vest were as follows: Number of Options (In Millions) Weighted Average Exercise Price Weighted Average Remaining Contractual Term (In Years) Aggregate Intrinsic Value (In Millions) Vested 43.8 $ 21.07 1.8 $ 609 Expected to vest 9.6 $ 24.07 4.1 $ 104 Total 53.4 $ 21.61 2.2 $ 713
Schedule of Stock Options Roll Forward [Table Text Block]	Stock option activity for each period was as follows: Number of Options (In Millions) Weighted Average Exercise Price December 29, 2012 202.8 $ 20.20 Granted 20.1 $ 22.99 Exercised (65.0 ) $ 18.76 Cancelled and forfeited (3.0 ) $ 22.58 Expired (1.9 ) $ 22.56 December 28, 2013 153.0 $ 21.10 Granted 0.6 $ 25.34 Exercised (63.7 ) $ 19.87 Cancelled and forfeited (2.7 ) $ 23.70 Expired (9.9 ) $ 27.00 December 27, 2014 77.3 $ 21.30 Granted — $ — Exercised (21.9 ) $ 20.34 Cancelled and forfeited (1.1 ) $ 23.23 Expired (0.1 ) $ 20.87 December 26, 2015 54.2 $ 21.65 Options exercisable as of: December 28, 2013 111.5 $ 20.25 December 27, 2014 54.7 $ 20.29 December 26, 2015 43.8 $ 21.07
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	As of December 26, 2015 , outstanding options and exercisable options information, by range of exercise prices, was as follows: Outstanding Options Exercisable Options Range of Exercise Prices Number of Shares (In Millions) Weighted Average Remaining Contractual Life (In Years) Weighted Average Exercise Price Number of Shares (In Millions) Weighted Average Exercise Price $ 1.82 - $ 15.00 0.4 2.9 $ 11.70 0.4 $ 11.70 $ 15.01 - $ 20.00 21.7 0.8 $ 18.48 21.7 $ 18.48 $ 20.01 - $ 25.00 24.7 3.1 $ 22.92 16.9 $ 22.86 $ 25.01 - $ 27.42 7.4 3.3 $ 27.15 4.8 $ 27.23 Total 54.2 2.2 $ 21.65 43.8 $ 21.07

Gains (Losses) on Equity Inve50

Gains (Losses) on Equity Investments, Net (Tables)	12 Months Ended
	Dec. 26, 2015
Gains (Losses) on Equity Investments, Net [Abstract]
Schedule Of Gains (Losses) On Equity Investments, Net [Table Text Block]	The components of gains (losses) on equity investments, net for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Share of equity method investee losses, net $ (95 ) $ (69 ) $ (69 ) Impairments (185 ) (146 ) (123 ) Gains on sales, net 145 422 515 Dividends 52 57 46 Other, net 398 147 102 Total gains (losses) on equity investments, net $ 315 $ 411 $ 471

Interest and Other, Net (Tables

Interest and Other, Net (Tables)	12 Months Ended
	Dec. 26, 2015
Interest and Other, Net [Abstract]
Interest And Other, Net [Table Text Block]	The components of interest and other, net for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Interest income $ 124 $ 141 $ 104 Interest expense (337 ) (192 ) (244 ) Other, net 108 94 (11 ) Total interest and other, net $ (105 ) $ 43 $ (151 )

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Dec. 26, 2015
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	We computed our basic and diluted earnings per share of common stock for each period as follows: Years Ended Dec 26, Dec 27, Dec 28, Net income available to common stockholders $ 11,420 $ 11,704 $ 9,620 Weighted average shares of common stock outstanding—basic 4,742 4,901 4,970 Dilutive effect of employee equity incentive plans 64 75 68 Dilutive effect of convertible debt 88 80 59 Weighted average shares of common stock outstanding—diluted 4,894 5,056 5,097 Basic earnings per share of common stock $ 2.41 $ 2.39 $ 1.94 Diluted earnings per share of common stock $ 2.33 $ 2.31 $ 1.89

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 26, 2015
Income Tax Disclosure [Abstract]
Income Before Taxes And Provisions For Taxes [Table Text Block]	Income before taxes and the provision for taxes consisted of the following: Years Ended Dec 26, Dec 27, Dec 28, Income before taxes: U.S. $ 8,800 $ 11,565 $ 9,374 Non-U.S. 5,412 4,236 3,237 Total income before taxes 14,212 15,801 12,611 Provision for taxes: Current: Federal 2,828 3,374 2,730 State 40 38 68 Non-U.S. 842 969 716 Total current provision for taxes 3,710 4,381 3,514 Deferred: Federal (862 ) (263 ) (412 ) Other (56 ) (21 ) (111 ) Total deferred provision for taxes (918 ) (284 ) (523 ) Total provision for taxes $ 2,792 $ 4,097 $ 2,991 Effective tax rate 19.6 % 25.9 % 23.7 %
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	The difference between the tax provision at the statutory federal income tax rate and the tax provision as a percentage of income before income taxes (effective tax rate) for each period was as follows: Years Ended Dec 26, Dec 27, Dec 28, Statutory federal income tax rate 35.0 % 35.0 % 35.0 % Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates (7.9 ) (6.1 ) (5.8 ) Settlements, effective settlements, and related remeasurements (2.9 ) — — Domestic manufacturing deduction benefit (2.0 ) (2.1 ) (2.1 ) Research and development tax credits (1.7 ) (1.7 ) (3.5 ) Other (0.9 ) 0.8 0.1 Effective tax rate 19.6 % 25.9 % 23.7 %
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts for income tax purposes. Significant components of our deferred tax assets and liabilities at the end of each period were as follows: (In Millions) Dec 26, Dec 27, Deferred tax assets: Accrued compensation and other benefits $ 931 $ 982 Share-based compensation 424 438 Deferred income 694 691 Inventory 598 339 State credits and net operating losses 613 519 Other, net 760 715 Gross deferred tax assets 4,020 3,684 Valuation allowance (701 ) (595 ) Total deferred tax assets 3,319 3,089 Deferred tax liabilities: Property, plant and equipment (505 ) (1,171 ) Licenses and intangibles (563 ) (576 ) Convertible debt (1,042 ) (977 ) Unrealized gains on investments and derivatives (717 ) (1,017 ) Investment in non-U.S. subsidiaries (37 ) (252 ) Other, net (358 ) (291 ) Total deferred tax liabilities (3,222 ) (4,284 ) Net deferred tax assets (liabilities) 97 (1,195 ) Reported as: Current deferred tax assets 2,036 1,958 Non-current deferred tax assets 600 622 Non-current deferred tax liabilities (2,539 ) (3,775 ) Net deferred tax assets (liabilities) $ 97 $ (1,195 )
Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]	The aggregate changes in the balance of gross unrecognized tax benefits for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Beginning gross unrecognized tax benefits $ 577 $ 207 $ 189 Settlements and effective settlements with tax authorities and related remeasurements (452 ) (220 ) (2 ) Increases in balances related to tax positions taken during prior periods 4 173 21 Decreases in balances related to tax positions taken during prior periods (34 ) (1 ) (9 ) Increases in balances related to tax positions taken during current period 6 418 8 Ending gross unrecognized tax benefits $ 101 $ 577 $ 207

Other Comprehensive Income (L54

Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 26, 2015
Equity [Abstract]
Components Of Other Comprehensive Income (Loss) [Table Text Block]	The components of other comprehensive income (loss) and related tax effects for each period were as follows: December 26, 2015 December 27, 2014 December 28, 2013 Years Ended Before Tax Tax Net of Tax Before Tax Tax Net of Tax Before Tax Tax Net of Tax Change in unrealized holding gains (losses) on available-for-sale investments $ (999 ) $ 350 $ (649 ) $ 1,029 $ (359 ) $ 670 $ 1,963 $ (687 ) $ 1,276 Less: adjustment for (gains) losses on available-for-sale investments included in net income (93 ) 32 (61 ) (142 ) 49 (93 ) (146 ) 51 (95 ) Less: adjustment for (gains) losses on deferred tax asset valuation allowance included in net income — (18 ) (18 ) — (41 ) (41 ) — (26 ) (26 ) Change in unrealized holding gains (losses) on derivatives (298 ) 93 (205 ) (589 ) 160 (429 ) (166 ) 76 (90 ) Less: adjustment for (gains) losses on derivatives included in net income 522 (160 ) 362 13 (11 ) 2 30 (29 ) 1 Change in net prior service (costs) credits (2 ) 1 (1 ) (42 ) 5 (37 ) 17 (2 ) 15 Less: adjustment for amortization of net prior service costs (credits) 10 (2 ) 8 6 (2 ) 4 4 (1 ) 3 Change in actuarial gains (losses) 73 7 80 (433 ) 3 (430 ) 725 (275 ) 450 Less: adjustment for amortization of actuarial (gains) losses 67 (19 ) 48 37 (9 ) 28 101 (31 ) 70 Change in net foreign currency translation adjustment (187 ) 17 (170 ) (275 ) 24 (251 ) 45 (7 ) 38 Other comprehensive income (loss) $ (907 ) $ 301 $ (606 ) $ (396 ) $ (181 ) $ (577 ) $ 2,573 $ (931 ) $ 1,642
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects for each period were as follows: (In Millions) Unrealized Holding Gains (Losses) on Available-for-Sale Investments Deferred Tax Asset Valuation Allowance Unrealized Holding Gains (Losses) on Derivatives Prior Service Credits (Costs) Actuarial Gains (Losses) Foreign Currency Translation Adjustment Total December 28, 2013 $ 1,882 $ 67 $ 4 $ (14 ) $ (602 ) $ (94 ) $ 1,243 Other comprehensive income (loss) before reclassifications 1,029 — (589 ) (42 ) (433 ) (275 ) (310 ) Amounts reclassified out of accumulated other comprehensive income (loss) (142 ) — 13 6 37 — (86 ) Tax effects (310 ) (41 ) 149 3 (6 ) 24 (181 ) Other comprehensive income (loss) 577 (41 ) (427 ) (33 ) (402 ) (251 ) (577 ) December 27, 2014 2,459 26 (423 ) (47 ) (1,004 ) (345 ) 666 Other comprehensive income (loss) before reclassifications (999 ) — (298 ) (2 ) 73 (187 ) (1,413 ) Amounts reclassified out of accumulated other comprehensive income (loss) (93 ) — 522 10 67 — 506 Tax effects 382 (18 ) (67 ) (1 ) (12 ) 17 301 Other comprehensive income (loss) (710 ) (18 ) 157 7 128 (170 ) (606 ) December 26, 2015 $ 1,749 $ 8 $ (266 ) $ (40 ) $ (876 ) $ (515 ) $ 60
Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]	The amounts reclassified out of accumulated other comprehensive income (loss) into the consolidated statements of income, with presentation location, for each period were as follows: Income Before Taxes Impact for Years Ended (In Millions) Comprehensive Income Components Dec 26, Dec 27, Dec 28, Location Unrealized holding gains (losses) on available-for-sale investments: $ 2 $ 10 $ 8 Interest and other, net 91 132 138 Gains (losses) on equity investments, net 93 142 146 Unrealized holding gains (losses) on derivatives: Currency forwards (290 ) (31 ) (61 ) Cost of Sales (177 ) 18 30 Research and development (46 ) 2 — Marketing, general and administrative Other instruments — (2 ) 1 Cost of Sales (9 ) — — Interest and other, net (522 ) (13 ) (30 ) Amortization of pension and postretirement benefit components: Prior service credits (costs) (10 ) (6 ) (4 ) Actuarial gains (losses) (67 ) (37 ) (101 ) (77 ) (43 ) (105 ) Total amounts reclassified out of accumulated other comprehensive income (loss) $ (506 ) $ 86 $ 11

Operating Segments and Geogra55

Operating Segments and Geographic Information (Tables)	12 Months Ended
	Dec. 26, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information, by Segment [Table Text Block]	Net revenue and operating income (loss) for each period were as follows: Years Ended Dec 26, Dec 27, Dec 28, Net revenue: Client Computing Group Platform $ 30,654 $ 33,210 $ 32,385 Other 1,565 1,662 2,260 32,219 34,872 34,645 Data Center Group Platform 14,882 13,366 11,219 Other 1,095 1,021 944 15,977 14,387 12,163 Internet of Things Platform 1,976 1,814 1,485 Other 322 328 316 2,298 2,142 1,801 Software and services operating segments 2,167 2,216 2,188 All other 2,694 2,253 1,911 Total net revenue $ 55,355 $ 55,870 $ 52,708 Operating income (loss): Client Computing Group $ 8,165 $ 10,323 $ 8,708 Data Center Group 7,844 7,390 5,456 Internet of Things Group 515 583 532 Software and services operating segments 210 81 57 All other (2,732 ) (3,030 ) (2,462 ) Total operating income $ 14,002 $ 15,347 $ 12,291
Revenue from External Customers by Geographic Areas [Table Text Block]	Net revenue by country as presented below is based on the billing location of the customer. Revenue from unaffiliated customers for each period was as follows: Years Ended Dec 26, Dec 27, Dec 28, China (including Hong Kong) $ 11,679 $ 11,197 $ 9,890 Singapore 11,544 11,573 10,997 United States 11,121 9,828 9,091 Taiwan 10,661 8,955 8,888 Other countries 10,350 14,317 13,842 Total net revenue $ 55,355 $ 55,870 $ 52,708
Long-lived Assets by Geographic Areas [Table Text Block]	Net property, plant and equipment by country at the end of each period was as follows: (In Millions) Dec 26, Dec 27, Dec 28, United States $ 22,611 $ 24,020 $ 23,624 Ireland 5,789 5,433 2,986 Israel 1,661 1,957 2,667 Other countries 1,797 1,828 2,151 Total property, plant and equipment, net $ 31,858 $ 33,238 $ 31,428

Accounting Policies (Detail)

Accounting Policies (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Apr. 02, 2016	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Inventory Net Items Net Of Reserve Alternative [Abstract]
Raw materials		$ 532	$ 462
Work in process		2,893	2,375
Finished goods		1,742	1,436
Total Inventories		5,167	4,273
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross		83,396	79,709
Less: accumulated depreciation		(51,538)	(46,471)
Total property, plant and equipment, net		31,858	33,238	$ 31,428
Advertising [Abstract]
Advertising Expense		1,800	1,800	$ 1,900
Land and buildings [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross		25,578	22,989
Machinery and equipment [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross		$ 48,459	44,441
Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)		2 years
Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)		4 years
Construction in progress [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross		$ 9,359	12,279
Building [Member] | Minimum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)		10 years
Building [Member] | Maximum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)		25 years
ConstructionInProgressOnHold [Member]
Property, Plant and Equipment [Abstract]
Property, plant and equipment, gross		$ 3,400	$ 2,200
Subsequent Event [Member] | Machinery and equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	2 years
Subsequent Event [Member] | Machinery and equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Useful Life (in years)	5 years
Acquisition-related Developed Technology [Member] | Minimum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		3 years
Acquisition-related Developed Technology [Member] | Maximum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		9 years
Acquisition-related Customer Relationships [Member] | Minimum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		5 years
Acquisition-related Customer Relationships [Member] | Maximum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		11 years
Acquisition-related Brands [Member] | Minimum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		5 years
Acquisition-related Brands [Member] | Maximum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		8 years
Licensed Technology and Patents [Member] | Minimum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		2 years
Licensed Technology and Patents [Member] | Maximum [Member]
Identified Intangible Assets [Abstract]
Finite-Lived Intangible Assets, Useful Life (in years)		17 years

Fair Value (Detail)

Fair Value (Detail) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Jan. 31, 2011	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		$ 7,323	$ 9,063
Loans receivable		794	971
Non-marketable cost method investments		2,933	1,769
Reverse repurchase agreements		3,368	718
Long-term debt		20,036	12,059
NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loss Contingency, Cross License Annual Payment Amount, 2015-2016	$ 200
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure		32,662	23,708
Liabilities, Fair Value Disclosure		245	580
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Non-Marketable Equity Investments, Gains (Losses)		(160)	(128)	$ (106)
Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		2,368	268
Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		445	561
Loans Receivable, Fair Value Disclosure		137	505
Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		40	57
Loans Receivable, Fair Value Disclosure		342	216
Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		212	563
Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		33	17
Corporate debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,829	48
Corporate debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,120	806
Corporate debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		2,308	2,964
Corporate debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,208	1,194
Financial institution instruments | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		9,515	1,440
Financial institution instruments | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,072	1,199
Financial institution instruments | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,631	1,759
Financial institution instruments | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		552	508
Government debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		130	0
Government debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		490	425
Government debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		3,015	3,516
Government debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		127	315
Asset-backed securities | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		369	824
Asset-backed securities | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		4	6
Marketable equity securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		5,960	7,097
Corporate Debt, Financial Institution Instruments, Government Debt, And Marketable Equity Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		628	177
Fair Value, Assets, Level 2 to Level 1 Transfers, Amount		403	395
Level 1 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure		19,145	13,965
Liabilities, Fair Value Disclosure		2	0
Level 1 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		0	0
Level 1 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		32	0
Loans Receivable, Fair Value Disclosure		0	0
Level 1 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		0	0
Loans Receivable, Fair Value Disclosure		0	0
Level 1 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		2	0
Level 1 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 1 [Member] | Corporate debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 1 [Member] | Corporate debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		336	363
Level 1 [Member] | Corporate debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,744	2,625
Level 1 [Member] | Corporate debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		407	453
Level 1 [Member] | Financial institution instruments | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		8,238	321
Level 1 [Member] | Financial institution instruments | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		145	149
Level 1 [Member] | Financial institution instruments | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		930	1,146
Level 1 [Member] | Financial institution instruments | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		171	189
Level 1 [Member] | Government debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 1 [Member] | Government debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		65	252
Level 1 [Member] | Government debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,107	1,295
Level 1 [Member] | Government debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		79	75
Level 1 [Member] | Asset-backed securities | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 1 [Member] | Asset-backed securities | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 1 [Member] | Marketable equity securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		5,891	7,097
Level 2 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure		13,388	9,613
Liabilities, Fair Value Disclosure		243	580
Level 2 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		2,368	268
Level 2 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		412	559
Loans Receivable, Fair Value Disclosure		137	505
Level 2 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		30	35
Loans Receivable, Fair Value Disclosure		342	216
Level 2 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		210	563
Level 2 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		33	17
Level 2 [Member] | Corporate debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,829	48
Level 2 [Member] | Corporate debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		764	412
Level 2 [Member] | Corporate debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		564	339
Level 2 [Member] | Corporate debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		801	728
Level 2 [Member] | Financial institution instruments | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		1,277	1,119
Level 2 [Member] | Financial institution instruments | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		927	1,050
Level 2 [Member] | Financial institution instruments | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		701	613
Level 2 [Member] | Financial institution instruments | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		381	319
Level 2 [Member] | Government debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		130	0
Level 2 [Member] | Government debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		425	173
Level 2 [Member] | Government debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		1,908	2,221
Level 2 [Member] | Government debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		48	240
Level 2 [Member] | Asset-backed securities | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		275	766
Level 2 [Member] | Asset-backed securities | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	2
Level 2 [Member] | Marketable equity securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		69	0
Level 3 [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, Fair Value Disclosure		129	130
Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Reverse Repurchase Agreements, Fair Value Disclosure		0	0
Level 3 [Member] | Other Current Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		1	2
Loans Receivable, Fair Value Disclosure		0	0
Level 3 [Member] | Other Long-Term Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Assets, Fair Value Disclosure		10	22
Loans Receivable, Fair Value Disclosure		0	0
Level 3 [Member] | Other Accrued Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Other Noncurrent Liabilities [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative Financial Instruments, Liabilities, Fair Value Disclosure		0	0
Level 3 [Member] | Corporate debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Corporate debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		20	31
Level 3 [Member] | Corporate debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Corporate debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	13
Level 3 [Member] | Financial institution instruments | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Financial institution instruments | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Financial institution instruments | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Financial institution instruments | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government debt | Cash Equivalents [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government debt | Short-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Government debt | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		0	0
Level 3 [Member] | Government debt | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Level 3 [Member] | Asset-backed securities | Trading Assets [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading assets		94	58
Level 3 [Member] | Asset-backed securities | Other Long-Term Investments [Member] | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		4	4
Level 3 [Member] | Marketable equity securities | Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investments, Fair Value Disclosure		0	0
Carrying Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable		593	676
Loans receivable		315	250
Non-marketable cost method investments		2,933	1,769
Reverse repurchase agreements		1,000	450
Short-term Debt		2,593	1,580
Long-term debt		20,036	12,059
Carrying Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable		199	395
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		600	679
Loans receivable		315	250
Cost Method Investments, Fair Value Disclosure		3,904	2,599
Reverse repurchase agreements		1,000	450
Short-term Debt, Fair Value		3,076	2,145
Long-term debt		20,893	12,776
Fair Value [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		200	399
Fair Value [Member] | Level 1 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		0	0
Loans receivable		0	0
Cost Method Investments, Fair Value Disclosure		0	0
Reverse repurchase agreements		0	0
Short-term Debt, Fair Value		1,513	0
Long-term debt		14,058	11,467
Fair Value [Member] | Level 1 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		0	0
Fair Value [Member] | Level 2 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		600	679
Loans receivable		315	250
Cost Method Investments, Fair Value Disclosure		0	0
Reverse repurchase agreements		1,000	450
Short-term Debt, Fair Value		1,563	2,145
Long-term debt		6,835	1,309
Fair Value [Member] | Level 2 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		200	399
Fair Value [Member] | Level 3 [Member] | Not Recorded At Fair Value On Recurring Basis [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Grants Receivable, Fair Value Disclosure		0	0
Loans receivable		0	0
Cost Method Investments, Fair Value Disclosure		3,904	2,599
Reverse repurchase agreements		0	0
Short-term Debt, Fair Value		0	0
Long-term debt		0	0
Fair Value [Member] | Level 3 [Member] | Not Recorded At Fair Value On Recurring Basis [Member] | NVIDIA Corporation cross-license agreement liability [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Notes Payable, Fair Value Disclosure		$ 0	$ 0

Cash and Investment (Detail)

Cash and Investment (Detail) - USD ($) $ in Millions	Dec. 26, 2015	Dec. 27, 2014
Cash and Cash Equivalents [Abstract]
Available-for-sale investments	$ 22,007	$ 13,038
Cash	1,466	805
Equity method investments	1,590	1,446
Loans receivable	794	971
Non-marketable cost method investments	2,933	1,769
Reverse repurchase agreements	3,368	718
Trading assets	7,323	9,063
Total cash and investments	$ 39,481	$ 27,810

Cash and Investments, Available

Cash and Investments, Available For Sale Investments (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Available-for-sale Securities [Abstract]
Fair Value	$ 16,047
Adjusted Cost, Total	19,311	$ 9,253
Gross Unrealized Gains, Total	2,710	3,794
Gross Unrealized Losses, Total	(14)	(9)
Fair Value, Total	22,007	13,038
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	2,200	1,700	$ 1,300
Available-for-sale Securities, Gross Realized Gains	133	136	146
Due in 1 year or less, Fair Value	5,893
Due in 1-2 years, Fair Value	1,268
Due in 2-5 years, Fair Value	620
Instruments not due at a single maturity date, Fair Value	8,266
Cash and Cash Equivalents [Member]
Available-for-sale Securities [Abstract]
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	144	509	$ 339
Asset-backed securities
Available-for-sale Securities [Abstract]
Adjusted Cost	5	8
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	(2)
Fair Value	4	6
Corporate debt
Available-for-sale Securities [Abstract]
Adjusted Cost	4,164	2,040
Gross Unrealized Gains	3	13
Gross Unrealized Losses	(10)	(5)
Fair Value	4,157	2,048
Financial institution instruments
Available-for-sale Securities [Abstract]
Adjusted Cost	11,140	3,146
Gross Unrealized Gains	1	2
Gross Unrealized Losses	(2)	(1)
Fair Value	11,139	3,147
Government debt
Available-for-sale Securities [Abstract]
Adjusted Cost	748	741
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(1)	(1)
Fair Value	747	740
Marketable equity securities
Available-for-sale Securities [Abstract]
Adjusted Cost	3,254	3,318
Gross Unrealized Gains	2,706	3,779
Gross Unrealized Losses	0	0
Fair Value	5,960	$ 7,097
Debt Securities [Member]
Available-for-sale Securities [Abstract]
Adjusted Cost	16,057
Due in 1 year or less, Cost	5,896
Due in 1-2 years, Cost	1,271
Due in 2-5 years, Cost	623
Instruments not due at a single maturity date, Cost	$ 8,267

Cash and Investments, Equity Me

Cash and Investments, Equity Method and Cost Method Investments (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 1,590	$ 1,446
Non-marketable cost method investments	2,933	1,769
IM Flash Technologies, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 872	$ 713
Equity Method Investment, Ownership Percentage	49.00%	49.00%
Related Party Transaction, Purchases from Related Party	$ 400	$ 400	$ 380
Due to Related Parties	20	60
Proceeds from Equity Method Investment, Dividends or Distributions, Return of Capital		6	45
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 872
Percentage Of Purchase Commitment Of Production Output And Production Related Services	49.00%
Cloudera, Inc. [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 256	$ 280
Equity Method Investment, Ownership Percentage	17.00%	17.00%
Non-marketable cost method investments	$ 454	$ 454
Intel-GE Care Innovations, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 64	$ 108
Equity Method Investment, Ownership Percentage	50.00%	50.00%
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount	$ 64
Other Equity Method Investments [Member]
Schedule of Equity Method Investments [Line Items]
Equity Method Investments	$ 398	$ 345
Clearwire, LLC [Member]
Schedule of Equity Method Investments [Line Items]
Proceeds from (Payments for) Other Financing Activities			328
Equity Method Investment, Realized Gain (Loss) on Disposal			$ 328

Cash and Investments, Non-Marke

Cash and Investments, Non-Marketable Cost Method Investments (Detail) $ in Millions, ¥ in Billions	12 Months Ended
	Dec. 26, 2015USD ($)	Dec. 27, 2014USD ($)	Dec. 28, 2013USD ($)	Dec. 27, 2014CNY (¥)
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	$ 2,933	$ 1,769
Cost-method Investments [Member]
Schedule of Cost-method Investments [Line Items]
Other than Temporary Impairment Losses, Investments	164	130	$ 103
Cloudera, Inc. [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	454	454
Beijing UniSpreadtrum Technology Ltd [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	966
Beijing UniSpreadtrum Technology Ltd Phase One [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	966
Subject To Regulatory Approvals And Other Closing Conditions [Member] | Beijing UniSpreadtrum Technology Ltd [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments		$ 1,500		¥ 9
Cost Method Investment, Ownership Percentage		20.00%		20.00%
Subject To Regulatory Approvals And Other Closing Conditions [Member] | Beijing UniSpreadtrum Technology Ltd Phase Two [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	$ 500

Cash and Investments, Trading A

Cash and Investments, Trading Assets (Detail) - Debt Securities [Member] - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule Of Trading Securities And Other Trading Assets [Line Items]
Trading Securities, Change in Unrealized Holding Gain (Loss)	$ (152)	$ (530)	$ (70)
Net gains (losses) on derivatives related to trading securities	$ 137	$ 525	$ 86

Derivative Financial Instrume63

Derivative Financial Instruments (Detail) AUD in Millions, $ in Millions	12 Months Ended
	Dec. 26, 2015USD ($)	Dec. 27, 2014USD ($)	Dec. 28, 2013USD ($)	Dec. 26, 2015AUD
Derivative [Line Items]
Deferred Compensation Liability, Current and Noncurrent	$ 1,300	$ 1,200
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge	13	0	$ 0
Net Change In Unrealized Gain Loss Recognized In Income Statement On Fair Value Hedging Instruments And On Hedged Item In Fair Value Hedge	0	0	0
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	26,655	27,076	23,739
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	482	559
Derivative Liability, Fair Value, Gross Liability	242	559
Offsetting Derivative Assets [Abstract]
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet	0	0
Derivative Assets Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet	482	559
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments	(201)	(365)
Derivative Assets Subject To Master Netting Arrangements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged	(188)	(78)
Derivative Assets Subject To Master Netting Arrangements, Net Amount	93	116
Reverse Repurchase Agreements, Gross Amounts Recognized	3,368	718
Reverse Repurchase Agreements, Gross Amounts Offset In The Balance Sheet	0	0
Reverse Repurchase Agreements, Net Amounts Presented In The Balance Sheet	3,368	718
Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments	0	0
Reverse Repurchase Agreements, Gross Amounts Not Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged	(3,368)	(718)
Reverse Repurchase Agreements, Net Amount	0	0
Total Assets, Gross Amounts Recognized	3,850	1,277
Total Assets, Gross Amounts Offset In The Balance Sheet	0	0
Total Assets, Net Amounts Presented In The Balance Sheet	3,850	1,277
Total Assets, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments	(201)	(365)
Total Assets, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged	(3,556)	(796)
Total Assets, Net Amount	93	116
Offsetting Derivative Liabilities [Abstract]
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet	0	0
Derivative Liabilities Subject To Master Netting Arrangements, Net Amounts Presented In The Balance Sheet	242	559
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Financial Instruments	(201)	(365)
Derivative Liability, Collateral, Obligation To Reclaim Cash Or Non-Cash	(27)	(80)
Derivative Liabilities Subject To Master Netting Arrangements, Gross Amounts Offset In The Balance Sheet - Cash And Non-Cash Collateral Received Or Pledged	14	114
Total Liabilities, Gross Amounts Recognized	242	559
Total Liabilities, Gross Amounts Offset In The Balance Sheet	0	0
Total Liabilities, Net Amounts Presented In The Balance Sheet	242	559
Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Financial Instruments	(201)	(365)
Total Liabilities, Gross Amounts Not Offset In The Balance Sheet - Cash and Non-Cash Collateral Received Or Pledged	(27)	(80)
Total Liabilities, Net Amount	14	114
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net [Abstract]
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	(298)	(589)	(166)
Not Designated as Hedging Instrument [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	250	659	219
Fair Value Hedging [Member]
Effect of Fair Value Hedges on Results of Operations [Abstract]
Derivative, Net Hedge Ineffectiveness Gain (Loss)	0	0	0
Other Current Assets [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	445	561
Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	20	6
Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	425	555
Other Long-Term Assets [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	40	57
Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	11	1
Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	29	56
Other Accrued Liabilities [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	212	563
Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	83	497
Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	129	66
Other Noncurrent Liabilities [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	33	17
Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	16	9
Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	17	8
Debt instruments under interest rate swaps [Member]
Derivative [Line Items]
Debt Instrument, Face Amount	4,400
2015 AUD-denominated Senior notes [Member]
Derivative [Line Items]
Debt Instrument, Face Amount | AUD				AUD 800
Currency Forwards [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	11,212	15,578	13,404
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net [Abstract]
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	(305)	(587)	(167)
Currency Forwards [Member] | Discontinued Hedging Instrument [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	478
Currency Forwards [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	(50)	144	44
Currency Forwards [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	20	6
Currency Forwards [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	20	207
Currency Forwards [Member] | Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	3	1
Currency Forwards [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Currency Forwards [Member] | Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	83	497
Currency Forwards [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	63	44
Currency Forwards [Member] | Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	2	9
Currency Forwards [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Currency Forwards [Member] | Beijing UniSpreadtrum Technology Ltd [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount		1,500
Currency Interest Rate Swaps [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	5,509	5,446	4,377
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income (Loss), Effective Portion, Net [Abstract]
Gains (Losses) Recognized in Other Comprehensive Income (Loss) on Derivatives (Effective Portion)	7	(2)	1
Currency Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	346	456	29
Currency Interest Rate Swaps [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Currency Interest Rate Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	370	344
Currency Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	7	0
Currency Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	18	34
Currency Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Currency Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	52	7
Currency Interest Rate Swaps [Member] | Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Currency Interest Rate Swaps [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Currency Interest Rate Swaps [Member] | 2015 AUD-denominated Senior notes [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	577
Embedded Debt Derivatives [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	3,600	3,600	3,600
Embedded Debt Derivatives [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Embedded Debt Derivatives [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Embedded Debt Derivatives [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	4
Embedded Debt Derivatives [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	17	8
Interest Rate Swaps [Member]
Effect of Fair Value Hedges on Results of Operations [Abstract]
Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments	(13)	0	0
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	5,212	1,347	1,377
Interest Rate Swaps [Member] | Not Designated as Hedging Instrument [Member] | Interest and Other, Net [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	(6)	(3)	0
Interest Rate Swaps [Member] | Other Current Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Interest Rate Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	2	3
Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	1	0
Interest Rate Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Interest Rate Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	12	11
Interest Rate Swaps [Member] | Other Noncurrent Liabilities [Member] | Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	14	0
Interest Rate Swaps [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Interest Rate Swaps [Member] | Debt instruments under interest rate swaps [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	4,400
Total Return Swaps [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	1,061	1,056	914
Total Return Swaps [Member] | Not Designated as Hedging Instrument [Member] | Various [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	(27)	68	140
Total Return Swaps [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	32	0
Total Return Swaps [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	0	0
Total Return Swaps [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	2	0
Total Return Swaps [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Other Derivative Instruments [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	61	49	67
Other Derivative Instruments [Member] | Interest and Other, Net [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	(2)	0	0
Other Derivative Instruments [Member] | Not Designated as Hedging Instrument [Member] | Gains (Losses) On Equity Investments, Net [Member]
Derivative Instruments Not Designation as Hedging Instruments [Abstract]
Gains (Losses) Recognized in Income on Derivatives	(11)	(6)	6
Other Derivative Instruments [Member] | Other Current Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	1	1
Other Derivative Instruments [Member] | Other Long-Term Assets [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Asset, Fair Value, Gross Asset	11	22
Other Derivative Instruments [Member] | Other Accrued Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Other Derivative Instruments [Member] | Other Noncurrent Liabilities [Member] | Not Designated as Hedging Instrument [Member]
Derivative Instruments in Statements of Financial Position, Fair Value [Abstract]
Derivative Liability, Fair Value, Gross Liability	0	0
Total Currency Exchange Rate Derivatives [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	16,721	21,024	17,781
Total Currency Exchange Rate Derivatives [Member] | Chinese Yuan [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	2,231	3,097	1,116
Total Currency Exchange Rate Derivatives [Member] | Euro [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	6,084	7,486	6,874
Total Currency Exchange Rate Derivatives [Member] | Israeli Shekel [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	1,674	2,489	2,244
Total Currency Exchange Rate Derivatives [Member] | Japanese Yen [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	2,663	3,779	4,116
Total Currency Exchange Rate Derivatives [Member] | Other Currencies [Member]
Gross Notional Amounts [Abstract]
Derivative, Notional Amount	$ 4,069	$ 4,173	$ 3,431

Concentrations of Credit Risk (

Concentrations of Credit Risk (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Total Credit Exposure To Any Single Counterparty [Member]
Concentration Risk [Line Items]
Concentration Risk, Credit Risk, Financial Instrument, Maximum Exposure	$ 500
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	46.00%	46.00%	44.00%
Accounts Receivable, Net [Member] | Accounts Receivable Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration Risk, Percentage	49.00%	43.00%

Acquisitions (Detail)

Acquisitions (Detail) - USD ($) $ / shares in Units, $ in Millions	Dec. 28, 2015	Apr. 02, 2016	Jun. 27, 2015	Dec. 27, 2014	Sep. 28, 2013	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Series of Individually Immaterial Business Acquisitions [Member]
Business Acquisition [Line Items]
Business Combinations During Period, Consideration Transferred						$ 1,000	$ 963	$ 925
Lantiq Semiconductor [Member]
Business Acquisition [Line Items]
Business Combinations During Period, Consideration Transferred			$ 345
Axxia Networking Business of Avago Technologies Limited [Member]
Business Acquisition [Line Items]
Business Combinations During Period, Consideration Transferred				$ 650
Stonesoft Oyj [Member]
Business Acquisition [Line Items]
Business Combinations During Period, Consideration Transferred					$ 381
Subsequent Event [Member]
Business Acquisition [Line Items]
Proceeds from Lines of Credit		$ 4,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Long-term Debt	$ 1,500
Subsequent Event [Member] | Altera Corporation [Member]
Business Acquisition [Line Items]
Business Combinations During Period, Consideration Transferred	$ 14,500
Business Acquisition, Share Price	$ 54
2015 Senior notes [Member]
Business Acquisition [Line Items]
Debt Instrument, Face Amount						$ 9,500

Divestitures (Detail)

Divestitures (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Mar. 29, 2014	Dec. 26, 2015
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Divestiture of Businesses, Net of Cash Divested		$ 153
Intel Media Assets [Member]
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Proceeds from Divestiture of Businesses, Net of Cash Divested	$ 150

Goodwill (Detail)

Goodwill (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014
Goodwill [Roll Forward]
Goodwill, Beginning Balance	$ 10,861	$ 10,513
Goodwill, Acquisitions	677	580
Goodwill, Currency Exchange and Other	(206)	(232)
Goodwill, Ending Balance	11,332	10,861
Goodwill, Impaired, Accumulated Impairment Loss	719
Client Computing Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	3,708	3,689
Goodwill, Acquisitions	370	19
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	4,078	3,708
Goodwill, Impaired, Accumulated Impairment Loss	365
Data Center Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	2,376	1,969
Goodwill, Acquisitions	28	407
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	2,404	2,376
Goodwill, Impaired, Accumulated Impairment Loss	275
Internet of Things Group [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	428	428
Goodwill, Acquisitions	0	0
Goodwill, Currency Exchange and Other	0	0
Goodwill, Ending Balance	428	428
Goodwill, Impaired, Accumulated Impairment Loss	79
Software and services operating segments [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	4,236	4,409
Goodwill, Acquisitions	10	41
Goodwill, Currency Exchange and Other	(206)	(214)
Goodwill, Ending Balance	4,040	4,236
All other [Member]
Goodwill [Roll Forward]
Goodwill, Beginning Balance	113	18
Goodwill, Acquisitions	269	113
Goodwill, Currency Exchange and Other	0	(18)
Goodwill, Ending Balance	$ 382	$ 113

Identified Intangible Assets, F

Identified Intangible Assets, Finite-Lived Intangible Assets (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	$ 7,742	$ 7,921
Accumulated Amortization	(4,750)	(4,466)
Net	2,992	3,455
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	890	1,169	$ 1,242
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2016	774
Future Amortization Expense, 2017	497
Future Amortization Expense, 2018	330
Future Amortization Expense, 2019	309
Future Amortization Expense, 2020	260
Acquisition-related Developed Technology [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	2,928	3,009
Accumulated Amortization	(2,276)	(2,192)
Net	652	817
Identified Intangible Assets, Acquired During Period [Abstract]
Identified Intangible Assets Acquired During Period	$ 238	$ 175
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	6 years	6 years
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2016	$ 260
Future Amortization Expense, 2017	115
Future Amortization Expense, 2018	101
Future Amortization Expense, 2019	98
Future Amortization Expense, 2020	64
Acquisition-related Customer Relationships [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	1,738	$ 1,698
Accumulated Amortization	(1,219)	(1,001)
Net	519	697
Identified Intangible Assets, Acquired During Period [Abstract]
Identified Intangible Assets Acquired During Period	$ 110	$ 79
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	11 years	9 years
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2016	$ 229
Future Amortization Expense, 2017	143
Future Amortization Expense, 2018	42
Future Amortization Expense, 2019	25
Future Amortization Expense, 2020	22
Acquisition-related Brands [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	59	$ 61
Accumulated Amortization	(55)	(49)
Net	4	12
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2016	3
Future Amortization Expense, 2017	0
Future Amortization Expense, 2018	0
Future Amortization Expense, 2019	0
Future Amortization Expense, 2020	0
Licensed Technology and Patents [Member]
Identified Intangible Assets By Major Class [Abstract]
Gross Assets, Finite-lived Intangible Assets	3,017	3,153
Accumulated Amortization	(1,200)	(1,224)
Net	$ 1,817	$ 1,929
Identified Intangible Assets, Acquired During Period [Abstract]
Acquired Finite-lived Intangible Asset, Weighted Average Useful Life (in years)	7 years	8 years
Finite Lived Intangible Assets Purchased	$ 176	$ 93
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
Future Amortization Expense, 2016	282
Future Amortization Expense, 2017	239
Future Amortization Expense, 2018	187
Future Amortization Expense, 2019	186
Future Amortization Expense, 2020	174
Cost of sales [Member] | Acquisition-related Developed Technology [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	343	600	576
Cost of sales [Member] | Licensed Technology and Patents [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	282	275	272
Amortization of acquisition-related intangibles [Member] | Acquisition-related Customer Relationships [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	258	284	279
Amortization of acquisition-related intangibles [Member] | Acquisition-related Brands [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	7	10	12
Reduction of revenue [Member] | Other Intangible Assets [Member]
Identified Intangible Assets, Amortization Expenses [Abstract]
Amortization of intangibles	$ 0	$ 0	$ 103

Identified Intangible Assets, I

Identified Intangible Assets, Indefinite-Lived Intangible Assets (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 27, 2014	Dec. 26, 2015
Indefinite-lived Intangible Assets [Line Items]
Intangible Assets Gross	$ 991	$ 941
Acquisition-related Brands [Member]
Indefinite-lived Intangible Assets [Line Items]
Gross assets, Indefinite-Lived Intangible Assets	788	767
Other Intangible Assets [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-lived Intangible Assets Acquired	197
Gross assets, Indefinite-Lived Intangible Assets	$ 203	$ 174

Identified Intangible Assets, T

Identified Intangible Assets, Total Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 26, 2015	Dec. 27, 2014
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Total identified intangible assets, gross	$ 8,683	$ 8,912
Identified intangible assets, net	$ 3,933	$ 4,446

Other Long-Term Assets (Detail)

Other Long-Term Assets (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014
Schedule of Cost-method Investments [Line Items]
Equity method investments	$ 1,590	$ 1,446
Non-marketable cost method investments	2,933	1,769
Non-current deferred tax assets	600	622
Pre-payments for property, plant and equipment	623	636
Loans receivable	642	416
Grants receivable	318	312
Reverse repurchase agreements	350	350
Other	679	954
Total other long-term assets	7,735	$ 6,505
Transfers From Other Long-Term Assets to Property, Plant, And Equipment Related To Prepaid Equipment	213
Beijing UniSpreadtrum Technology Ltd [Member]
Schedule of Cost-method Investments [Line Items]
Non-marketable cost method investments	$ 966

Restructuring And Asset Impai72

Restructuring And Asset Impairment Charges (Detail) $ in Millions	12 Months Ended
	Dec. 26, 2015USD ($)Employee	Dec. 27, 2014USD ($)	Dec. 28, 2013USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	$ 354	$ 295	$ 240
2015 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Activities, Completion Date	Dec. 26, 2015
Restructuring and Related Cost, Incurred Cost	$ 264	0	0
Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date | Employee	4,000
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	$ 0
Restructuring Reserve, Additional accruals	306
Restructuring Reserve, Adjustments	(42)
Restructuring Reserve, Cash payments	(226)
Restructuring Reserve, Non-cash settlements	(6)
Restructuring Reserve, Ending Balance	32	0
2015 Restructuring Program [Member] | Employee severance and benefit arrangements [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	250
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	0
Restructuring Reserve, Additional accruals	292
Restructuring Reserve, Adjustments	(42)
Restructuring Reserve, Cash payments	(225)
Restructuring Reserve, Non-cash settlements	0
Restructuring Reserve, Ending Balance	25	0
2015 Restructuring Program [Member] | Asset impairments and other restructuring charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	14
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	0
Restructuring Reserve, Additional accruals	14
Restructuring Reserve, Adjustments	0
Restructuring Reserve, Cash payments	(1)
Restructuring Reserve, Non-cash settlements	(6)
Restructuring Reserve, Ending Balance	$ 7	0
2013 Restructuring Program [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Activities, Completion Date	Dec. 26, 2015
Restructuring and Related Cost, Incurred Cost	$ 90	295	240
Restructuring and Related Cost, Number of Positions Eliminated | Employee	940
Restructuring and Related Cost, Cost Incurred to Date	$ 625
Restructuring and Related Cost, Number of Positions Eliminated, Inception to Date | Employee	8,500
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	$ 132	183
Restructuring Reserve, Additional accruals	110	283
Restructuring Reserve, Adjustments	(20)	12
Restructuring Reserve, Cash payments	(181)	(333)
Restructuring Reserve, Non-cash settlements	(3)	(13)
Restructuring Reserve, Ending Balance	38	132	183
2013 Restructuring Program [Member] | Employee severance and benefit arrangements [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	82	265	201
Restructuring and Related Cost, Cost Incurred to Date	548
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	121	183
Restructuring Reserve, Additional accruals	101	252
Restructuring Reserve, Adjustments	(19)	13
Restructuring Reserve, Cash payments	(171)	(327)
Restructuring Reserve, Non-cash settlements	0	0
Restructuring Reserve, Ending Balance	32	121	183
2013 Restructuring Program [Member] | Asset impairments and other restructuring charges [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Incurred Cost	8	30	39
Restructuring and Related Cost, Cost Incurred to Date	77
Restructuring Reserve [Roll Forward]
Restructuring Reserve, Beginning Balance	11	0
Restructuring Reserve, Additional accruals	9	31
Restructuring Reserve, Adjustments	(1)	(1)
Restructuring Reserve, Cash payments	(10)	(6)
Restructuring Reserve, Non-cash settlements	(3)	(13)
Restructuring Reserve, Ending Balance	$ 6	$ 11	$ 0

Deferred Income (Detail)

Deferred Income (Detail) - USD ($) $ in Millions	Dec. 26, 2015	Dec. 27, 2014
Deferred Revenue Arrangement [Line Items]
Current deferred income	$ 2,188	$ 2,205
Total deferred income	2,718	2,688
Shipments Of Components To Distributors [Member]
Deferred Revenue Arrangement [Line Items]
Current deferred income	920	944
Software Services And Other [Member]
Deferred Revenue Arrangement [Line Items]
Current deferred income	1,268	1,261
Non-current deferred income	$ 530	$ 483

Borrowings, Short-term Debt (De

Borrowings, Short-term Debt (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014
Debt Disclosure [Abstract]
Drafts payable	$ 41	$ 16
Commercial paper	0	500
Current portion of long-term debt	2,602	1,088
Less: debt issuance costs associated with the current portion of long-term debt	(9)	(8)
Total short-term debt	2,634	1,596
Board Of Directors Maximum Borrowing Capacity Authorization	5,000	3,000
Maximum Borrowings, Commercial Paper Program	900	$ 2,400
Line of Credit Facility, Maximum Borrowing Capacity	5,000
Line of Credit Facility, Fair Value of Amount Outstanding	$ 0

Borrowings, Long-term Debt (Det

Borrowings, Long-term Debt (Detail) $ / shares in Units, AUD in Millions	12 Months Ended
	Dec. 26, 2015USD ($)$ / sharesshares	Dec. 26, 2015AUDshares	Dec. 27, 2014USD ($)$ / sharesshares	Dec. 28, 2013USD ($)
Debt Instrument [Line Items]
Long-term debt	$ 22,707,000,000		$ 13,195,000,000
Less: current portion of long-term debt	(2,602,000,000)		(1,088,000,000)
Less: debt issuance costs	(69,000,000)		(48,000,000)
Total long-term debt	20,036,000,000		12,059,000,000
Derivative, Notional Amount	26,655,000,000		27,076,000,000	$ 23,739,000,000
Outstanding principal	24,276,000,000
Temporary equity	897,000,000		912,000,000
Year Payable, 2016	1,500,000,000
Year Payable, 2017	3,000,000,000
Year Payable, 2018	0
Year Payable, 2019	181,000,000
Year Payable, 2020	1,750,000,000
Year Payable, 2021 and thereafter	17,845,000,000
Cross Currency Interest Rate Contract [Member]
Debt Instrument [Line Items]
Derivative, Notional Amount	$ 5,509,000,000		5,446,000,000	$ 4,377,000,000
2015 Senior notes due December 2045 at 4.70% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 14, 2045
Stated Interest Rate	4.70%	4.70%
Long-term debt	$ 908,000,000		0
Debt Instrument, Face Amount	915,000,000
2015 AUD-denominated Senior notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount | AUD		AUD 800
2015 AUD-denominated Senior notes [Member] | Cross Currency Interest Rate Contract [Member]
Debt Instrument [Line Items]
Derivative, Notional Amount	$ 577,000,000
2015 AUD-denominated Senior notes due December 2019 at 3.25% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 1, 2019
Stated Interest Rate	3.25%	3.25%
Long-term debt	$ 181,000,000		0
2015 AUD-denominated Senior notes due December 2022 at 4.00% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 1, 2022
Stated Interest Rate	4.00%	4.00%
Long-term debt	$ 397,000,000		0
2015 Senior notes due August 2045 at 4.90% [Member]
Debt Instrument [Line Items]
Maturity Date	Aug. 11, 2045
Stated Interest Rate	4.90%	4.90%
Long-term debt	$ 1,009,000,000		0
Debt Instrument, Face Amount	1,000,000,000
July 2015 Senior notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 7,000,000,000
2015 Senior notes due July 2020 at 2.45% [Member]
Debt Instrument [Line Items]
Maturity Date	Jul. 29, 2020
Stated Interest Rate	2.45%	2.45%
Long-term debt	$ 1,748,000,000		0
2015 Senior notes due July 2022 at 3.10% [Member]
Debt Instrument [Line Items]
Maturity Date	Jul. 29, 2022
Stated Interest Rate	3.10%	3.10%
Long-term debt	$ 996,000,000		0
2015 Senior notes due July 2025 at 3.70% [Member]
Debt Instrument [Line Items]
Maturity Date	Jul. 29, 2025
Stated Interest Rate	3.70%	3.70%
Long-term debt	$ 2,247,000,000		0
2015 Senior notes due July 2045 at 4.90% [Member]
Debt Instrument [Line Items]
Maturity Date	Jul. 29, 2045
Stated Interest Rate	4.90%	4.90%
Long-term debt	$ 1,998,000,000		0
2012 Senior notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 6,200,000,000
2012 Senior notes due December 2017 at 1.35% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 15, 2017
Stated Interest Rate	1.35%	1.35%
Long-term debt	$ 2,999,000,000		2,998,000,000
2012 Senior notes due December 2022 at 2.70% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 15, 2022
Stated Interest Rate	2.70%	2.70%
Long-term debt	$ 1,492,000,000		1,495,000,000
2012 Senior notes due December 2032 at 4.00% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 15, 2032
Stated Interest Rate	4.00%	4.00%
Long-term debt	$ 744,000,000		744,000,000
2012 Senior notes due December 2042 at 4.25% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 15, 2042
Stated Interest Rate	4.25%	4.25%
Long-term debt	$ 924,000,000		924,000,000
2011 Senior notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 5,000,000,000
2011 Senior notes due October 2016 at 1.95% [Member]
Debt Instrument [Line Items]
Maturity Date	Oct. 1, 2016
Stated Interest Rate	1.95%	1.95%
Long-term debt	$ 1,499,000,000		1,499,000,000
2011 Senior notes due October 2021 at 3.30% [Member]
Debt Instrument [Line Items]
Maturity Date	Oct. 1, 2021
Stated Interest Rate	3.30%	3.30%
Long-term debt	$ 1,997,000,000		1,997,000,000
2011 Senior notes due October 2041 at 4.80% [Member]
Debt Instrument [Line Items]
Maturity Date	Oct. 1, 2041
Stated Interest Rate	4.80%	4.80%
Long-term debt	$ 1,490,000,000		1,490,000,000
2009 Junior Subordinated Convertible Debentures Due August 2039 At 3.25% [Member]
Debt Instrument [Line Items]
Maturity Date	Aug. 1, 2039
Stated Interest Rate	3.25%	3.25%
Long-term debt	$ 1,103,000,000		1,088,000,000
Less: current portion of long-term debt	(1,103,000,000)		(1,088,000,000)
Debt Instrument, Face Amount	$ 2,000,000,000
Annual effective interest rate	7.20%	7.20%
Trading Days Period Prior To Semi Annual Interest Period, Contingent Interest	10 days
Principal Amount Per Debenture Used In Conversion Rate	$ 1,000
Debenture Interest Period Length, Contingent Interest	6 months
Average Lowerbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	$ 650
Average Upperbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	$ 1,500
Minimum Percentage Of Contingent Interest That Could Accrue Per Year	0.25%
Maximum Percentage Of Contingent Interest That Could Accrue Per Year	0.50%
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 13,000,000		8,000,000
Company Stock As Percentage Of Conversion Price, Surrender For Conversion	130.00%
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Surrender for Conversion	20 days
Trading Day Period Ending On Last Day Of Preceeding Fiscal Quarter, Surrender for Conversion	30 days
Company Stock As Percentage Of Conversion Price, Redemption Of Principal	150.00%
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 130% Of Conversion Price, Redemption Of Principal	20 days
Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal	30 days
Outstanding principal	$ 2,000,000,000		2,000,000,000
Equity component carrying amount	613,000,000		613,000,000
Debt Instrument, Unamortized Discount	$ 897,000,000		$ 912,000,000
Conversion rate (shares of common stock per $1,000 principal amount of debentures) | shares	46.58	46.58	46.06
Effective conversion price (per share of common stock) | $ / shares	$ 21.47		$ 21.71
Debt Instrument, Convertible, Remaining Discount Amortization Period (in years)	24 years
Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share | $ / shares	$ 0.14
2005 Junior Subordinated Convertible Debentures Due December 2035 At 2.95% [Member]
Debt Instrument [Line Items]
Maturity Date	Dec. 15, 2035
Stated Interest Rate	2.95%	2.95%
Long-term debt	$ 975,000,000		$ 960,000,000
Debt Instrument, Face Amount	$ 1,600,000,000
Annual effective interest rate	6.45%	6.45%
Trading Days Period Prior To Semi Annual Interest Period, Contingent Interest	10 days
Principal Amount Per Debenture Used In Conversion Rate	$ 1,000
Debenture Interest Period Length, Contingent Interest	6 months
Average Lowerbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	$ 800
Average Upperbound Trading Price Per Debenture Prior To Semi Annual Interest Period, Contingent Interest	$ 1,300
Minimum Percentage Of Contingent Interest That Could Accrue Per Year	0.25%
Maximum Percentage Of Contingent Interest That Could Accrue Per Year	0.40%
Embedded Derivative, Fair Value of Embedded Derivative Liability	$ 4,000,000		4,000,000
Company Stock As Percentage Of Conversion Price, Redemption Of Principal	130.00%
Trading Day Period Prior To Notice of Redemption Date, Redemption Of Principal	30 days
Trading Days During 30 Day Period In Which Company Stock Has Been At Least 150% Of Conversion Price, Redemption Of Principal	20 days
Outstanding principal	$ 1,600,000,000		1,600,000,000
Equity component carrying amount	466,000,000		466,000,000
Debt Instrument, Unamortized Discount	$ 625,000,000		$ 640,000,000
Conversion rate (shares of common stock per $1,000 principal amount of debentures) | shares	35.82	35.82	34.95
Effective conversion price (per share of common stock) | $ / shares	$ 27.92		$ 28.61
Debt Instrument, Convertible, Remaining Discount Amortization Period (in years)	20 years
Conversion Rate Adjustments, Quarterly Dividend Distributions Excess Per Share | $ / shares	$ 0.10
2015 Senior notes [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 9,500,000,000

Retirement Benefit Plans (Detai

Retirement Benefit Plans (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Apr. 02, 2016	Dec. 31, 2016	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Retirement Contribution Plans, Textual Detail [Abstract]
Defined Contribution Plan, Cost Recognized			$ 337	$ 286	$ 298
Defined Benefit Plan, Funded Status Percentage [Abstract]
Defined Benefit Plan, Funded Status Of Plan (percent)			55.00%
U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation			$ 990	892	1,137
Service cost			18	88
Interest cost			33	49
Actuarial (gain) loss			126	760
Currency exchange rate changes in projected benefit obligation			0	0
Plan curtailments			0	(1,083)
Other changes in projected benefit obligation			(79)	(59)
Fair value of plan assets			627	623	$ 649
Actual return on plan assets			(4)	30
Employer contributions			90	0
Currency exchange rate changes			0	0
Other changes in plan assets			(82)	(56)
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets			0	0
Other long-term liabilities			(363)	(269)
Accumulated other comprehensive loss (income), before tax			158	1
Net amount recognized			(205)	(268)
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)			0	0
Net actuarial gain (loss)			(158)	(1)
Accumulated Benefit Obligations [Abstract]
Defined Benefit Plan, Accumulated Benefit Obligation			899	808
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets [Abstract]
Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations			899	808
Plans with accumulated benefit obligations in excess of plan assets: Plan assets			627	623
Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations			990	892
Plans with projected benefit obligations in excess of plan assets: Plan assets			$ 627	$ 623
Defined Benefit Plan, Funded Status Percentage [Abstract]
Defined Benefit Plan, Funded Status Of Plan (percent)			63.00%
Defined Benefit Plan, Component Of Worldwide Pension And Postretirement Benefit Obligation (percent)			27.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate			4.00%	3.80%
Rate of compensation increase			3.70%	3.80%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate			3.80%	4.60%	3.90%
Expected long-term rate of return on plan assets			6.10%	5.40%	4.50%
Rate of compensation increase			3.80%	3.80%	4.10%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost			$ 26	$ 36	$ 230
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2016			57
Estimated Benefit Payments, 2017			61
Estimated Benefit Payments, 2018			69
Estimated Benefit Payments, 2019			70
Estimated Benefit Payments, 2020			70
Estimated Benefit Payments, 2021-2025			362
U.S. Pension Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets		5.60%
Defined Benefit Plan, Estimated Future Employer Contributions [Abstract]
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year		$ 10
U.S. Pension Benefits [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			$ 368	347
Defined Benefit Plan, Target Plan Asset Allocations (percent)			55.00%
U.S. Pension Benefits [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			$ 255	254
Defined Benefit Plan, Target Plan Asset Allocations (percent)			45.00%
U.S. Pension Benefits [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			$ 4	20
U.S. Pension Benefits [Member] | Total assets measured at fair value [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			627	621
U.S. Pension Benefits [Member] | Cash [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			0	2
U.S. Pension Benefits [Member] | Level 1 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			74
U.S. Pension Benefits [Member] | Level 1 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			54
U.S. Pension Benefits [Member] | Level 1 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			16
U.S. Pension Benefits [Member] | Level 1 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			4
U.S. Pension Benefits [Member] | Level 2 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			515
U.S. Pension Benefits [Member] | Level 2 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			314
U.S. Pension Benefits [Member] | Level 2 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			201
U.S. Pension Benefits [Member] | Level 2 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			0
U.S. Pension Benefits [Member] | Level 3 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			38
U.S. Pension Benefits [Member] | Level 3 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			0
U.S. Pension Benefits [Member] | Level 3 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			38
U.S. Pension Benefits [Member] | Level 3 [Member] | Other Investments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			0
Non-U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation			2,140	2,423	1,695
Service cost			128	104
Interest cost			63	66
Actuarial (gain) loss			(250)	767
Currency exchange rate changes in projected benefit obligation			(190)	(254)
Plan curtailments			0	0
Other changes in projected benefit obligation			(34)	45
Fair value of plan assets			1,011	1,017	$ 1,005
Actual return on plan assets			42	80
Employer contributions			72	73
Currency exchange rate changes			(66)	(114)
Other changes in plan assets			$ (54)	$ (27)
Defined Benefit Plan, Percentage Of Plan Assets Invested In Qualified Insurance Companies			33.00%	35.00%
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets			$ 15	$ 14
Other long-term liabilities			(1,144)	(1,420)
Accumulated other comprehensive loss (income), before tax			908	1,217
Net amount recognized			(221)	(189)
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)			(12)	(13)
Net actuarial gain (loss)			(896)	(1,204)
Accumulated Benefit Obligations [Abstract]
Defined Benefit Plan, Accumulated Benefit Obligation			1,600	1,700
Defined Benefit Plan, Plans with Benefit Obligations in Excess of Plan Assets [Abstract]
Plans with accumulated benefit obligations in excess of plan assets: Accumulated benefit obligations			1,239	1,344
Plans with accumulated benefit obligations in excess of plan assets: Plan assets			645	616
Plans with projected benefit obligations in excess of plan assets: Projected benefit obligations			2,079	2,361
Plans with projected benefit obligations in excess of plan assets: Plan assets			$ 934	$ 941
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate			3.10%	2.70%
Rate of compensation increase			3.80%	4.00%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate			2.80%	4.00%	4.20%
Expected long-term rate of return on plan assets			5.70%	5.70%	5.20%
Rate of compensation increase			4.00%	4.10%	4.30%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost			$ 198	$ 165	$ 116
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2016			26
Estimated Benefit Payments, 2017			28
Estimated Benefit Payments, 2018			31
Estimated Benefit Payments, 2019			34
Estimated Benefit Payments, 2020			37
Estimated Benefit Payments, 2021-2025			251
Non-U.S. Pension Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets		5.30%
Defined Benefit Plan, Estimated Future Employer Contributions [Abstract]
Defined Benefit Plan, Estimated Future Employer Contributions in Next Fiscal Year		$ 58
Non-U.S. Pension Benefits [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			345	521
Non-U.S. Pension Benefits [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			644	476
Non-U.S. Pension Benefits [Member] | Total assets measured at fair value [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			989	997
Non-U.S. Pension Benefits [Member] | Cash [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			$ 22	20
Non-U.S. Pension Benefits [Member] | Plan Assets That We Have Control Over - Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Defined Benefit Plan, Target Plan Asset Allocations (percent)			50.00%
Non-U.S. Pension Benefits [Member] | Plan Assets That We Have Control Over - Fixed Income Instruments [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Defined Benefit Plan, Target Plan Asset Allocations (percent)			50.00%
Non-U.S. Pension Benefits [Member] | Level 1 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			$ 274
Non-U.S. Pension Benefits [Member] | Level 1 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			274
Non-U.S. Pension Benefits [Member] | Level 1 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			0
Non-U.S. Pension Benefits [Member] | Level 2 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			666
Non-U.S. Pension Benefits [Member] | Level 2 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			56
Non-U.S. Pension Benefits [Member] | Level 2 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			610
Non-U.S. Pension Benefits [Member] | Level 3 [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			49
Non-U.S. Pension Benefits [Member] | Level 3 [Member] | Equity Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			15
Non-U.S. Pension Benefits [Member] | Level 3 [Member] | Fixed Income Securities [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Fair value of plan assets			34
U.S. Postretirement Medical Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Projected benefit obligation			560	546	509
Service cost			30	26
Interest cost			21	23
Actuarial (gain) loss			(21)	10
Currency exchange rate changes in projected benefit obligation			0	0
Plan curtailments			0	0
Other changes in projected benefit obligation			(16)	(22)
Fair value of plan assets			410	427	$ 395
Actual return on plan assets			6	33
Employer contributions			1	0
Currency exchange rate changes			0	0
Other changes in plan assets			(24)	(1)
Defined Benefit Plan, Amounts Recognized in Balance Sheet [Abstract]
Other long-term assets			0	0
Other long-term liabilities			(150)	(119)
Accumulated other comprehensive loss (income), before tax			39	33
Net amount recognized			(111)	(86)
Defined Benefit Plan, Amounts Recognized in Other Comprehensive Income (Loss) [Abstract]
Net prior service credit (cost)			(43)	(48)
Net actuarial gain (loss)			$ 4	$ 15
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Benefit Obligation [Abstract]
Discount rate			4.10%	4.10%
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Discount rate			3.90%	4.60%	4.20%
Expected long-term rate of return on plan assets			7.40%	7.40%	7.70%
Defined Benefit Plan, Net Periodic Benefit Cost [Abstract]
Defined Benefit Plan, Net Periodic Benefit Cost			$ 26	$ 17	$ 77
Defined Benefit Plan, Expected Future Benefit Payments, Fiscal Year Maturity [Abstract]
Estimated Benefit Payments, 2016			19
Estimated Benefit Payments, 2017			21
Estimated Benefit Payments, 2018			24
Estimated Benefit Payments, 2019			27
Estimated Benefit Payments, 2020			31
Estimated Benefit Payments, 2021-2025			214
U.S. Postretirement Medical Benefits [Member] | Scenario, Forecast [Member]
Defined Benefit Plan, Weighted Average Assumptions Used in Calculating Net Periodic Benefit Cost [Abstract]
Expected long-term rate of return on plan assets		7.00%
Employees At Or Above A Specific Grade Level And Generally All Highly Compensated Employees [Member] | U.S. Pension Benefits [Member]
Projected Benefit Obligation and Plan Assets [Abstract]
Plan curtailments			$ (1,100)
Qualified U.S. Retirement Contribution Plans [Member] | Subsequent Event [Member]
Retirement Contribution Plans, Textual Detail [Abstract]
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 318

Commitments (Detail)

Commitments (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Operating Leases, Rent Expense, Net [Abstract]
Operating Leases, Rent Expense	$ 253	$ 257	$ 270
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Minimum rental commitments payable, 2016	234
Minimum rental commitments payable, 2017	209
Minimum rental commitments payable, 2018	167
Minimum rental commitments payable, 2019	144
Minimum rental commitments payable, 2020	120
Minimum rental commitments payable, 2021 and thereafter	326
Minimum rental commitments payable, Total	1,200
Capital Addition Purchase Commitments [Member]
Unrecorded Unconditional Purchase Obligation [Abstract]
Unrecorded Unconditional Purchase Obligation	5,700	3,500
Other Purchase Obligations And Commitments [Member]
Unrecorded Unconditional Purchase Obligation [Abstract]
Unrecorded Unconditional Purchase Obligation	$ 4,000	$ 2,500

Commitments, Long Term Purchase

Commitments, Long Term Purchase Obligation (Detail) - 12 months ended Dec. 26, 2015 - ASML Holding N.V. [Member] - Research and Development Arrangement [Member] € in Millions, $ in Millions	EUR (€)	USD ($)	EUR (€)
Long-term Purchase Commitment [Line Items]
Long-term Purchase Commitment, Amount	€ 829
Purchase Commitment, Remaining Minimum Amount Committed		$ 403	€ 367

Employee Equity Incentive Pla79

Employee Equity Incentive Plans (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	1 Months Ended	12 Months Ended			36 Months Ended
	May. 31, 2015	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013	Dec. 26, 2015	Dec. 24, 2015	Dec. 29, 2012
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Market-Based Restricted Stock Units Performance Period (In Years)		3 years
Share-based Compensation		$ 1,305	$ 1,148	$ 1,118
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense		533	555	385
Closing Price of Intel Common Stock						$ 34.98
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value		42	68	186
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value		$ 284	$ 611	$ 265
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Date		Apr. 1, 2021
Participation Percentage in Stock Purchase Plan		77.00%	76.00%	76.00%	77.00%
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, ending balance		54.2			54.2
Number Of RSUs expected to vest		102.5			102.5
Stock Options Vested And Expected To Vest [Abstract]
Number of options expected to vest		9.6			9.6
Total number of options vested and expected to vest		53.4			53.4
Weighted-average exercise price for expected to vest options (in dollars per share)		$ 24.07			$ 24.07
Weighted-average exercise price for vested and expected to vest options (in dollars per share)		$ 21.61			$ 21.61
Weighted-average remaining contractual term for vested options (in years)		1 year 10 months
Weighted-average remaining contractual term for expected to vest options (in years)		4 years 1 month
Weighted-average remaining contractual term for vested and expected to vest options (in years)		2 years 2 months
Aggregate intrinsic value for vested options		$ 609			$ 609
Aggregate intrinsic value for expected to vest options		104			104
Total Aggregate intrinsic value for vested and expected to vest options		$ 713			$ 713
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options outstanding, beginning balance		77.3	153	202.8
Number of options granted		0	0.6	20.1
Number of options exercised		(21.9)	(63.7)	(65)
Number of options cancelled and forfeited		(1.1)	(2.7)	(3)
Number of options expired		(0.1)	(9.9)	(1.9)
Number of options outstanding, ending balance		54.2	77.3	153	54.2
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Weighted-average exercise price of stock options (in dollars per share)		$ 21.65	$ 21.30	$ 21.10	$ 21.65		$ 20.20
Weighted-average exercise price for stock option grants during the year (in dollars per share)		0	25.34	22.99
Weighted-average exercise price for stock option exercises during the year (in dollars per share)		20.34	19.87	18.76
Weighted-average exercise price for stock option cancellations and forfeitures during the year (in dollars per share)		23.23	23.70	22.58
Weighted-average exercise price for stock option expirations during the year (in dollars per share)		$ 20.87	$ 27	$ 22.56
Number of options exercisable		43.8	54.7	111.5	43.8
Weighted-average exercise price for options exercisable (in dollars per share)		$ 21.07	$ 20.29	$ 20.25	$ 21.07
Range Of Exercise Prices And Options Outstanding [Abstract]
Weighted-average remaining Contractual Life (in years), Total		2 years 2 months
Minimum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Exercise Price Of Options Exercised (In Dollars Per Share)					1.12
Maximum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Exercise Price Of Options Exercised (In Dollars Per Share)					$ 27.42
Market Based Restricted Stock Units [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		3 years 1 month
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, ending balance		4.7			4.7
Market Based Restricted Stock Units [Member] | Minimum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Vesting range (percent)		0.00%			0.00%
Market Based Restricted Stock Units [Member] | Maximum [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Vesting range (percent)		200.00%			200.00%
Restricted Stock Units (RSUs) [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Service Period		4 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 1,800			$ 1,800
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		1 year 2 months
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units [Roll Forward]
Number of RSUs outstanding, beginning balance		119.4	113.3	109.3
Number of RSUs granted		42.4	57.2	53.4
Number of RSUs vested		(46.6)	(42.5)	(44.5)
Number of RSUs forfeited		(7.8)	(8.6)	(4.9)
Number of RSUs outstanding, ending balance		107.4	119.4	113.3	107.4
Share-based Compensation Arrangements By Share-based Payment Award, Restricted Stock Units, Weighted Average Exercise Price [Roll Forward]
Weighted-average grant date fair value of RSU balance (in dollars per share)		$ 26.93	$ 23.89	$ 22.47	$ 26.93		$ 22.03
Weighted-average grant date fair value of granted RSUs (in dollars per share)		31.63	25.40	21.45
Weighted-average grant date fair value of vested RSUs (in dollars per share)		23.61	22.33	20.21
Weighted-average grant date fair value of forfeited RSUs (in dollars per share)		25.76	$ 22.94	$ 22.06
Weighted-average grant date fair value of RSUs expected to vest (in dollars per share)		$ 26.93			$ 26.93
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Risk-free interest rate		0.60%	0.50%	0.20%
Dividend yield		2.90%	3.30%	3.80%
Volatility (percent)		27.00%	23.00%	25.00%
Stock Option Awards [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		7 years
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 13			$ 13
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		8 months
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Estimated values (in dollars per share)			$ 3.61	$ 3.11
Expected life (in years)			5 years 1 month 17 days	5 years 2 months 12 days
Risk-free interest rate			1.70%	0.80%
Dividend yield			3.60%	3.90%
Volatility (percent)			23.00%	25.00%
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Number of options granted		0
2006 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized	34
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		753			753
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		258.4			258.4
2006 Stock Purchase Plan [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		373			373
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant		181.3			181.3
Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent		85.00%
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 14			$ 14
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		2 months
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period		15.8	19.4	20.5
Employee Purchases, Amount		$ 421	$ 393	$ 369
Restricted Stock Units, Stock Options, And Stock Purchase Plan Estimated Values And Weighted Average Assumptions [Abstract]
Estimated values (in dollars per share)		$ 6.56	$ 5.87	$ 4.52
Expected life (in years)		6 months	6 months	6 months
Risk-free interest rate		0.10%	0.10%	0.10%
Dividend yield		3.10%	3.20%	4.00%
Volatility (percent)		25.00%	22.00%	22.00%
Restricted Stock or Stock Units, 2006 Plan [Member] | Restricted Stock Units (RSUs) [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Total Fair Value		$ 1,500	$ 1,100	$ 1,000
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Intrinsic Value Amount		1,100	949	899
Share-based Compensation [Member]
Employee Equity Incentive Plans, (Textual) (Details) [Abstract]
Other Inventory, Capitalized Costs, Gross		$ 49	$ 39	$ 38	$ 49
$1.82-$15.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options		0.4			0.4
Weighted-average remaining Contractual Life (in years)		2 years 11 months
Weighted-average exercise price for outstanding options (in dollars per share)		$ 11.70			$ 11.70
Number of exercisable options		0.4			0.4
Weighted-average exercise price for exercisable options (in dollars per share)		$ 11.70			$ 11.70
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)		1.82
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)		$ 15
$15.01-$20.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options		21.7			21.7
Weighted-average remaining Contractual Life (in years)		10 months
Weighted-average exercise price for outstanding options (in dollars per share)		$ 18.48			$ 18.48
Number of exercisable options		21.7			21.7
Weighted-average exercise price for exercisable options (in dollars per share)		$ 18.48			$ 18.48
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)		15.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)		$ 20
$20.01-$25.00 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options		24.7			24.7
Weighted-average remaining Contractual Life (in years)		3 years 1 month
Weighted-average exercise price for outstanding options (in dollars per share)		$ 22.92			$ 22.92
Number of exercisable options		16.9			16.9
Weighted-average exercise price for exercisable options (in dollars per share)		$ 22.86			$ 22.86
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)		20.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)		$ 25
$25.01-$27.42 [Member]
Range Of Exercise Prices And Options Outstanding [Abstract]
Number of outstanding options		7.4			7.4
Weighted-average remaining Contractual Life (in years)		3 years 4 months
Weighted-average exercise price for outstanding options (in dollars per share)		$ 27.15			$ 27.15
Number of exercisable options		4.8			4.8
Weighted-average exercise price for exercisable options (in dollars per share)		$ 27.23			$ 27.23
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Lower Range Limit (in dollars per share)		25.01
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Upper Range Limit (in dollars per share)		$ 27.42

Common Stock Repurchases (Detai

Common Stock Repurchases (Detail) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Common Stock Repurchases [Line Items]
Stock Repurchased During Period, Value	$ 3,001	$ 10,792	$ 2,147
Common Stock Repurchase Program [Member]
Common Stock Repurchases [Line Items]
Stock Repurchase Program, Authorized Amount	65,000
Stock Repurchase Program, Remaining Authorized Repurchase Amount	$ 9,400
Stock Repurchased and Retired During Period, Shares	95.7		94.1
Stock Repurchased and Retired During Period, Value	$ 3,000		$ 2,100
Stock Repurchased During Period, Shares		332.4
Stock Repurchased During Period, Value		$ 10,800
Accumulated Stock Repurchased During Program, Total Shares	4,800
Accumulated Stock Repurchased During Program, Total Value	$ 104,900
Restricted Stock Unit Withholdings [Member]
Common Stock Repurchases [Line Items]
Stock Repurchased and Retired During Period, Shares	13.5	12	13.1
Stock Repurchased and Retired During Period, Value	$ 442	$ 332	$ 293

Gains (Losses) on Equity Inve81

Gains (Losses) on Equity Investments, Net (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule Of Investment Type [Line Items]
Share of equity method investee losses, net	$ (95)	$ (69)	$ (69)
Impairments	(185)	(146)	(123)
Other, net	398	147	102
Total gains (losses) on equity investments, net	315	411	471
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds	2,200	1,700	1,300
Available-for-sale Securities, Gross Realized Gains	133	136	146
Clearwire Corporation [Member] | Marketable equity securities
Schedule Of Investment Type [Line Items]
Available-for-sale Securities, Gross Realized Gains (Losses), Sale Proceeds			142
Available-for-sale Securities, Gross Realized Gains			111
Clearwire, LLC [Member] | Equity Method Investments [Member]
Schedule Of Investment Type [Line Items]
Proceeds from Sale, Maturity and Collection of Investments			328
Equity Method Investment, Realized Gain (Loss) on Disposal			328
Interest In Clearwire, LLC And Shares In Clearwire Corporation [Member]
Schedule Of Investment Type [Line Items]
Gain (Loss) On Sale Of Combined Investment			439
Equity Investments [Member]
Schedule Of Investment Type [Line Items]
Gains on sales, net	145	422	515
Investment Income, Dividend	$ 52	$ 57	$ 46

Interest and Other, Net (Detail

Interest and Other, Net (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Interest and Other, Net [Line Items]
Interest income	$ 124	$ 141	$ 104
Interest expense	(337)	(192)	(244)
Other, net	108	94	(11)
Total interest and other, net	(105)	43	(151)
Interest Costs, Capitalized During Period	258	$ 276	$ 246
2015 Senior notes [Member]
Interest and Other, Net [Line Items]
Debt Instrument, Face Amount	$ 9,500

Earnings Per Share (Detail)

Earnings Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Earnings Per Share [Abstract]
Net income available to common stockholders	$ 11,420	$ 11,704	$ 9,620
Weighted average shares of common stock outstanding-basic	4,742	4,901	4,970
Dilutive effect of employee equity incentive plans (shares)	64	75	68
Dilutive effect of convertible debt (shares)	88	80	59
Weighted average shares of common stock outstanding-diluted	4,894	5,056	5,097
Basic earnings per share of common stock	$ 2.41	$ 2.39	$ 1.94
Diluted earnings per share of common stock	$ 2.33	$ 2.31	$ 1.89
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (shares)	2	10	55

Income Taxes (Detail)

Income Taxes (Detail) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Income Before Taxes and Provision for Taxes [Abstract]
Income before taxes: U.S.	$ 8,800	$ 11,565	$ 9,374
Income before taxes: Non-U.S.	5,412	4,236	3,237
Income before taxes	14,212	15,801	12,611
Provision for taxes, Current: Federal	2,828	3,374	2,730
Provision for taxes, Current: State	40	38	68
Provision for taxes, Current: Non-U.S.	842	969	716
Total current provision for taxes	3,710	4,381	3,514
Provision for taxes, Deferred: Federal	(862)	(263)	(412)
Provisions For Taxes, Deferred: Other	(56)	(21)	(111)
Total deferred provision for taxes	(918)	(284)	(523)
Total Provision for taxes	$ 2,792	$ 4,097	$ 2,991
Effective tax rate	19.60%	25.90%	23.70%
Effective Income Tax Rate, Continuing Operations, Tax Rate Reconciliation [Abstract]
Statutory federal income tax rate	35.00%	35.00%	35.00%
Increase (reduction) in rate resulting from: Non-U.S. income taxed at different rates	(7.90%)	(6.10%)	(5.80%)
Effective Income Tax Rate Reconciliation, Tax Settlement, Percent	(2.90%)	0.00%	0.00%
Increase (reduction) in rate resulting from: Domestic manufacturing deduction benefit	(2.00%)	(2.10%)	(2.10%)
Increase (reduction) in rate resulting from: Research and Development tax credits	(1.70%)	(1.70%)	(3.50%)
Increase (reduction) in rate resulting from: Other	(0.90%)	0.80%	0.10%
Taxes, Other Textual Details [Abstract]
Income tax holiday termination date, end of range	Dec. 31, 2023
Income Tax Holiday, Aggregate Dollar Amount	$ 85	$ 166	$ 213
Income Tax Holiday, Income Tax Benefits Per Share, Diluted	$ 0.02	$ 0.03	$ 0.04
Income tax benefits (deficiencies) attributable to equity-based compensation transactions allocated to stockholders' equity	$ 172	$ 103	$ 3
Income Taxes Receivable, Current	468	79
Accrued Income Taxes, Current	272	443
Long-term income taxes payable	114	262
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Accrued compensation and other benefits	931	982
Deferred tax assets, Share-based compensation	424	438
Deferred tax assets, Deferred income	694	691
Deferred tax assets, Inventory	598	339
Deferred tax assets, State credits and net operating losses	613	519
Deferred tax assets, Other, net	760	715
Gross deferred tax assets	4,020	3,684
Deferred tax assets, Valuation allowance	(701)	(595)
Total deferred tax assets	3,319	3,089
Deferred tax liabilities, Property, plant and equipment	(505)	(1,171)
Deferred tax liabilities, Licenses and intangibles	(563)	(576)
Deferred tax liabilities, Convertible debt	(1,042)	(977)
Deferred Tax Liabilities, Unrealized Gains On Investments And Derivatives	(717)	(1,017)
Deferred tax liabilities, Investments in non-U.S. subsidiaries	(37)	(252)
Deferred tax liabilities, Other, net	(358)	(291)
Total deferred tax liabilities	(3,222)	(4,284)
Net deferred tax assets (liabilities)		(1,195)
Net deferred tax assets (liabilities)	97
Current deferred tax assets	2,036	1,958
Non-current deferred tax assets	600	622
Non-current deferred tax liabilities	(2,539)	(3,775)
Valuation Allowance [Line Items]
Valuation Allowance, Amount	701	595
Deferred Tax Liability Not Recognized [Line Items]
Undistributed Earnings of Foreign Subsidiaries	26,900
Other Basis Differences For Certain Non-U.S. Subsidiaries	1,800
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, Gross, Beginning Balance	577	207	189
Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities	(452)	(220)	(2)
Unrecognized tax benefits, Increases in balances related to tax positions taken during prior periods	4	173	21
Unrecognized tax benefits, Decreases in balances related to tax positions taken during prior periods	(34)	(1)	(9)
Unrecognized tax benefits, Increases in balances related to tax positions taken during current periods	6	418	8
Unrecognized tax benefits, Gross, Ending Balance	101	577	$ 207
Unrecognized Tax Benefits that Would Impact Effective Tax Rate	32	485
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense		21
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued	34	44
TaxBenefitFromSettlementsAndRemeasurements	$ 419
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards, Expiration Dates	Dec. 31, 2035
State Credit Carry Forwards [Member]
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Valuation allowance	$ (607)
Valuation Allowance [Line Items]
Valuation Allowance, Amount	607
Matters Related To Our Non-U.S. Subsidiaries [Member]
Components of Deferred Tax Assets and Liabilities [Abstract]
Deferred tax assets, Valuation allowance		(94)
Valuation Allowance [Line Items]
Valuation Allowance, Amount		$ 94
State [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	101
Non-U.S. [Member]
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	384
Operating loss carryforwards that have a valuation allowance	$ 218
U.S. State and Non-U.S. [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Year Which Prior Years' Tax Returns Are Generally No Longer Subject To Tax Examination (date)	Dec. 31, 2002
U.S. Federal [Member]
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Year Which Prior Years' Tax Returns Are No Longer Subject To Tax Examination (date)	Dec. 31, 2009
Operating Loss Carryforwards [Line Items]
Operating Loss Carryforwards	$ 171

Other Comprehensive Income (L85

Other Comprehensive Income (Loss), Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Change in unrealized holding gain (loss) on available-for-sale investments, Before Tax	$ (999)	$ 1,029	$ 1,963
Change in unrealized holding gain (loss) on available-for-sale investments, Tax	350	(359)	(687)
Change in unrealized holding gain (loss) on available-for-sale investments, Net of Tax	(649)	670	1,276
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Before Tax	(93)	(142)	(146)
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Tax	32	49	51
Less: adjustment for (gain) loss on available-for-sale investments included in net income, Net of Tax	(61)	(93)	(95)
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Tax	(18)	(41)	(26)
Less: adjustment for (gain) loss on deferred tax asset valuation allowance included in net income, Net of Tax	(18)	(41)	(26)
Change in unrealized holding gain (loss) on derivatives, Before Tax	(298)	(589)	(166)
Change in unrealized holding gain (loss) on derivatives, Tax	93	160	76
Change in unrealized holding gain (loss) on derivatives, Net of Tax	(205)	(429)	(90)
Less: adjustment for (gain) loss on derivatives included in net income, Before Tax	522	13	30
Less: adjustment for (gain) loss on derivatives included in net income, Tax	(160)	(11)	(29)
Less: adjustment for (gain) loss on derivatives included in net income, Net of Tax	362	2	1
Change in prior service costs, Before Tax	(2)	(42)	17
Change in prior service costs, Tax	1	5	(2)
Change in prior service costs, Net of Tax	(1)	(37)	15
Less: adjustment for amortization of prior service costs, Before Tax	10	6	4
Less: adjustment for amortization of prior service costs, Tax	(2)	(2)	(1)
Less: adjustment for amortization of prior service costs, Net of Tax	8	4	3
Change in actuarial valuation, Before Tax	73	(433)	725
Change in actuarial valuation, Tax	7	3	(275)
Change in actuarial valuation, Net of Tax	80	(430)	450
Less: adjustment for amortization of actuarial (gain) loss, Before Tax	67	37	101
Less: adjustment for amortization of actuarial (gain) loss, Tax	(19)	(9)	(31)
Less: adjustment for amortization of actuarial (gain) loss, Net of Tax	48	28	70
Change in net foreign currency translation adjustment, Before Tax	(187)	(275)	45
Change in net foreign currency translation adjustment, Tax	17	24	(7)
Change in net foreign currency translation adjustment, Net of Tax	(170)	(251)	38
Total other comprehensive income (loss), Before Tax	(907)	(396)	2,573
Total other comprehensive income (loss), Tax	301	(181)	(931)
Other comprehensive income (loss)	(606)	(577)	1,642
Other Comprehensive Income (Loss), Pension And Other Postretirement Benefit Plans, Increase In Actuarial Loss Arising During Period, Before Tax		(1,400)
Other Comprehensive Income (Loss), Pension And Other Postretirement Benefit Plans, Decrease In Actuarial Loss Arising During Period, Before Tax		1,000
Accumulated Other Comprehensive Income (Loss), Net of Tax	60	666	1,243
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(1,413)	(310)
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	506	(86)
Defined Benefit Plan, Amortization of Net Prior Service Cost (Credit)	7
Defined Benefit Plan, Amortization of Net Gains (Losses)	42
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months	(185)
Unrealized holding gains (losses) on available-for-sale investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	382	(310)
Other comprehensive income (loss)	(710)	577
Accumulated Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment Including Other Than Temporary Impairments, Net of Tax	1,749	2,459	1,882
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(999)	1,029
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	(93)	(142)
Deferred Tax Asset Valuation Allowance [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	(18)	(41)
Other comprehensive income (loss)	(18)	(41)
Accumulated Other Comprehensive Income Loss Net Change In Deferred Tax Asset Valuation Allowance	8	26	67
Other Comprehensive Income (Loss), before Reclassifications, before Tax	0	0
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	0	0
Unrealized holding gains (losses) on derivatives [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	(67)	149
Other comprehensive income (loss)	157	(427)
Accumulated Other Comprehensive Income (Loss), Cumulative Changes in Net Gain (Loss) from Cash Flow Hedges, Effect Net of Tax	(266)	(423)	4
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(298)	(589)
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	522	13
Prior service credits (costs) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: adjustment for amortization of prior service costs, Before Tax	(10)	(6)	(4)
Total other comprehensive income (loss), Tax	(1)	3
Other comprehensive income (loss)	7	(33)
Accumulated Other Comprehensive Income Loss Net Prior Service Cost Net Of Tax	(40)	(47)	(14)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(2)	(42)
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	10	6
Actuarial gains (losses) [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Less: adjustment for amortization of actuarial (gain) loss, Before Tax	(67)	(37)	(101)
Total other comprehensive income (loss), Tax	(12)	(6)
Other comprehensive income (loss)	128	(402)
Accumulated Other Comprehensive Income Loss Net Actuarial Gains Loss Net Of Tax	(876)	(1,004)	(602)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	73	(433)
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	67	37
Foreign Currency translation adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Total other comprehensive income (loss), Tax	17	24
Other comprehensive income (loss)	(170)	(251)
Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax	(515)	(345)	$ (94)
Other Comprehensive Income (Loss), before Reclassifications, before Tax	(187)	(275)
Amounts Reclassified Out Of Accumulated Other Comprehensive Income (Loss), before Tax	$ 0	$ 0

Other Comprehensive Income (L86

Other Comprehensive Income (Loss), Reclassification out of Accumulated Other Comprehensive Income (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Interest and other, net	$ (105)	$ 43	$ (151)
Gains (losses) on equity investments, net	315	411	471
Income before taxes	14,212	15,801	12,611
Cost of sales	(20,676)	(20,261)	(21,187)
Research and development	(12,128)	(11,537)	(10,611)
Marketing, general and administrative	(7,930)	(8,136)	(8,088)
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	10	6	4
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	67	37	101
Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	(506)	86	11
Unrealized holding gains (losses) on available-for-sale investments [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Interest and other, net	2	10	8
Gains (losses) on equity investments, net	91	132	138
Income before taxes	93	142	146
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	(522)	(13)	(30)
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Currency Forwards [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Cost of sales	(290)	(31)	(61)
Research and development	(177)	18	30
Marketing, general and administrative	(46)	2	0
Unrealized holding gains (losses) on derivatives [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member] | Other Instruments [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Interest and other, net	(9)	0	0
Cost of sales	0	(2)	1
Prior service credits (costs) [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive (Income) Loss, Amortization Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Prior Service Cost (Credit), before Tax	(10)	(6)	(4)
Actuarial gains (losses) [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI, Pension and Other Postretirement Benefit Plans, for Net Gain (Loss), before Tax	(67)	(37)	(101)
Amortization of pension and postretirement benefit components [Member] | Reclassification out of Accumulated Other Comprehensive Income [Member]
Reclassification out of Accumulated Other Comprehensive Income [Line Items]
Income before taxes	$ (77)	$ (43)	$ (105)

Contingencies (Detail)

Contingencies (Detail) $ / shares in Units, shares in Millions, $ in Millions, € in Billions	1 Months Ended					12 Months Ended
	Jan. 31, 2015USD ($)	May. 31, 2013USD ($)	Jun. 30, 2012$ / shares	May. 31, 2009USD ($)	May. 31, 2009EUR (€)	Dec. 31, 2008USD ($)shares	Aug. 19, 2010$ / shares
McAfee, Inc. [Member] | McAfee Shareholder Litigation [Member]
Loss Contingencies [Line Items]
Cash Per Share of Acquiree Common Stock and Common Stock Subject to Restricted Stock Awards, Vested Restricted Stock Unit Awards, and Vested Performance Stock Unit Awards Upon Completion of Acquisition | $ / shares							$ 48
McAfee, Inc. [Member] | McAfee Shareholder Litigation [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Loss Contingency, Plaintiffs Damages Expert Value Assertion of Share of Acquiree for Purposes of Assessing Damages | $ / shares			$ 62.08
EC Fine [Member]
Loss Contingencies [Line Items]
Loss Contingency, Fine				$ 1,400	€ 1.1
Lehman Matter [Member]
Loss Contingencies [Line Items]
Loss Contingency, Pre-Payment Amount For Forward-Purchase Agreement						$ 1,000
Loss Contingency, Cash Collateral Received For Forward-Purchase Agreement						$ 1,000
Loss Contingency, Shares Of Intel Common Stock Required To Be Delivered Under Forward-Purchase Agreement | shares						50
Loss Contingency, Cash Collateral Foreclosed On In Forward-Purchase Agreement						$ 1,000
Lehman Matter [Member] | Settled Litigation [Member]
Loss Contingencies [Line Items]
Loss Contingency, Damages Sought, Value	$ 129	$ 312
Lehman Matter [Member] | Settled Litigation [Member] | London Interbank Offered Rate (LIBOR) [Member]
Loss Contingencies [Line Items]
Loss Contingency, Basis Spread On Variable Rate For Damages Sought		13.50%

Operating Segments and Geogra88

Operating Segments and Geographic Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule Of Segment Reporting Information [Abstract]
Net revenue	$ 55,355	$ 55,870	$ 52,708
Operating income (loss)	14,002	15,347	12,291
Client Computing Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	32,219	34,872	34,645
Operating income (loss)	8,165	10,323	8,708
Client Computing Group [Member] | Platform [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	30,654	33,210	32,385
Client Computing Group [Member] | Other Product Or Service [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	1,565	1,662	2,260
Data Center Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	15,977	14,387	12,163
Operating income (loss)	7,844	7,390	5,456
Data Center Group [Member] | Platform [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	14,882	13,366	11,219
Data Center Group [Member] | Other Product Or Service [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	1,095	1,021	944
Internet of Things Group [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,298	2,142	1,801
Operating income (loss)	515	583	532
Internet of Things Group [Member] | Platform [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	1,976	1,814	1,485
Internet of Things Group [Member] | Other Product Or Service [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	322	328	316
Software and services operating segments [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,167	2,216	2,188
Operating income (loss)	210	81	57
All other [Member]
Schedule Of Segment Reporting Information [Abstract]
Net revenue	2,694	2,253	1,911
Operating income (loss)	$ (2,732)	$ (3,030)	$ (2,462)

Operating Segments and Geogra89

Operating Segments and Geographic Information, Revenue by Major Customers (Detail) - Customer Concentration Risk [Member] - Sales Revenue, Net [Member]	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	46.00%	46.00%	44.00%
Hewlett-Packard Company [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	18.00%	18.00%	17.00%
Dell Inc. [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	15.00%	16.00%	15.00%
Lenovo Group Limited [Member]
Revenue, Major Customer [Line Items]
Entity-Wide Revenue, Major Customer, Percentage	13.00%	12.00%	12.00%

Operating Segments and Geogra90

Operating Segments and Geographic Information, Revenues from External Customers by Country (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	$ 55,355	$ 55,870	$ 52,708
China (Including Hong Kong) [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,679	11,197	9,890
Singapore [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,544	11,573	10,997
United States [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	11,121	9,828	9,091
Taiwan [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	10,661	8,955	8,888
Other countries [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	10,350	14,317	13,842
Outside the U.S. [Member]
Schedule of Revenues from External Customers, By Country [Line Items]
Net revenue	$ 44,200	$ 46,000	$ 43,600

Operating Segments and Geogra91

Operating Segments and Geographic Information, Long-Lived Assets (Detail) - USD ($) $ in Millions	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 31,858	$ 33,238	$ 31,428
United States [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	22,611	24,020	23,624
Ireland [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	5,789	5,433	2,986
Israel [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,661	1,957	2,667
Other countries [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,797	1,828	2,151
Outside the U.S. [Member]
Schedule Of Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 9,200	$ 9,200	$ 7,800

Valuation and Qualifying Acco92

Valuation and Qualifying Accounts (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 26, 2015	Dec. 27, 2014	Dec. 28, 2013
Allowance for doubtful receivables [Member]
Valuation Allowances And Reserves, Disclosure [Roll Forward]
Valuation Allowances And Reserves, Beginning Balance	$ 38	$ 38	$ 38
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	12	10	5
Valuation Allowances And Reserves, Net (Deductions) Recoveries	(10)	(10)	(5)
Valuation Allowances And Reserves, Ending Balance	40	38	38
Valuation allowance for deferred tax assets [Member]
Valuation Allowances And Reserves, Disclosure [Roll Forward]
Valuation Allowances And Reserves, Beginning Balance	595	456	389
Valuation Allowances And Reserves, Additions Charged to Expenses/Other Accounts	190	128	88
Valuation Allowances And Reserves, Net (Deductions) Recoveries	(84)	11	(21)
Valuation Allowances And Reserves, Ending Balance	$ 701	$ 595	$ 456